Abstract

Depression is lowered mood with changes in thought, motivation and body, classed among behavioral symptoms and emotions, ranging from low mood to clinical levels; the concept grew from melancholia. Scales overlap little and one diagnosis covers many symptom combinations; cognitive accounts were revised, not abandoned, and negative interpretation bias appears on direct but not indirect measures. Expression, prevalence and care vary with culture, ethnicity, social position, stigma and minority stress, on mostly correlational evidence; anxiety and chronic illness often accompany depression, which predicts suicidal outcomes only weakly. Cortisol and cytokine elevations hold with caveats, a simple serotonin deficit is disputed and genome-wide work ties depression to 102 variants. In adults, antidepressants beat placebo acutely at moderate to very low certainty, psychotherapy roughly matches medication, and internet-delivered CBT beats control conditions while psilocybin and app evidence is early.

Keywords: depression, depressive symptoms, cognitive model, rumination, learned helplessness

Depression, in the sense used here, is a state of lowered mood together with a cluster of symptoms that vary in number, kind and intensity from one person to the next. On this reading depression is not just a diagnosis that some people are given: everyone sits somewhere along it at any moment, and when young people drawn from the general population were examined with taxometric methods, their depression varied by degree instead of forming a distinct category (Hankin et al., 2005). Elevated symptoms are common. A meta-analysis of adolescents worldwide put the share with elevated depressive symptoms at 34% (95% CI 0.30 to 0.38), an estimate based on symptom measures rather than diagnoses, and found girls higher (Shorey et al., 2022). At the clinical end, the Global Burden of Disease Study 2010 ranked depressive disorders among the leading sources of disease burden across 187 countries, although data from developing countries were sparse (Ferrari et al., 2013).

The page first sets out what the term covers and the history of the concept, from melancholia to explicit diagnostic criteria, then how symptoms are measured and what depression is like in first-person accounts from young people and adults, before turning to the depressive disorders, the diagnostic categories, specifiers and disputed subtypes that are drawn across that range of symptoms. It then reviews the cognitive accounts (Beck's model, learned helplessness and hopelessness, rumination, and biased attention, interpretation and memory), the debate over whether depressed people judge more accurately, the behavioral and interpersonal accounts (reinforcement and activity, reassurance seeking and stress generation), the biological accounts (from serotonin, glutamate, inflammation and stress hormones to genetics, sleep, circadian rhythms and brain networks), the evolutionary accounts, and how culture and social context bear on depression, disparities between groups included. Two sections follow on comorbidity, the overlap of depression with anxiety, trauma, substance use and physical illness, and on suicide and self-harm. The treatment section covers what treatment trials show, from medication and psychotherapy, including how psychological treatments and antidepressants are thought to work, to electroconvulsive therapy, magnetic stimulation, ketamine and esketamine, together with how brain stimulation and ketamine are thought to work, and emerging treatments such as psilocybin, internet-delivered CBT and smartphone apps. Living with Depression then turns to quality of life, work, stigma and families. Table 1 lists the disorders, specifiers and subtypes, Table 2 gathers the standing of each account in one place, and a worked example shows how to read the effect sizes that recur throughout.

Key Takeaways

  • Taxometric work on young people found depression to vary by degree, not to fall into a separate category, and MeSH likewise distinguishes depression from depressive disorder by severity.
  • The concept's history runs through melancholia, a word that for centuries could mean either a disturbance of mood or a partial insanity confined to a few abnormal beliefs; by the late nineteenth century affect had become its main aspect, and explicit research criteria with high initial reliability followed in the 1970s.
  • Symptom profiles in depressed outpatients were highly varied: 3703 patients produced 1030 distinct profiles, though symptoms were scored only as present or absent. Qualitative accounts from young people, and a small interview study that found anhedonia broader than lost pleasure, describe depression in terms checklists miss.
  • Diagnostic systems mark out several categories across the same range of symptoms, among them persistent depressive disorder and premenstrual dysphoric disorder, while proposed subtypes remain contested: melancholic patients' cognitive disadvantage was moderate and absent in drug-free patients, and the evidence on atypical depression as a subtype is mixed.
  • Beck's cognitive model, learned helplessness theory and response styles theory have each been revised by later work rather than discarded; the behavioral model stands as revised, its mechanism not yet properly tested, and the interpersonal accounts are supported in part, with causation not established. Among the processing biases, reading ambiguous material negatively reached g = 0.72 across 87 studies, but the effect rested on direct measures: indirect measures gave a non-significant g = 0.04.
  • Distress may be voiced mainly through bodily or mainly through psychological symptoms depending on culture, and in a heterogeneous meta-analysis with few incidence and persistence studies, low socioeconomic status was tied more strongly to depression persisting than to its onset. Lesbian, gay and bisexual people had at least twice the 12-month depression of heterosexual people, an excess attributed to minority stress, although the stress processes were inferred rather than examined directly and the later evidence is cross-sectional; in pooled US surveys, depressed Latino, Asian American and African American adults went untreated more often than non-Latino whites.
  • Comorbidity is common: in one Dutch cohort, 67% of people with a current depressive disorder also had a current anxiety disorder, and pooled studies found diabetes doubled the odds of depression. On suicide, depression and hopelessness forecast later ideation, attempts and death only with effects weaker than anticipated, smallest for death, and broad risk-factor categories predicted suicidal thoughts and behaviours only slightly better than chance.
  • Biological findings are uneven. Depressed people had higher cortisol on average (d = 0.60, shrinking to d = 0.33 in the more rigorous studies and varying with patient group and method), whereas whether low serotonin causes depression is disputed: an umbrella review of 17 studies, most of them systematic reviews and meta-analyses, found no consistent link, a critical commentary judged that conclusion overstated, and separately the candidate gene-by-environment hypothesis found no support in very large samples.
  • In adults with major depressive disorder, all 21 antidepressants studied outperformed placebo in acute treatment, with certainty rated moderate to very low. Analyses put the average drug-placebo difference at about two Hamilton points (1.80 in FDA trial data), and whether that average is clinically meaningful is unresolved. Among newer treatments, psilocybin did not differ significantly from escitalopram on the primary outcome of one six-week trial, guided and unguided internet-delivered CBT both outperformed control conditions, and the efficacy evidence for smartphone apps is still early.
  • How psychological treatments work is less clear than whether they work: in a dismantling trial, behavioral activation alone did as well as full cognitive therapy, which does not show that changing beliefs plays no role, and a review of 35 mediator studies named showing that a mediator causes change as probably the field's biggest challenge.

What Depression Is

The National Library of Medicine's thesaurus defines depression as “depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders” (MeSH, D003863), and its indexing note adds that the heading covers both humans and animals and is distinguished from depressive disorder by degree.

The heading therefore marks out a range of states rather than a disease entity. That framing fits the taxometric evidence: when Hankin and colleagues applied Meehl's procedures to structured interview data from a population-based sample of young people, the structure of depression came out continuous, with a skewness adjustment required and both youth and parent reports in the data (Hankin et al., 2005). On this view, a clinical diagnosis draws a line across a dimension rather than detecting a separate kind.

The thesaurus also lists emotional depression as an entry term for the heading, which names low mood as a passing emotional state rather than a disorder. Nesse argued that low mood, with the pessimism and lack of motivation that accompany it, may be adaptive in unpropitious situations, while stressing that these were hypotheses awaiting specific tests (Nesse, 2000). Emotional depression in this sense overlaps with sadness, and one of its components, anhedonia, has become a research topic in its own right.

Figure 1

Depression as a Dimension and the Kinds of Evidence About It

A dimension of depressive symptoms with four kinds of evidence A horizontal bar shading from light to dark, labelled from low mood on the left to the clinical range on the right. Below it, four boxes: Measurement, Cognitive accounts, Biological accounts, Treatment trials. Low mood Clinical range Depressive symptoms vary in number, kind and severity Measurement Cognitive accounts Biological accounts Treatment trials
Note. Original schematic of the page's organisation: depression treated as a dimension of symptoms (Hankin et al., 2005) and the four kinds of evidence the sections review; it adds no claim beyond the cited sources.

History of the Concept

The modern idea of depression grew out of melancholia, a term that carried two meanings for most of its history. Hippocratic medicine (460–379 BC) stressed the affective side of melancholia, and Galen later added delusion to the picture; for centuries the word could denote either a disturbance of mood or a partial insanity confined to a few abnormal beliefs (Telles-Correia & Marques, 2015). For Pinel, melancholia remained a disorder of abnormal beliefs, not of affect, and Esquirol divided it between a depressive lypemania and an expansive monomania; on Telles-Correia and Marques's reading, affect came back to the centre of the concept, ranking above beliefs, around 1900 (Telles-Correia & Marques, 2015).

The decisive shift came in the century after 1780. Reading 12 authors from the 1780s to the 1880s, Kendler found that the earliest writers placed melancholia among disorders of the intellect, whereas those of the 1860s to 1880s, Kraepelin among them, regarded it as a primary disorder of mood (Kendler, 2020). The route was not a straight line. For delusional melancholia, the earlier causal order (intellect first, mood second) was reversed, and two texts from the 1850s already treated melancholia without delusions as a mood disorder; Kendler concluded that the nosological pathway was more complex than usually assumed, noting in what he called a historical sketch that the nosologists worked top-down from faculty psychology as well as bottom-up from clinical studies (Kendler, 2020).

Freud's Mourning and Melancholia set grief beside melancholia and contrasted the two (Freud, 1957). Desmet read the essay as a mechanism built from narcissistic identification, the difference between interpersonal and intrapersonal loss, and the interplay of conscious and unconscious dynamics, and argued that the theory must be tested as a whole mechanism rather than piece by piece (Desmet, 2013). His proposed schema, to be examined in naturalistic single case studies, is explicitly preliminary, and he noted that the clinical component of his own analysis rested mainly on unsystematic observations, and he argued that what had been tested empirically was no more than a caricature of Freud's theory (Desmet, 2013).

Twentieth-century psychiatry moved toward operational definitions. Textbooks published between 1900 and 1960 gave more weight to cognitive, physical and psychomotor features than DSM-5 criteria do, while the DSM leans more on neurovegetative symptoms and covers a narrower range of mood and cognitive content; Kendler argued that the DSM should index the disorder, not constitute it (Kendler, 2016). Feighner and colleagues set out explicit diagnostic criteria for 14 psychiatric illnesses and presented them as provisional, a system they expected to change once tested (Feighner et al., 1972); in their initial studies, diagnoses made with the Research Diagnostic Criteria then proved highly reliable (Spitzer et al., 1978). Beck's monograph on the clinical, experimental and theoretical aspects of depression opened the cognitive account (Beck, 1967). The page follows that line in the cognitive model and the parallel one in biological accounts.

A fuller narrative appears in the history section of the major depressive disorder page.

Depressive Symptoms and How They Are Measured

For a short plain-language guide to the signs of depression and when to get help, see Depression Symptoms.

The Symptoms

For diagnosis, the symptoms of depression are a fixed list. The diagnostic manual DSM-5 (American Psychiatric Association, 2013) sets nine criterion symptoms for major depressive disorder, two of them core: depressed mood and a loss of interest or pleasure (Fried & Nesse, 2015). The remaining seven are disturbed sleep, a change in appetite or weight, low energy, movement that is agitated or slowed, trouble concentrating or deciding, a sense of worthlessness or guilt, and thoughts of death or suicide (Fried & Nesse, 2015). A diagnosis applies a count: five or more of the nine, at least one of them core (Fried & Nesse, 2015). Several of the nine are compounds that can be met in opposite directions, by insomnia or hypersomnia and by agitation or slowing (Fried & Nesse, 2015), which matters for the counting described later in this section.

Self-Report Questionnaires

Depressive symptoms, the second entry term under the heading, are usually counted with self-report questionnaires. Beck and colleagues introduced one of the earliest such tools, an inventory for measuring depression (Beck et al., 1961). For community research, Radloff developed the CES-D, a self-report scale of depressive symptomatology tested in household surveys and psychiatric settings; it showed very high internal consistency, only adequate test-retest repeatability and validity supported by its links with clinical ratings and other self-report scales (Radloff, 1977). In medical settings the PHQ-9 is one such questionnaire. Its validation drew on 6,000 patients from 8 primary care and 7 obstetrics-gynecology clinics, 580 of whom were also interviewed by a mental health professional, and a score of 10 or more identified major depression with a sensitivity and a specificity of 88% each, with similar results in both clinic types (Kroenke et al., 2001).

Rating Scales, Interviews and Screening

Severity is also graded with rating scales, and these differ in who does the rating. One is Hamilton's rating scale for depression (Hamilton, 1960). The Montgomery-Åsberg scale (MADRS) was built to be sensitive to change with treatment: item selection used 106 patients and a comprehensive psychopathology scale of 65 items, from which the 17 symptoms seen most often in depressive illness were taken, and the final scale kept 10 items (Montgomery & Åsberg, 1979). Agreement between its raters was high, its scores correlated significantly with the Hamilton scale, and it separated responders from non-responders better than that scale did, which its authors took to imply that trials could use smaller samples (Montgomery & Åsberg, 1979). The Quick Inventory of Depressive Symptomatology (QIDS) has 16 items and two formats, self-report (QIDS-SR(16)) and clinician-rated (QIDS-C(16)); in 596 adult outpatients with chronic major depressive disorder, the self-report format had an internal consistency of alpha = .86 and correlated r = .86 with the Hamilton scale, HAM-D(24) (Rush et al., 2003). These are the scales behind results reported elsewhere on this page.

The reference standard for a diagnosis is an interview, and interviews differ: semistructured ones are administered by clinicians, whereas fully structured ones can be given by lay interviewers (Levis et al., 2019). Participant-level data from 58 studies with 17 357 participants were pooled in a meta-analysis of PHQ-9 screening accuracy, and where the reference diagnosis came from a semistructured interview (29 studies), treating a total score of at least 10 as a positive screen yielded a sensitivity of 0.88 (0.83 to 0.92) and a specificity of 0.85 (0.82 to 0.88) (Levis et al., 2019). Neither figure is perfect, so some people scoring 10 or above do not have major depression and some scoring lower do. A score at or above the cut-off therefore marks possible major depression for further assessment and is not a diagnosis: at the 14% prevalence found where semistructured interviews were the standard, about half of those screening positive would not have major depression (Levis et al., 2019).

Symptom Profiles and Scale Content

A total score hides a great deal of variety. Fried and Nesse reanalyzed STAR*D data from 3703 depressed outpatients and counted 1030 unique symptom profiles, a profile being any unique combination of 12 symptoms from the QIDS-16, each scored as present or absent (Fried & Nesse, 2015). The count reflects those scoring rules: insomnia and hypersomnia were scored separately, as were psychomotor agitation and retardation, whereas the direction of weight and appetite change was not scored, and a profile did not have to include the core symptoms (Fried & Nesse, 2015). Of the profiles, 501 (48.6%) belonged to one individual and 864 (83.9%) were each held by no more than five people; the 30 most common together covered 888 subjects (24%), and the single most common, at 1.8% of the sample, was the profile with every symptom scored absent (Fried & Nesse, 2015). Medications prescribed for the other medical conditions that many participants reported may have affected their symptoms, and the heterogeneity was unchanged in a subsample restricted to the median symptom count (Fried & Nesse, 2015).

The instruments themselves disagree about what to count. A content analysis of seven common depression scales found 52 distinct symptoms between them, with a mean Jaccard overlap of 0.36; 40% of the symptoms appeared in only one scale and 12% in all seven (Fried, 2017). Because the coding was conservative, the true heterogeneity is probably larger, and results that hold for one scale may not replicate with another.

Prevalence Estimates

Estimates of how common the disorder is depend on these choices. The National Comorbidity Survey Replication, a face-to-face household survey of 9090 US adults conducted from February 2001 to December 2002, estimated the lifetime prevalence of major depressive disorder at 16.2% and the 12-month prevalence at 6.6%; it also found treatment mostly inadequate and the disorder rarely the primary one (Kessler et al., 2003). These figures concern a diagnosis, not the broader range of depressed mood the heading covers.

Interactive demonstration

Two people, one label

Tick the symptoms each person reports. Both could meet the same threshold on a sum score while sharing few symptoms. The index runs from 0 (no overlap) to 1 (identical lists).

Person A

Person B

Person A reports 5 symptoms and Person B 5; they share 2 of 8, an overlap of 0.25.
Published: 3,703 outpatients showed 1,030 distinct profiles, 48.6% of profiles belonged to a single person, and the commonest covered 1.8% of patients. Seven common scales span 52 symptoms with a mean overlap of 0.36.
The two checklists are illustrative and the overlap is computed live as shared symptoms divided by all symptoms either person reports (the Jaccard index). The published figures are those reported by Fried and Nesse (2015) for 3,703 outpatients and by Fried (2017) for seven depression scales; the symptom labels are plain-language summaries, not diagnostic criteria.

The Experience of Depression

When so many combinations of symptoms can lead to the same diagnosis, a count of items cannot show what depression is like for the person living with it, and first-person accounts help fill that gap. A qualitative meta-synthesis brought together 39 studies with 884 participants from 16 countries, all aged 10 to 24, so its conclusions apply to young people only (Viduani et al., 2024). The experiences participants described most often were loneliness, sadness and pulling away from other people, and some of what they reported lies outside the DSM and ICD criteria (Viduani et al., 2024). Their accounts also turned on finding support and care, on the way culture and surroundings colored what they went through, and on their efforts to understand what was happening to them. Most participants were female, most studies came from high-income countries, and as a qualitative synthesis the review reports no effect sizes (Viduani et al., 2024).

Interviews with 34 adolescents aged 13 to 18 suggest that anhedonia, in lived experience, is much broader than the loss of pleasure a symptom checklist names (Watson et al., 2020). The teenagers spoke of feeling cut off from friends and from any sense of belonging, of doubting who they were and what their lives were for, of finding it hard to get motivated or stay engaged, and of joy draining away as their emotions went flat. Emotional blunting was not reported by everyone, and only 12 of the interviewees came from a clinical sample, so the study offers a detailed picture from a small group rather than a measure of how common each experience is (Watson et al., 2020). The way distress is put into words also differs between cultures. In a comparison of 175 Chinese and 107 Euro-Canadian outpatients using three methods, the Chinese group reported more somatic symptoms and the Euro-Canadian group more psychological ones (Ryder et al., 2008). Of the two, the psychological difference was larger and more consistent, since the somatic difference appeared with only two of the three methods, and a tendency toward externally oriented thinking mediated the somatic difference (Ryder et al., 2008). Distress, in other words, may be voiced mainly through the body or mainly through thoughts and feelings, which matters for any instrument that counts one kind of symptom more than the other.

Qualitative syntheses give adults' own accounts of depression and its care. A meta-ethnography pooling 20 papers on 474 people with depression found that seeking help was felt as a threat to identity; leaning on alternative coping strategies was likewise tied to treatment delay, and social networks could either support the search for care or set up conflict around it (Doblyte & Jiménez-Mejías, 2017). Once treatment began, accounts of antidepressants were mixed. A thematic meta-synthesis of 27 studies (2937 participants) found that some people judged the medication helpful while others described feeling not myself or felt that the medication was masking the real problem; many saw it as the only option available, and an explanation framed as a biochemical deficit felt stigmatizing (Crowe et al., 2023). Its authors concluded that patients need options, information and informed choice, but 59% of the participants came from a single study and 70% were women (Crowe et al., 2023).

Depressive Disorders

Read against the evidence that depression in young people varies by degree (Hankin et al., 2005), some of the categories below may be cut points or course labels laid across one range of symptoms rather than separate kinds of illness, and several of them remain in dispute. Table 1 lists each category with its standing and an example instrument or key source.

Each category is also only as clear as the instrument used to detect it. The Hospital Anxiety and Depression Scale shows how unstable that can be: across 50 latent variable studies published between May 2000 and May 2010, a systematic review found no consistent structure, with exploratory analyses tending toward two factors, confirmatory analyses toward three and item response analyses mostly toward one, and the scale told anxiety and depression apart poorly (Cosco et al., 2012). Coyne and van Sonderen went further and argued that the scale should be abandoned (Coyne & van Sonderen, 2012).

Table 1

Depressive Disorders, Specifiers and Disputed Subtypes

CategoryStandingExample instrument or key source
Major depressive disorderReference category; no single mechanism explains it (Otte et al., 2016)Otte et al., 2016
Persistent depressive disorderGroups chronic forms; often more disabling than episodic MDD (Schramm et al., 2020)Schramm et al., 2020
Treatment-resistant depressionRemission fell with each further STAR*D step (Rush et al., 2006)MeSH, D061218
Premenstrual dysphoric disorderFull DSM-5 category, as an expert review urged (Epperson et al., 2012)C-PASS scoring of daily DRSP ratings (Eisenlohr-Moul et al., 2017)
DMDD / youth irritabilityUncommon, highly comorbid, distinctiveness unresolved (Copeland et al., 2013); syndrome status needs verification (Leibenluft, 2011)Child and Adolescent Psychiatric Assessment (Copeland et al., 2013); Affective Reactivity Index (Stringaris et al., 2012)
Substance-induced depressive disorderSeparable by structured interview, slightly less reliably than primary diagnoses (Hasin et al., 2006)PRISM-IV (Hasin et al., 2006)
Due to another medical conditionComorbid depression worsens health beyond either condition (Moussavi et al., 2007)World Health Survey (Moussavi et al., 2007)
Other specified (recurrent brief depression)Well defined; raised suicide-attempt risk with MDD (Pezawas et al., 2005)ICD-10 and DSM-IV criteria (Pezawas et al., 2005)
Peripartum onsetPooled perinatal prevalence 11.9% (Woody et al., 2017)Edinburgh Postnatal Depression Scale (Cox et al., 1987)
Seasonal affective disorderDeficits persisted into summer in medication-free winter cases (Hjordt et al., 2017)Rosenthal et al., 1984
With anxious distressCommon in MDD; validity supported (Zimmerman et al., 2019)Semistructured diagnostic interviews (Zimmerman et al., 2019)
With mixed featuresCommon but understudied; criteria criticised as weakly grounded (Koukopoulos & Sani, 2014)Meta-analysis of 17 studies (Na et al., 2021)
Melancholic featuresArgued distinct (Parker et al., 2010); cognitive gap absent in drug-free patients (Zaninotto et al., 2016)Parker et al., 2010
Atypical featuresContested; mixed evidence as a subtype (Łojko & Rybakowski, 2017)DSM-5 atypical specifier (Łojko & Rybakowski, 2017)
Psychotic featuresCombined symptom scale tracked response; needs validation (Østergaard et al., 2014)Psychotic Depression Assessment Scale (Østergaard et al., 2014)
With catatoniaAbout 9% pooled prevalence across clinical samples of mixed conditions; highly heterogeneous (Solmi et al., 2018)Meta-analysis of 74 studies (Solmi et al., 2018)
Vascular depressionContested; causality unproven (Aizenstein et al., 2016); mechanisms untested (Taylor et al., 2013)Alexopoulos et al., 1997
Bipolar depressionNo specific cognitive profile versus major depression yet; verbal memory differed in euthymia (Samamé et al., 2017)Samamé et al., 2017
Prolonged grief disorderOnly modest overlap with MDD (phi=0.25) (Prigerson et al., 2021)PG-13-R (Prigerson et al., 2021)
Mixed depressive and anxiety disorder (ICD-11)Impairing; prevalence varies with criteria (Möller et al., 2016)Möller et al., 2016

Note. The table names categories, not diagnostic criteria. The citation in the Standing column names the work that standing rests on.

Each category is taken in turn below, followed by what is known about cognition in it.

Major Depressive Disorder

Major depressive disorder is the reference category against which the other depressive disorders are drawn. A disease primer estimated that about one in six adults develop it over a lifetime, with women affected about twice as often, and put its heritability at approximately 35%, a figure it treated as an estimate only (Otte et al., 2016). The same primer described the disorder as multifactorial: childhood abuse, the hypothalamic-pituitary-adrenal axis, changes in hippocampal volume and the brain's affective-salience and cognitive control networks are all implicated, and no single mechanism accounts for the whole (Otte et al., 2016).

DSM-5-TR grades a current episode as mild, moderate or severe, and it records whether the disorder is in partial or full remission (American Psychiatric Association, 2022). Remission is not the same as a return to normal cognition. A meta-analysis of 252 studies, setting 11 882 remitted patients against 8533 healthy controls, found significant deficits on 55 of 75 cognitive variables, most of them small or medium in size; the deficits were greater in people with more previous episodes, although results were inconsistent across studies (Semkovska et al., 2019). The severity and remission section of the major depressive disorder page treats these ratings in more detail.

The DSM-5-TR also records the course of the disorder, coding whether a major depressive episode is a single episode or one of a recurrent series (American Psychiatric Association, 2022).

Cognitive Implications

The cognitive profile of major depressive disorder is the best measured, so the subsections that follow describe each other category against it. A meta-analysis drawing on 7,707 participants across 113 studies found executive function impaired across a wide range of tasks, with effect sizes running from d = 0.32–0.97; the analysis could not establish that the impairment causes depression, nor that it is specific to the disorder (Snyder, 2013). A second meta-analysis, limited to studies that used the Cambridge Neuropsychological Test Automated Battery (CANTAB), found that cognitive deficits outlasted the mood episode and were still present in remitted depression, though in remission the memory deficits were not significant (Rock et al., 2014). The negative biases in what depressed people attend to, remember and conclude are taken up separately, in the section on biased attention, memory and thinking.

Persistent Depressive Disorder

Persistent depressive disorder is a label for course rather than a new kind of depression. It brings chronic major depression, dysthymia and recurrent major depression without recovery under one name, and a narrative review judged it often more disabling than episodic major depression (Schramm et al., 2020). Little is known about what causes it, though the causes are probably multifactorial, and in its dysthymic form it can be hard to detect until a major depressive episode is superimposed on it; the review's authors favoured a dimensional view of how depression runs its course (Schramm et al., 2020).

The DSM-5-TR qualifies persistent depressive disorder with specifiers for the episode pattern within the chronic course: with pure dysthymic syndrome, with persistent major depressive episode, or with intermittent major depressive episodes (with or without a current episode), together with an early-onset or late-onset specifier (American Psychiatric Association, 2022). The Major Depressive Disorder article describes these specifiers in clinical detail.

Cognitive Implications

The evidence here is of a different kind from the test-based findings above. One cross-sectional study compared three groups (24 never-ill controls, 27 outpatients whose major depression was not chronic, and 42 outpatients with chronic depression), measuring maladaptive core beliefs, dysfunctional attitudes, a ruminative response style and attributional style; the chronically depressed group generally scored higher than the nonchronic group on these variables, with mood state and personality disorder symptoms controlled (Riso et al., 2003). These are measures of cognitive vulnerability, not neuropsychological tests, and a single cross-sectional comparison cannot say whether such thinking comes before chronic depression or after it.

Treatment-Resistant Depression

Course also shows in how depression responds to repeated treatment. In the STARD trial, 3,671 outpatients with nonpsychotic major depression moved through a sequence of treatment steps, and the share who remitted shrank from 36.8% at the first step to 30.6%, 13.7% and 13.0% at the later ones, while relapse grew more common among those who needed more steps (Rush et al., 2006). After each of the first three steps, patients who entered follow-up in remission relapsed less often than those who did not, and the trial left open which sequence of treatments works best (Rush et al., 2006). Depression that does not yield to repeated treatment is called treatment-resistant depression. The National Library of Medicine's thesaurus indexes it as a separate descriptor, Depressive Disorder, Treatment-Resistant, and defines it as “Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies” (MeSH, D061218). The way remission shrank across STARD's later steps suggests why such a category is needed. The section on what treatment trials show describes electroconvulsive therapy, magnetic stimulation, ketamine and esketamine, and the second ketamine trial and the esketamine trial covered there enrolled patients with treatment-resistant depression specifically.

Cognitive Implications

The cognitive data cited here for this category come from late life only. In a secondary analysis of baseline data from one multicentre trial, OPTIMUM, run at four US sites and one in Canada, 369 adults aged 60 and older with treatment-resistant depression performed below norms on the NIH Toolbox-Cognition Battery in inhibitory control, processing speed, verbal and nonverbal memory and the battery's fluid composite, while their working memory and set shifting fell within the normative range (Ainsworth et al., 2025). Where set shifting was impaired, depressive symptoms improved less, whereas impaired inhibitory control did not predict outcome; the participants had a high premorbid IQ (Ainsworth et al., 2025). The pattern therefore describes treatment-resistant depression in older adults; younger adults were not studied.

Premenstrual Dysphoric Disorder

An expert review argued that the evidence warranted giving premenstrual dysphoric disorder its own place as a full diagnosis in DSM-5, after it had been confined to Appendix B of DSM-IV, and put its prevalence at 2%–5% of premenopausal women (Epperson et al., 2012). How the condition is measured turns largely on whether symptoms are rated daily or recalled afterwards. Two hundred women with premenstrual emotional symptoms kept Daily Record of Severity of Problems ratings for two to four months, and in 98% of cases expert diagnoses matched the output of C-PASS, the Carolina Premenstrual Assessment Scoring System; what the women recalled afterwards was a poor guide to the diagnosis made from their daily ratings, and the work is an initial validation only (Eisenlohr-Moul et al., 2017).

A retrospective questionnaire fared worse in a study of 127 women aged 20–45, recruited through the media at one hospital. Set against daily DRSP ratings, the Premenstrual Symptoms Screening Tool showed poor agreement (Kappa = 0.12) and overestimated PMDD, which limits it to screening (Henz et al., 2018). The comparison has its own weaknesses: 55% of participants dropped out of the daily ratings, and women with depression were excluded (Henz et al., 2018).

Cognitive Implications

Research on cognition in this disorder is young. A narrative review judged the findings on whether cognitive performance changes from one phase of the menstrual cycle to another to be inconsistent, and described cognitive work on premenstrual syndrome and PMDD as still at an early stage (Le et al., 2020). Whether any effects stem from mood or from hormones remained unsettled, and the reviewers found that progesterone had been largely neglected (Le et al., 2020).

Disruptive Mood Dysregulation Disorder and Youth Irritability

Disruptive mood dysregulation disorder proved relatively uncommon, especially after early childhood, in data from three community studies, covering 3,258 children aged 2 to 17 across 7,881 observations: prevalence estimates ran from 0.8% to 3.3%, children who met the definition very often had other disorders too, and the condition reached the threshold for psychiatric caseness (Copeland et al., 2013). Its overlap with oppositional defiant disorder was far heavier than with anything else, at odds ratios of OR 52.9 to 103.0, which leaves it uncertain whether the condition is a separate disorder at all, let alone one that belongs only with the mood disorders (Copeland et al., 2013). The interviews had been built for other disorders, the samples were community rather than clinical and not nationally representative, and whether the disorder is distinct from existing diagnoses remained unresolved (Copeland et al., 2013).

Severe mood dysregulation, marked by nonepisodic irritable mood in young people, has been studied as a neighbouring syndrome. A narrative review of this emerging literature concluded that such irritability in youth carries an elevated risk of anxiety and unipolar depression in adulthood rather than of bipolar disorder, while cautioning that its standing as a distinct syndrome still needs verification and that no specific treatment exists (Leibenluft, 2011). Irritability can be measured briefly: the Affective Reactivity Index has six symptom items and one impairment item, and in samples of 218 US and 88 UK youth its internal consistency fell between alpha = 0.88 and alpha = 0.92; the samples were open to referral bias, and the index has not been tried with adults (Stringaris et al., 2012).

Cognitive Implications

On cognition in severe mood dysregulation, the same narrative review could draw only on an emerging literature, which had begun to set these young people beside youths with bipolar disorder (Leibenluft, 2011). Both groups had trouble labelling the emotions shown in faces, and both showed more frustration than typically developing children, yet the brain mechanisms behind these difficulties apparently differed between the two groups (Leibenluft, 2011).

Substance-Induced Depression

A depression that follows from substance use has to be told apart from one that would have occurred anyway, and a structured interview can do this with reasonable consistency. Retest agreement on major depression diagnoses reached kappas of 0.66 to 0.75 when blind raters interviewed 285 substance-abusing patients twice with the PRISM-IV, with diagnoses of substance-induced depression only a little less reliable than the primary diagnoses (Hasin et al., 2006).

Cognitive Implications

The available cognitive evidence concerns depression that co-occurs with a substance use disorder, not depression induced by a substance as such. Drawing on 19 studies published over 17 years, 13 of them on bipolar disorder and five on major depression, a systematic review concluded that having both disorders may make cognitive impairment worse, with attention and executive functions most affected in the studies of bipolar disorder (Miguel et al., 2023). The reviewers added that not every study of bipolar disorder with a substance use disorder found the comorbidity made impairment worse, that studies combining major depression with a substance use disorder were few, and that standardized research is needed (Miguel et al., 2023).

Depressive Disorder Due to Another Medical Condition

DSM-5-TR lists depressive disorder due to another medical condition as a separate category within the depressive disorders (American Psychiatric Association, 2022). The studies below concern depression occurring alongside physical illness rather than this diagnosis as such. In World Health Survey data from 245 404 adults in 60 countries, depression lowered health scores more than angina, arthritis, asthma or diabetes, and people with depression plus a chronic disease had worse health than those with either condition alone; the authors called depression an urgent public-health priority (Moussavi et al., 2007). After stroke, a meta-analysis of 61 studies and 25 488 people put the frequency of depression at 31% (95% confidence interval 28% to 35%), lower at later follow-ups (25% between one and five years, 23% at five years), with wide variation between studies and no reduction since an earlier review (Hackett & Pickles, 2014). The substance and medical section of the major depressive disorder page covers these categories.

Cognitive Implications

No cited study isolates cognitive findings for this category; the overlap of depression with physical illness is taken up in the comorbidity section.

Other Specified and Unspecified Depressive Disorders

DSM-5-TR names several presentations that fall short of a full depressive disorder: recurrent brief depression, short-duration depressive episode and depressive episode with insufficient symptoms as other specified forms, together with unspecified depressive disorder (American Psychiatric Association, 2022). A review described recurrent brief depressive disorder as well defined and prevalent, and found the risk of a suicide attempt higher when it combines with major depressive disorder than in major depression alone; the review judged that highly selected patient samples, among other factors, had probably produced false-negative results in placebo-controlled treatment studies (Pezawas et al., 2005). Subthreshold depression, symptoms below the major-depression threshold, carries forward risk: across 16 longitudinal cohorts (n = 67 318) it nearly doubled the incidence of later major depression (IRR = 1.95, 95% CI 1.28–2.97), with no difference by age group or between community and primary-care samples, which the authors read as favouring indicated prevention (Lee et al., 2019). The other specified section of the major depressive disorder page describes these presentations further.

Cognitive Implications

The cited sources report course, suicide risk and incidence, not cognition, so cognitive findings for these residual categories are thin.

Peripartum Onset

DSM-5-TR applies the peripartum-onset specifier when an episode begins during pregnancy or in the four weeks after delivery (American Psychiatric Association, 2022; Radoš et al., 2024), and perinatal depression is common, with a pooled prevalence of 11.9% (95% CI 11.4-12.5) across 96 studies (Woody et al., 2017); the peripartum onset section of the major depressive disorder page covers it in depth.

A clinical review described postpartum depression as common and as affecting the woman, the infant and the family (Stewart & Vigod, 2016). The Edinburgh Postnatal Depression Scale was developed for this period. It has 10 items, takes about 5 minutes to complete and, when checked against Research Diagnostic Criteria in 84 mothers, screened adequately for postnatal depression (Cox et al., 1987).

Cognitive Implications

Fourteen studies of pregnant or postnatal women, gathered from 11 electronic databases, went into a systematic review of how mothers process infant emotion, and the results suggested that depression and anxiety were each tied to a bias toward reading negative emotion in infants (Webb & Ayers, 2015). A further result, on disengagement in depression, was only tentative, and very few of the studies concerned post-traumatic stress disorder (Webb & Ayers, 2015).

Seasonal Pattern

Rosenthal and colleagues described seasonal affective disorder in 29 patients whose depressions came with hypersomnia and carbohydrate craving, many of whom had bipolar II disorder; in preliminary studies with 11 patients, bright artificial light appeared to act as an antidepressant (Rosenthal et al., 1984).

The DSM-5-TR treats a seasonal pattern as a specifier of course, not as a disorder in its own right (American Psychiatric Association, 2022); its clinical criteria are covered in the Major Depressive Disorder article. For treatment, a meta-analysis of 19 randomized controlled trials in adults with seasonal affective disorder found that bright light therapy lowered depression ratings more than placebo (18 studies, 610 patients; SMD = –0.37, 95% CI: –0.63 to –0.12) and raised the response rate (16 studies, 559 patients; RR = 1.42, 95% CI: 1.08–1.85), but the authors judged the evidence limited, citing moderate heterogeneity, a moderate-to-high risk of bias and small-to-medium samples (Pjrek et al., 2020).

Cognitive Implications

Twenty-nine medication-free people with winter seasonal affective disorder and 30 matched healthy controls were later tested once in summer and once in winter. Their deficits in working memory and processing speed carried over into the summer, which suggests a trait rather than a passing state, and only processing speed moved with changes in symptoms; the study was limited to winter-pattern patients off medication (Hjordt et al., 2017).

With Anxious Distress

With anxious distress is one of the specifiers DSM-5-TR attaches to a depressive episode (American Psychiatric Association, 2022). In 260 patients with major depressive disorder assessed by semistructured interview in the MIDAS project, the specifier proved common; patients who met it had more anxiety and drug use disorders, higher anxiety scores, and poorer functioning and coping than those who did not, which the authors took as support for its validity (Zimmerman et al., 2019). Treatment outcome points the same way: in a secondary analysis of 2,876 outpatients from STAR*D, anxious depression remitted less often and more slowly, drew more side effects and fared worse at the second treatment level than nonanxious depression, and the authors linked it to poorer acute antidepressant outcomes (Fava et al., 2008). The anxious distress section of the major depressive disorder page covers the specifier further.

Cognitive Implications

None of the studies cited for this specifier measured cognition, so no cognitive findings specific to anxious distress can be reported here.

With Mixed Features

With mixed features is a DSM-5-TR specifier for a depressive episode (American Psychiatric Association, 2022). Pooling 17 studies and 20 samples, a meta-analysis found mixed features common in both major depressive episodes and manic or hypomanic episodes, with lower prevalence in East Asia than in other regions; the included studies carried moderate to high risk of bias, much of the heterogeneity went unexplained, and the authors called for more prevalence research (Na et al., 2021). A historical and systematic review argued that the DSM-5 criteria for the specifier rest on a weak basis and may even be harmful for treatment decisions (Koukopoulos & Sani, 2014). The mixed features section of the major depressive disorder page discusses the debate.

Cognitive Implications

The sources cited here address prevalence and diagnostic criteria only; the cognitive profile of mixed-features depression is not established by them.

Melancholic Features

In the run-up to DSM-5, Parker and colleagues made the case for classifying melancholia as a distinct mood disorder (Parker et al., 2010).

In the DSM-5-TR, melancholic features are not a separate disorder but a specifier attached to a depressive episode (American Psychiatric Association, 2022); the Major Depressive Disorder article gives the clinical criteria.

Cognitive Implications

Pooling nine studies, a meta-analysis found that patients with melancholic major depression did worse than non-melancholic patients across several cognitive domains, with effect sizes from ES=-0.31 to ES=-0.46 (Zaninotto et al., 2016). Those effects were moderate rather than large, the melancholic groups were older and more severely ill, though neither age nor severity moderated the result, and among drug-free patients the difference vanished (Zaninotto et al., 2016).

A six-week prospective study compared melancholic (n=142), atypical (n=76) and undifferentiated (n=91) major depression with healthy controls (n=200) on neuropsychological tests. While depressed, the three subtypes had deficits in common, but they recovered differently over the six weeks; attention was not impaired, and test performance did not predict treatment outcome (Lin et al., 2014). Drop-out was high, and the evidence counts as preliminary only (Lin et al., 2014).

Atypical Features

Atypical depression, recorded in DSM-5 as a specifier, includes leaden paralysis, oversleeping, overeating, sensitivity to interpersonal rejection and mood reactivity, though whether mood reactivity must be present is disputed (Łojko & Rybakowski, 2017). Its share of depressed patients shifts with the method of counting: 15%–29% of them in epidemiological studies that used DSM criteria, against 18%–36% in clinical studies (Łojko & Rybakowski, 2017). A narrative review reported mixed evidence on its standing as a subtype, with family studies giving some support: it overlaps with the bipolar spectrum and with seasonal affective disorder, biological findings are often inconsistent and frequently shared with non-atypical patients, and no comprehensive treatment guidelines exist (Łojko & Rybakowski, 2017).

Cognitive Implications

In the six-week comparison described under melancholic features, the atypical group had the deficits found in all three subtypes during the depressed state, but in that state it also differed from the melancholic group in processing speed and verbal fluency (Lin et al., 2014). The evidence on atypical depression as a subtype remains mixed (Łojko & Rybakowski, 2017), and the cognitive disadvantage that marks out melancholia disappeared in patients not taking drugs (Zaninotto et al., 2016).

Psychotic Features

For psychotic depression, a secondary analysis of a trial with 259 patients found that the 11-item Psychotic Depression Assessment Scale, which rates depressive and psychotic symptoms together, was a sensitive measure of treatment response, although one of its tests of the treatment difference was only marginal (Østergaard et al., 2014). The trial was not designed to validate the scale, included delusional depression only, and the scale still needs further validation (Østergaard et al., 2014).

DSM-5-TR separates mood-congruent psychotic features, whose content fits the depressive themes, from mood-incongruent ones (American Psychiatric Association, 2022). Over a ten-year prospective follow-up of 452 patients with DSM-III major depression, those with delusions took longer to recover, received antipsychotics more often and spent more time depressed, yet their ten-year outcome did not differ from that of nondelusional patients; no demographic, historical or index-episode variable told mood-incongruent cases apart from mood-congruent ones, though the authors noted that the boundary of a delusion is somewhat fuzzy (Maj et al., 2007). The psychotic features section of the major depressive disorder page expands on the distinction.

Cognitive Implications

A review and meta-analysis set out to compare cognitive impairment in psychotic and nonpsychotic major depression, a question on which the picture of severity had previously been unclear (Fleming et al., 2004). Its summary reports no effect sizes, and the studies it drew on assessed cognition by differing methods (Fleming et al., 2004).

A later meta-analysis pooling 12 studies found poorer cognition in psychotic than in nonpsychotic major depression, with an overall effect size of 0.38 that grew to 0.69 when only drug-free patients were compared, and its authors judged that the link between psychosis and cognitive deficits seems supported (Zaninotto et al., 2015).

With Catatonia

With catatonia is a DSM-5-TR specifier that can apply to a depressive episode (American Psychiatric Association, 2022). Across 74 studies and 110764 patients with a range of conditions, catatonia had a pooled prevalence of 9.0% (95% CI = 6.9-11.7); prevalence ran higher in smaller samples and in samples with fewer patients with major depressive disorder, but the results were highly heterogeneous (I2 = 98%), showed publication bias, and in the authors' view call for cautious interpretation (Solmi et al., 2018). The catatonia section of the major depressive disorder page gives more detail.

Cognitive Implications

The cited evidence on catatonia concerns how often it occurs, not cognition, so its cognitive implications in depression remain undocumented here.

Late-Life and Vascular Depression

The vascular depression hypothesis holds that cerebrovascular disease, through ischemic lesions that disrupt prefrontal systems, may give rise to some depressive syndromes of old age; its originators set it out as a hypothesis supported by the comorbidity of depression and vascular disease, with directions for research (Alexopoulos et al., 1997). Sixteen years on, a narrative review still treated it as a hypothesis, tying late-life depression to cerebral hyperintensities and executive dysfunction and putting forward hypoperfusion, inflammatory and disconnection mechanisms that had yet to be tested (Taylor et al., 2013). The hypothesis remains contested: a 2016 consensus report still described vascular depression as a possible late-life subtype whose causal basis had not been proven, observing that it lacked accepted diagnostic criteria and any place in DSM-5, that autopsy data cast doubt on the role of the lesions, and that treatment outcomes had been unsatisfying (Aizenstein et al., 2016).

Cognitive Implications

Executive difficulties also stood out in a cross-sectional comparison of 39 inpatients aged 60 or over, all of whom had not responded to antidepressants, with 18 controls: executive function was the core deficit, whereas a slowing of processing speed did not survive Bonferroni correction, and the sample was small (Dybedal et al., 2013). Depression with marked cognitive impairment has been called pseudodementia. A systematic review of 18 studies with 284 patients, 238 of them depressed, found that some went on to irreversible dementia, but outcomes varied considerably, follow-up ranged from weeks to 18 years and study quality was poor (Connors et al., 2019).

Bipolar Depression

The line between depressive disorders and bipolar disorder is not sharp. Many of the first patients described with seasonal affective disorder had bipolar II disorder (Rosenthal et al., 1984), and atypical features overlap with the bipolar spectrum (Łojko & Rybakowski, 2017). In the other direction, nonepisodic irritability in youth was associated with a raised risk of unipolar depression and anxiety in adulthood but not of bipolar disorder (Leibenluft, 2011).

Cognitive Implications

Neuropsychological testing does little to tell the two apart: a meta-analysis of comparative studies found no distinct profiles for major depressive disorder and bipolar disorder, with similar outcomes in the depressed phase and a single difference, in verbal memory during euthymia (g = 0.64) (Samamé et al., 2017). Even that difference might reflect how the samples were made up, or unequal exposure to factors that harm cognition, rather than the diagnoses themselves (Samamé et al., 2017).

Prolonged Grief and Bereavement

Grief marks a second boundary. Prigerson and colleagues validated the DSM-5-TR criteria for prolonged grief disorder, together with the PG-13-R scale, in three bereaved samples from Yale (N=270), Utrecht (N=163) and Oxford (N=239), and the disorder overlapped only modestly with major depressive disorder (phi=0.25) (Prigerson et al., 2021). Grief also raised a separate question for major depression itself. As DSM-5 was being drafted, a proposal circulated to remove the bereavement exclusion from the diagnosis; Wakefield and First's critical review defended the exclusion as valid and urged that it be retained, warning that dropping it would invite false positive diagnoses, while recommending adjustments to cut false negatives and judging three later studies on the question inconclusive (Wakefield & First, 2012). Zisook and colleagues took the other side. They brought studies published after 2006 into the earlier reviews and concluded that depression following a bereavement does not differ from a major depressive episode with any other trigger, so DSM-5 should drop the exclusion (Zisook et al., 2012). The two reviews therefore reached opposite conclusions, and the manual then decided the question for diagnostic purposes: DSM-5 (American Psychiatric Association, 2013) removed the bereavement exclusion, allows major depressive disorder to be diagnosed during and after bereavement, and added a note and a footnote to the criteria for a major depressive episode to guide clinicians (Iglewicz et al., 2013). That decision, argued over widely and in public, is still a matter of controversy (Iglewicz et al., 2013), and a review of what DSM-5 changed in the criteria judged that putting clinical judgment where the exclusion had been reduces the objectivity of the diagnosis (Uher et al., 2014).

Cognitive Implications

A theoretical review proposed a model that links prolonged grief to the way a loss becomes woven into the self-memory system, giving self-identity, attachment and autobiographical memory each a part in keeping grief from resolving (Maccallum & Bryant, 2013). When they proposed it, the authors set out directions for testing the model's propositions (Maccallum & Bryant, 2013). An earlier theory paper offers an alternative account, framed in terms of complicated grief and put forward as a framework for generating hypotheses (Boelen et al., 2006). On this account three processes keep such grief going, involving anxious and depressive avoidance, negative global beliefs, misinterpretations of one's own grief reactions and insufficient integration of the loss within the autobiographical knowledge base, and background variables are taken to exert their influence through these processes (Boelen et al., 2006).

Mixed Depressive and Anxiety Disorder

Mixed anxiety and depressive disorder is a boundary presentation: symptoms of both anxiety and depression that are present together but do not meet the threshold for a full anxiety or depressive disorder. ICD-11's diagnostic guidelines list mixed depressive and anxiety disorder among the depressive disorders (World Health Organization, 2024), while DSM-5-TR contains no matching category (American Psychiatric Association, 2022). A narrative position paper by Möller and colleagues reviewed the category as ICD-10 defines it (code F41.2) and set out why it matters for the classification of subthreshold anxiety and depression (Möller et al., 2016). The review places the presentation on a continuum of negative affect and discusses it against the tripartite model, which separates what anxiety and depression share from what distinguishes them (Möller et al., 2016). A fuller clinical treatment is in the Major Depressive Disorder article.

The review's case for taking the category seriously rests on impairment. People with the mixed presentation were reported to be about as impaired, and about as distressed, as people with a syndromal anxiety or depressive disorder, and at three months they showed roughly twice the distress of people with no diagnosis (Möller et al., 2016). On course, about half remitted within a year, only slightly more than the rates identified for major depressive disorder and generalized anxiety disorder; in a population twin survey re-assessed about 17 months later, 47% had remitted, 23% still had the mixed presentation, and 30% had developed a syndromal anxiety or depressive disorder (Möller et al., 2016). Childhood adversity and neuroticism were listed as risk factors, and the presentation's profile resembled generalized anxiety disorder more than major depressive disorder (Möller et al., 2016).

How common the presentation is depends heavily on the definition. Estimates in the review ran from 0.2% (4 of 1,634 participants) and 0.6% under some criteria to an 8.8% one-month prevalence under others, and the authors treated the divergence as a limitation of the criteria rather than a property of the condition (Möller et al., 2016). They also noted that randomized treatment studies are few, that predictors of course have yet to be identified, and that the criteria proposed for DSM-5 were not judged sufficiently reliable (Möller et al., 2016).

Cognitive Implications

The cited review reports no findings on cognition: it covers classification, prevalence, impairment, course and treatment, but not attention, memory or executive performance in this presentation (Möller et al., 2016). Its conceptual frame, the tripartite model and a continuum of negative affect, is a model of symptom structure rather than a cognitive result, so no cognitive profile of the mixed presentation can be stated from it.

The Cognitive Model

Aaron Beck's cognitive model holds that depression is maintained by how people process information about themselves. In 1963 Beck published a paper on thinking in depression that dealt with the idiosyncratic content of patients' thought and the cognitive distortions found in it (Beck, 1963). Reviewing over 40 years of research, Beck described a model that had grown in stages to include dysfunctional beliefs, information-processing biases, cognitive distortions and automatic thoughts, and he traced how it connects with biology, extending it to elevated cortisol, an overreactive amygdala and underactive prefrontal regions (Beck, 2008). He presented that integration as only recently demonstrated and treated the cortisol pathway as probably mediated by cognition.

The model sets out a sequence of causes, not only a style of thinking. Beck's theoretical review names two predisposing factors for depression, traumatic experience early in life and the dysfunctional beliefs a person forms, and casts later stressors congruent with that history as what precipitates it (Beck, 2008). In a theory paper's account of Beck's model, activated negative schemas give rise to negative automatic thoughts on three subjects, the world, the future and the self, which together are called the negative cognitive triad, and these cognitions maintain and worsen negative affect in a vicious circle (Koster et al., 2011). A later theory paper gave depressogenic beliefs the same three objects and proposed that they lead to appraisals of loss (Beck & Bredemeier, 2016). The review also names what the model came to include as it was expanded: dysfunctional beliefs, automatic thoughts, cognitive distortions and biases in the processing of information (Beck, 2008). A cognitive distortion, in this vocabulary, is a distorted way of thinking, the element examined in the social media language study described below (Bathina et al., 2021). By Beck's account the model reached this form through additions made in stages, so it stands as revised rather than fixed (Beck, 2008). The next paragraph gives the later restatement of this architecture in terms of schemas and modes.

The architecture of the model was later restated in general terms. In a theory paper looking back on 50 years of the approach, Beck and Haigh described a generic cognitive model meant to apply across disorders, in which schemas serve as the organizing structures, carrying a person's memories, rules, expectancies and self-evaluations, and related schemas are grouped into modes (Beck & Haigh, 2014). Their update added attentional focus, dual information processing and the energizing of schemas, and it placed adaptive and maladaptive functioning on a continuum (Beck & Haigh, 2014). The authors concluded that beliefs are what set one disorder apart from another and are what treatment should aim at, a conclusion offered as theory without new empirical data (Beck & Haigh, 2014). The Cognitive Triad Inventory was built to measure the cognitive triad introduced above, with reliability and validity examined in 26 depressed patients and a retest sample of 28 against scales of self-esteem and hopelessness; the samples were small (Beckham et al., 1986). Distorted thinking can also be traced in ordinary language: on social media, people who said they had been diagnosed with depression used more of it than a random sample did, a gap that topics, sentiment and pronoun use did not account for, although the diagnoses were self-reported and such language patterns point toward depression without diagnosing it (Bathina et al., 2021).

Experimental work supplied some of the model's early support. Derry and Kuiper had 48 women aged 18 to 65 (16 clinically depressed, 16 nondepressed psychiatric controls and 16 normal nondepressed participants) rate adjectives in structural, semantic or self-referent tasks before an unannounced recall test. The depressed group recalled depressed-content adjectives best when they had rated them for self-reference, consistent with a depressive self-schema (Derry & Kuiper, 1981); the sample was women only.

Cognitive therapy has since been linked to brain function. Clark and Beck proposed that it works alongside reduced activity in amygdalohippocampal regions and increased activity in higher-order frontal regions that support cognitive control, while acknowledging that the evidence was consistent with this picture rather than conclusive (Clark & Beck, 2010).

The model's standing is revised. Kube and colleagues noted that the original formulation had been criticized as too broad and recast it in predictive processing terms, in which depression involves rigid negative predictions that resist correction by prediction errors and sustain a negative feedback loop (Kube et al., 2020). The predictive processing account of depression is itself still a proposal awaiting tests, as its authors acknowledged (Kube et al., 2020).

Learned Helplessness and Hopelessness

The learned helplessness account began in the animal laboratory. In Seligman and Maier's experiment, dogs given yoked, inescapable shock in a harness, unlike dogs that had first learned to escape shock there by panel pressing, afterwards did poorly at learning to escape in a shuttle box, a failure the authors read as learned helplessness (Seligman & Maier, 1967). The report gave no statistics in its summary, and helplessness was an interpretation of the escape failure rather than something observed directly.

Abramson, Seligman and Teasdale judged that the original hypothesis lacked explanatory scope in humans and reformulated it with attribution theory. The reformulation proposed that how much an uncontrollable outcome affects someone turns on how they explain it, whether to internal or external, stable or unstable, and global or specific causes; it also told universal helplessness apart from personal helplessness and took up self-esteem (Abramson et al., 1978). Its implications for depression were only outlined. Abramson, Metalsky and Alloy later proposed hopelessness depression as a theory-based subtype of depression (Abramson et al., 1989), a line of work that ties the account to pessimism. Hopelessness theory has been supported only in part. A systematic review of 67 studies found consistent support for several major components, above all the interaction of negative inferential styles with negative life events, but most of that research involved mild symptoms in non-clinical samples, and whether the interaction prospectively predicts depressive episodes, which the reviewers called the theory's most central aspect, remained largely unexamined (Liu et al., 2015). The same review noted that the theory has been conflated with the reformulated learned helplessness model (Liu et al., 2015).

Half a century after the first experiments, Maier and Seligman revised the theory on neuroscientific grounds. They concluded that passivity in the face of aversive events is the default response and that what animals learn is the presence of control, detected through a pathway from the ventromedial prefrontal cortex to the dorsal raphe nucleus, so that the original theory had the sequence backward (Maier & Seligman, 2016). Learned helplessness theory is therefore revised, and the authors described its implications for depression as speculative (Maier & Seligman, 2016).

Rumination

Response styles theory proposed that how people respond to their own low mood shapes its course. Nolen-Hoeksema argued that ruminative responses prolong depression whereas distraction shortens it, and linked these styles to the gender difference in depression; the theory paper reported no statistics in its summary (Nolen-Hoeksema, 1991). Later longitudinal analyses found that rumination predicted depressive disorders, including new onsets, but its link to chronicity disappeared once baseline symptoms were controlled, and a link to mixed anxiety and depressive symptoms was only tentative (Nolen-Hoeksema, 2000).

The gender difference received a direct test. In a two-wave study of approximately 1,100 community adults aged 25 to 75, chronic strain, low mastery and rumination together accounted for the gender difference in depressive symptoms; rumination only partly amplified the effect of strain, and the variables influenced one another over time (Nolen-Hoeksema et al., 1999).

Response styles theory has been revised and extended (Nolen-Hoeksema et al., 2008; Watkins & Roberts, 2020). The first revision came in a 2008 narrative review, which concluded that rumination predicts the onset of depression more clearly than its duration, that the benefit of distraction was inconsistent in correlational studies, and that rumination is tied to other forms of psychopathology as well (Nolen-Hoeksema et al., 2008). Watkins widened the frame to repetitive thought in general, including worry, and argued in a narrative review without quantitative synthesis that it can have constructive as well as unconstructive outcomes, proposing construal level as one factor that may decide which (Watkins, 2008). A more recent appraisal by Watkins and Roberts treated rumination as a vulnerability that cuts across diagnoses and carries many harmful consequences, and proposed a model, drawing on habit and executive control among other factors, that by their own account offers only a partial answer; they judged trials of treatments aimed at rumination to be preliminary (Watkins & Roberts, 2020).

Other risk factors bear on the same outcomes. In two population-based studies of middle-aged and older adults, one followed over three years, loneliness was associated with more depressive symptoms net of social support and perceived stress, and in the second study also hostility, and the two influenced each other over time; the summary reported no effect sizes (Cacioppo et al., 2006). Stressful life events, a central form of psychological stress, showed a substantial causal association with the onset of major depression in a population registry of female twins with 316 onsets over 24,648 person-months, although about one-third of the association was noncausal (Kendler et al., 1999). The study included women only, and dependent events were more strongly linked than independent ones.

Rumination has also been traced in brain activity at rest. Comparing 35 young adults in their first episode of major depressive disorder, none of them yet treated, with 35 matched healthy controls, Zhu and colleagues found connectivity across the anterior default mode network, which takes in the medial prefrontal cortex and anterior cingulate, to be higher in the patients, and within the patient group stronger anterior connectivity went with higher rumination scores (Zhu et al., 2012). The link is correlational, and the sample was limited to young adults in a first, untreated episode. The brain networks subsection of the biological accounts sets out the wider evidence, which is contested and includes a larger study that found connectivity in this network reduced rather than raised, though only in recurrent depression and not in first-episode drug-naive patients.

Biased Attention, Memory and Thinking

Depression is associated with a tilt in cognitive processing toward negative material. Gotlib and Joormann reviewed evidence on how depressed people elaborate negative information and struggle to use positive stimuli to regulate negative mood, and they connected these patterns to cognitive control, working memory and inhibitory processes that bear on rumination; they also called for integrative studies that bring in neural and genetic factors (Gotlib & Joormann, 2010). One laboratory study of 101 adults, 22 currently with major depressive disorder, 47 remitted and 32 healthy controls, used a negative affective priming task and found that the currently depressed group inhibited negative material less well; within that group alone, weaker inhibition went with more rumination, and because the design was correlational it cannot show which comes first (Joormann & Gotlib, 2010).

Attention

Attentional bias is the best quantified of these tendencies. A meta-analysis of 29 studies of depressed, dysphoric and mood-induced participants found that dot probe studies showed a bias toward negative stimuli of d = 0.52, whereas the emotional Stroop effect was only marginally significant, and no moderator reached significance in tests with limited power (Peckham et al., 2010). How well such tasks capture bias is itself in question. The standard dot-probe bias score has poor reliability, which limits what it can reveal; Rodebaugh and colleagues showed the problem in their own data from 24 patients with anxiety disorders and put forward trial-level bias scores as an alternative that still needs replication (Rodebaugh et al., 2016). Gaze measures share the reliability problem. In the eye-tracking studies the same paper reviewed, the indices most often used showed low to modest reliability, and in one study global eye-tracking measures had split-half reliability below .40, whereas indices computed across a whole five-second trial held up well (Rodebaugh et al., 2016). Eye tracking follows gaze directly, though it misses covert attention, and a meta-analysis of 33 such experiments suggested that in depression the bias lies less in orienting toward threat than in weaker orienting to positive stimuli and longer gaze held on dysphoric ones, findings that rest on only four to six depression studies per comparison (Armstrong & Olatunji, 2012).

Interpretation

Interpretation bias is the habit of settling ambiguous information, such as an unclear remark or an uncertain outcome, on its negative reading. Pooling 87 studies with N=9443, a meta-analysis put the link between depression and this bias at g=0.72 (95% CI 0.62 to 0.82), with similar sizes in clinical depression, remitted depression and elevated symptoms (Everaert et al., 2017). The bias showed up both as negative readings and as a missing positive one. It was larger when the material referred to the self, while instructing participants to use mental imagery made no significant difference (Everaert et al., 2017). Method mattered most: direct measures produced the effect, but indirect measures gave g=0.04, which was not significant, so the authors caution that methodological choices shape what the evidence appears to show (Everaert et al., 2017).

Memory

Memory shows a parallel pattern. Williams and colleagues linked overgeneral autobiographical memory, in which people retrieve summaries of repeated events instead of specific episodes, to emotional disorder, and elaborated a model in which capture and rumination, functional avoidance and limited executive capacity and control each contribute (Williams et al., 2007a). Neuroimaging studies of remembering one's own past converge on a core brain network that it shares with imagining the future and understanding other minds, a network that overlaps the default mode (Spreng et al., 2009). In the untreated first-episode sample described under rumination, depressed young adults with weaker connectivity in the posterior default mode network, centred on the posterior cingulate and precuneus, tended to produce more overgeneral memories, a correlation that cannot show which comes first (Zhu et al., 2012).

How the Biases Interact

The combined cognitive bias hypothesis holds that these biases are not independent but interact. Everaert, Koster and Derakshan reviewed behavioral studies showing that attention, interpretation and memory biases are interrelated in depression, while noting that it remained unclear whether single or multiple biases matter most and how well the biases predict later symptoms (Everaert et al., 2012). A test followed two years later: tracking the eye movements of 71 undergraduates with a broad range of depression scores (62 women and 9 men), Everaert and colleagues found that a path model running from attention bias through interpretation bias to memory bias fitted the data, although the cross-sectional design rules out causal conclusions and in that path model depression scores did not predict memory bias directly, although the two were correlated (Everaert et al., 2014). The hypothesis therefore remains a proposal: the 2014 test was cross-sectional and cannot show causation, although its authors reported that a follow-up study replicated the result, and which biases matter most is still unsettled (Everaert et al., 2012; Everaert et al., 2014).

Executive Control and Disengagement

Broader deficits appear on neuropsychological tests. Across 113 studies with 7,707 participants, major depressive disorder was associated with impairment across many aspects of executive function, with effect sizes from d = 0.32 to 0.97, but the meta-analysis could not establish whether the impairment causes depression or whether it is specific to the disorder (Snyder, 2013). A meta-analysis of studies using the CANTAB battery found that cognitive deficits persisted beyond mood episodes into remitted depression, although memory deficits in remitted patients were not significant (Rock et al., 2014).

The impaired disengagement hypothesis offers one account of why control problems matter. Koster and colleagues proposed that depressed people find it hard to pull attention away from negative material: when conflict signalling is weak or attentional control is low, negative content stays in focus, rumination set off by a stressor is drawn out, and the repeated cycle can settle into habitual brooding (Koster et al., 2011). The paper is a theoretical narrative review that outlined how its causal predictions could be tested; many of the studies it draws on used undergraduates, and, citing an earlier review, it described the general deficit in attentional control as not very large and seen mostly in severe depression (Koster et al., 2011). The hypothesis has been supported in part. Sanchez and colleagues tracked eye movements in people with major depressive disorder and in controls who had never had a disorder. The depressed group needed more time to move their gaze off sad faces, and within that group, slower disengagement predicted weaker recovery of sad mood after a stress induction (Sanchez et al., 2013). The authors suggested that this difficulty may help keep negative affect going, but the study does not show that it causes that affect (Sanchez et al., 2013).

At the level of brain networks, a meta-analysis of 27 seed-based resting-state datasets (556 people with major depressive disorder, 518 controls) reported an imbalance in connectivity across large-scale networks, including the frontoparietal control network, the default network and the dorsal attention network, with hypoconnectivity in some pathways and hyperconnectivity in others (Kaiser et al., 2015). The authors cautioned that only seed-based studies were pooled, that methods varied across them, that anatomical specificity should be read with care, and that it remains unclear how resting patterns relate to performance during a task (Kaiser et al., 2015).

Testing Whether Biases Cause Depression

A bias that accompanies depression need not help cause it, and three kinds of study take up the question. The first follows people before they become ill. College freshmen, 347 of them and free of any disorder at the start, were grouped by negative cognitive style and tracked for 2.5 years; compared with the low-risk group, those at high cognitive risk showed 3.5-6.8 times greater odds of hopelessness, major and minor depression, counting both first onsets and recurrences (Alloy et al., 2006). The prediction was only partly specific to depression: the risk groups did not differ in pure anxiety, yet high-risk students more often developed anxiety that came together with depression (Alloy et al., 2006).

A second approach, framed in diathesis-stress terms around cognitive reactivity and the activation of vulnerable constructs, relies on priming and longitudinal designs. Reviewing that work, Scher and colleagues concluded that cognitive vulnerability to unipolar depression has support in adults and growing support in children, whereas evidence on direct links to onset, relapse and recurrence was building more slowly (Scher et al., 2005).

The third approach is experimental: it tries to change the biases and watches for a change in symptoms. Pooling 49 randomized trials of cognitive bias modification, Cristea and colleagues found an effect on depression, across the 17 trials that measured it, of g = 0.43 that shrank to 0.33 once two outliers were set aside and to a non-significant 0.09 after trim-and-fill adjustment for publication bias; trial quality was suboptimal, and their verdict was that the effects are small, or none (Cristea et al., 2015). On balance, prospective studies support negative cognition as a vulnerability for depression, while experimental attempts to alter the biases have so far produced only weak effects.

Is Depression More Realistic?

Depressive realism is the claim that mildly depressed people judge some aspects of reality more accurately than nondepressed people. In four experiments, Alloy and Abramson asked depressed and nondepressed students how much control their button presses had over the onset of a green light. The depressed students judged contingency accurately, whereas the nondepressed students overestimated contingency when noncontingent outcomes were frequent or desired, and the authors evaluated both learned helplessness and a self-serving motivational bias as explanations; predictions drawn from learned helplessness theory received minimal support at best (Alloy & Abramson, 1979). All participants were students.

The meta-analytic picture is more limited. Moore and Fresco pooled 75 studies with 7305 participants and found a small overall depressive realism effect, d = -.07 (Moore & Fresco, 2012). The effect depended on the methodological paradigm, was stronger when no objective standard of reality was available and when depression was assessed by self-report, and nondepressed people showed a larger positive bias than depressed people. A preregistered replication with 246 online workers and 134 undergraduates found depressive symptoms unrelated to both illusory control and overconfidence, although its summary reported no effect sizes (Dev et al., 2022). Depressive realism is therefore contested: the pooled effect is small and shifts with the paradigm, and a preregistered attempt to reproduce it did not succeed (Moore & Fresco, 2012; Dev et al., 2022).

Interactive demonstration

How much control do you have over the light?

Choose a condition, then on each of 20 trials either press the button or wait, and watch whether the light comes on. At the end, rate how much control you think you had. Mix pressing and waiting so the two can be compared.

Trial 1 of 20
Light after pressing: 0% of 0 trials. Light after waiting: 0% of 0 trials. Actual control (the difference): 0 points.
An illustrative version of the button-press contingency task used by Alloy and Abramson (1979); outcomes follow fixed sequences rather than chance, and the actual contingency is computed from your own trials. A meta-analysis of 75 studies found a small overall depressive realism effect, d = -.07, that depended on the paradigm (Moore and Fresco, 2012).

Behavioral and Interpersonal Accounts

Not every psychological account of depression is cognitive. Two other families of theory place the problem elsewhere: one in what a person does and how far that activity is rewarded, the other in how relationships respond.

Reinforcement and Activity

On the behavioral model of depression, the changes seen in the disorder arise when positive reinforcement is low (Manos et al., 2010). In an early study by Lewinsohn, ninety men and women in three diagnostic groups gave daily self-reports for 30 consecutive days: mood was significantly related to the number of pleasant activities in every group, and depressed participants reported fewer of them (Lewinsohn & Graf, 1973). A narrative review roots behavioral activation in Lewinsohn's behavioral model (Dimidjian et al., 2011), so the behavioral activation arm of the 1996 component trial (Jacobson et al., 1996) and the stand-alone treatment set out in 2001 (Jacobson et al., 2001), both described under How Psychological Treatments Are Thought to Work, came out of this older tradition.

Behavioral activation has trial support, with reservations. In a meta-analysis of 26 randomized controlled trials (1524 participants) it outperformed control conditions by a large margin (SMD −0.74) and antidepressant medication by a moderate one (SMD −0.42), but the medication result rests on only 4 trials and a confidence interval that touches zero, most trials were of low quality, follow-up periods were short, and the effect shrank at 6–9 months (Ekers et al., 2014).

Whether behavioral activation works for the reason the model gives is a separate question. A critical review of the psychopathology model and of the mechanism theory behind behavioral activation suggested improvements in the measurement of activation and reinforcement so that both could be tested (Manos et al., 2010). The model therefore stands as revised: it survives as the basis of behavioral activation, with its proposed mechanism still to be properly tested.

Reassurance Seeking and Stress Generation

A 1976 paper by Coyne set out an interactional description of the disorder (Coyne, 1976), and the interactional theory of depression that originated with him ties excessive reassurance seeking both to depression and to rejection by others (Starr & Davila, 2008). Two meta-analyses found both links as concurrent associations: reassurance seeking correlated with depression at r = .32 across 38 studies (N = 6,973) and, more weakly, with interpersonal rejection at .14 across 16 studies (Starr & Davila, 2008). The depression association was larger in self-report than in interview studies, and the rejection association was larger for target-reported than for informant-reported rejection; the authors read the results as supporting the model with several important caveats, and they reviewed prospective studies only qualitatively (Starr & Davila, 2008). A later, larger meta-analysis pooling 134 effects from 102 studies found depression moderately and positively correlated with excessive reassurance seeking (r = .33, 95% CI [.31, .36], k = 103) and with negative feedback seeking, a second interpersonal behavior (r = .26, 95% CI [.21, .32], k = 31), and neither symptom severity nor gender moderated the effects (Wakeling et al., 2020). A narrative review describes interpersonal theories of depression as positing that depressed people interact in ways that elicit rejection, which raises the risk of later depression, and still calls for integrative models and better measurement of interpersonal constructs (Hames et al., 2013); the associations are replicated, but the causal chain the theory proposes is not established.

The stress generation hypothesis holds that depression predicts later dependent stress, meaning stressful events that the person has some part in bringing about. Hammen put the idea forward after interviewing 60 women about life events over 1 year: 14 had unipolar depression, and the other three groups comprised 22 women with neither an illness nor a disorder, 13 with a chronic medical illness and 11 with bipolar disorder (Hammen, 1991). Stress from interpersonal events was significantly greater for the unipolar women than for all the others, and dependent events also tended to be more numerous for them, though that was a tendency only, in small groups; Hammen concluded that women with unipolar depression probably generate their own stress (Hammen, 1991). A systematic review of 57 articles found the pattern replicated and the support substantial, while still calling for more research (Liu & Alloy, 2010). Stress generation was more specific to depression than to anxiety, in one comparison of 59 people recurrent depression went with more dependent events than first-onset depression, and in individual studies reassurance seeking itself predicted interpersonal stress, although many of the studies measured stress by self-report (Liu & Alloy, 2010). A later, larger systematic review with a Bayesian meta-analysis of 104 studies (N = 31,541) found generally strong support for the claim that psychopathology predicts subsequent dependent stress, and predicts it more strongly than independent stress; its effect sizes (d) of 0.36 to 0.52 describe psychopathology overall, not depression alone (Liu et al., 2024). Effects were larger over shorter follow-ups and with self-report than with interviews, and mediation by dependent stress was tested in relatively few studies, which were reviewed only qualitatively and which the authors read as generally supportive (Liu et al., 2024). A preregistered multilevel meta-analysis of 95 longitudinal studies (38,228 participants) found the same asymmetry: psychopathology predicted subsequent dependent stress more strongly (r = .23) than subsequent independent stress (r = .10) (Rnic et al., 2023). Stress generation appeared across a range of diagnoses and its effects were larger for depression than for anxiety, although the authors note that depression accounts for most of the effect sizes published to date (Rnic et al., 2023).

Interpersonal psychotherapy is the treatment named for this interpersonal focus. In a meta-analysis of randomized trials (thirty-eight studies, 4,356 patients) it did better than control conditions across 16 studies (d = 0.63), did not differ significantly from other psychotherapies across ten studies, and was somewhat less effective than pharmacotherapy (d = -0.19, with one outlier removed); combination treatment did no better than interpersonal psychotherapy alone, a comparison that few studies have made (Cuijpers et al., 2011).

The interactional theory is supported in part, by concurrent associations that cannot show reassurance seeking to cause depression or rejection. The stress generation hypothesis is also supported in part, by a replicated prospective pattern that does not by itself establish depression as the cause of the later events.

Biological Accounts

Serotonin and Monoamines

The serotonin hypothesis of depression, the idea that depression results from too little serotonin activity, remains contested (Moncrieff et al., 2023; Jauhar et al., 2023). An umbrella review of 17 studies, most of them systematic reviews and meta-analyses, found no consistent association between serotonin and depression (Moncrieff et al., 2023). The authors rated evidence on 5-HT 1A receptor binding and the serotonin transporter as weak, found the tryptophan depletion evidence weak and limited to people with a family history of depression, and noted that many included studies did not exclude prior antidepressant use, which might itself lower serotonin. The underlying reviews overlapped, were not pooled and varied in quality, so the review weighs the evidence rather than settling the biology. Jauhar and colleagues answered in a critical commentary that the umbrella review had overstated its null conclusion, and they pointed to tryptophan depletion results and to PET imaging of the 5-HT 1A receptor and the serotonin transporter as evidence it had not given due weight (Jauhar et al., 2023). Their reply has limits of its own: the depletion effects came with wide confidence intervals, some of those studies came from the same research group, removing a potential outlier shrank the pooled effect, and several of the commentary's authors declared ties to the pharmaceutical industry (Jauhar et al., 2023). Some commentators hold that the simple form of the hypothesis had lost ground before this exchange: an editorial critique of the umbrella review described the hypothesis, which dates from 1967, as long faulted for one-sidedness and since replaced by neurobiological theories of greater complexity, and its authors, unsurprised by the review's negative findings, still judged that the theory remains relevant, though only in part (Möller & Falkai, 2023), while an earlier commentary had called simple theories tying low serotonin to low mood untenable (Cowen & Browning, 2015). A content analysis points the other way on what the profession held: among 30 papers on serotonin and depression and 30 etiology reviews, all highly cited, and influential textbooks sampled from 1990 to 2010, the majority of the reviews supported the theory, most of the papers supported it strongly and every textbook supported it in at least some sections, some of them noting that it remained provisional (Ang et al., 2022), so the disagreement here concerns the theory's past standing, and it remains unresolved.

Glutamate

A narrative review makes the case for a glutamate hypothesis of depression: it casts the glutamate system as a primary mediator in mood disorders, proposes that stress increases glutamate transmission (a link drawn from animal models) and shifts the emphasis away from monoamines and toward neuroplasticity (Sanacora et al., 2012). The review itself calls the hypothesis putative and describes glutamate as potentially a final common pathway through which antidepressants act (Sanacora et al., 2012); the hypothesis is proposed, not established. Forty-nine studies whose technique was proton magnetic resonance spectroscopy were pooled in a meta-analysis covering 1066 healthy controls and 1180 patients, which found the combined glutamate-plus-glutamine measure (Glx) lower in patients' medial frontal cortex, a standardized mean difference (SMD) of −0.38 with a 95% CI from −0.69 to −0.07 (Moriguchi et al., 2019). The difference from controls was significant in medicated patients (SMD −0.50; CI from −0.80 to −0.20) and not significant in unmedicated ones (SMD −0.27; CI from −0.76 to 0.21), though it became significant in unmedicated patients as well once one study was left out, and the authors found the treated and untreated groups hard to compare because the studies were so heterogeneous (Moriguchi et al., 2019). The authors' conclusion was hedged, namely that depression may involve such an abnormality, and it agrees with the glutamate hypothesis (Moriguchi et al., 2019). Ketamine's antidepressant action has been attributed to inhibition of NMDA receptors, among other proposed mechanisms (Zanos & Gould, 2018); the subsection How Brain Stimulation and Ketamine Are Thought to Work covers them.

Inflammation

The cytokine theory of depression ties low mood to inflammation. Dantzer and colleagues reviewed evidence that inflammation produces sickness behaviour and that, when this response becomes maladaptive, it can lead to depression in vulnerable people; they described the similarity between sickness and depression as only partial, the human studies as mostly cross-sectional and the mechanisms as still in their infancy (Dantzer et al., 2008). A meta-analysis of 24 studies found higher concentrations of TNF-alpha (weighted mean difference 3.97 pg/mL) and IL-6 (1.78 pg/mL) in people with major depression than in controls, but no significant difference for other cytokines, and all measures were unstimulated (Dowlati et al., 2010). A later meta-analysis comparing 3212 participants with major depressive disorder against 2798 healthy controls again found IL-6 and TNF-alpha raised, yet several other cytokines showed no significant difference, heterogeneity between studies was large and only peripheral levels were measured (Köhler et al., 2017). The cytokine theory is therefore supported to the extent that IL-6 and TNF-alpha are raised in major depressive disorder, with two qualifications: the raised markers sit amid large heterogeneity between studies, and several cytokines show no alteration at all (Köhler et al., 2017).

Stress Hormones

Overactivity of the hypothalamic-pituitary-adrenal (HPA) axis, the hormonal system that ends in cortisol release, has been reported in major depression across roughly 40 years of research, although how that overactivity arises and how it might contribute to the disorder are still unclear (Pariante & Lightman, 2008). A meta-analysis pooling 671 effect sizes from 361 studies and 18,454 individuals found that depressed people had higher cortisol than nondepressed people (d = 0.60) and higher adrenocorticotropic hormone (d = 0.28), while corticotropin-releasing hormone did not differ significantly (d = 0.02) (Stetler & Miller, 2011). Counting only the methodologically sound studies, the cortisol difference was smaller, at d = 0.33 (Stetler & Miller, 2011). It was wider in older, hospitalised samples than in younger outpatients, and wider again where depression had melancholic or psychotic features; men and women did not differ, and methodological differences between studies limited the comparisons (Stetler & Miller, 2011).

The standing is that HPA hyperactivity is a reliable average finding in depression, but its size varies a good deal with the patient group and the study method.

Neurotrophic Factors

The neurotrophic hypothesis of depression proposes that reduced brain-derived neurotrophic factor contributes to depression and that antidepressants act partly by raising it. Duman and Monteggia set out the case in a critical review that acknowledged some limitations and treated the role of other growth factors as only possible (Duman & Monteggia, 2006). Pooled data from 2384 antidepressant-free depressed patients and 2982 healthy controls did show lower serum BDNF in depression, but the gap was smaller in newer and larger studies, publication bias inflated the effects, and BDNF levels bore no consistent relation to symptom severity (Molendijk et al., 2014). The neurotrophic hypothesis is supported to the extent that serum BDNF is lower in depression, but the evidence is noisier than first thought and the effect smaller in newer, larger studies (Molendijk et al., 2014).

Genetics

Genetics shows the clearest revision. Carriers of a short allele in the promoter of the serotonin transporter gene responded worse to stressful life events than other members of a representative birth cohort tracked prospectively: for them, such events led to more depressive symptoms and more suicidality (Caspi et al., 2003). The candidate gene-by-environment hypothesis that grew from such findings is now superseded: preregistered analyses in samples of 62,138 to 443,264 people found no support for 18 candidate genes or for their interaction with childhood abuse or socioeconomic adversity, the candidates performed no better than noncandidate genes, and the authors judged earlier positive findings likely to be false positives (Border et al., 2019). Genome-wide work has replaced that approach. Pooling three cohorts totalling 807,553 people, 246,363 with depression, a genome-wide meta-analysis found 102 independent variants and enrichment in prefrontal brain regions, and 87 of the variants held up in a replication sample of 1,306,354; the depression phenotypes, however, were broad and often self-declared (Howard et al., 2019).

Reward and Motivation

Reward processing offers a link to motivation. Treadway and Zald argued that anhedonia should be split into a consummatory part (pleasure in reward) and a motivational part (pursuit of reward), and found the evidence tying dopamine to anhedonia contradictory; the review presented no new data (Treadway & Zald, 2011). In a functional imaging study using a monetary incentive delay task, 30 unmedicated people with major depressive disorder showed a weaker striatal response to monetary gains than 31 healthy comparison participants; the nucleus accumbens result did not survive correction and was treated as preliminary, and activation did not correlate with anhedonia (Pizzagalli et al., 2009). Pizzagalli's stress and anhedonia model proposes that stress disrupts dopaminergic reward learning and so produces anhedonia, with the probabilistic reward task as one measure; he called the model heuristic and its evidence initial, and much of the stress-dopamine link comes from animal data (Pizzagalli, 2014). The model therefore remains a proposal: a heuristic framework that rests so far on initial evidence (Pizzagalli, 2014).

Animal Models

Animal models raise their own questions. Porsolt and colleagues introduced a forced swim model of depression sensitive to antidepressant treatments (Porsolt et al., 1977). In a commentary, Molendijk and de Kloet argued that immobility in the forced swim test is an adaptive shift from active to passive coping, not a sign of depression, and that treating it as one reads rodent behaviour anthropomorphically (Molendijk & de Kloet, 2015).

Sleep and Circadian Rhythms

Poor sleep may come before depression, and it is also something depression shares with other conditions. A meta-analysis pooling twenty-one longitudinal epidemiological studies, published between 1980 and 2010, found that insomnia at baseline raised the risk of later depression (OR = 2.60, CI: 1.98-3.42) (Baglioni et al., 2011). The studies were heterogeneous and did not always account for confounders. Once outliers were adjusted for they became homogeneous, and the estimate was OR = 2.10 (CI: 1.86-2.38) (Baglioni et al., 2011).

Sleep changes are not unique to depression, however. Controlled polysomnography studies, pooled in a later meta-analysis, found sleep continuity problems in most of the mental disorders examined and changes in sleep depth and REM pressure in a smaller set that included mood and anxiety disorders, and no single sleep parameter was exclusive to any one disorder (Baglioni et al., 2016). Two conditions showed no alterations: attention-deficit/hyperactivity disorder and seasonal affective disorder, the condition described under Seasonal Pattern above (Baglioni et al., 2016). REM changes in depression are therefore genuine but shared, which limits their worth as a marker on their own, although no two disorders showed the same overall sleep profile.

Circadian rhythms offer a second route. These are cycles of roughly 24 hours, set by a master clock in the hypothalamus. A narrative review argued that disrupted rhythms and mood disorders affect each other in both directions, whether the disruption comes from night-shift work, jet lag or artificial light at night, with the effects falling on susceptible individuals (Walker et al., 2020). Direct interactions between the two have been studied only recently, and the reviewers treated the benefits of lifestyle change as presumed, not shown (Walker et al., 2020).

Brain Networks

Imaging research has also asked how large-scale brain networks communicate in depression. The best-known network account, the default mode network hyperconnectivity hypothesis, ties depression to excess connectivity within the default mode network. Its standing is contested, because a large multisite study found that connectivity fell rather than rose (Yan et al., 2019).

The hypothesis grew from resting-state work. Its founding study applied independent component analysis to resting-state fMRI from 28 people with depression and 20 healthy controls, and found that the subgenual cingulate and the thalamus contributed more to the default-mode network in the depressed group, with a large effect in the subgenual cingulate (Cohen's d = 1.01) (Greicius et al., 2007). Medication exposure may confound that comparison, because the controls were unmedicated (Greicius et al., 2007). A meta-analysis of seed-based resting-state functional connectivity studies pooled 27 datasets with 556 people with major depressive disorder and 518 controls. It found connectivity among large-scale networks out of balance in depression, with hyperconnectivity in some pairings and hypoconnectivity in others, involving the default, frontoparietal, affective and attention networks (Kaiser et al., 2015). The analysis covered seed-based studies only, and their methods varied. It could not tell whether the pattern belongs to rest or to task states, and the authors urged caution about anatomical specificity (Kaiser et al., 2015).

A review that paired meta-analyses with a proposed model linked depressive rumination to hyperconnectivity between the default-mode network and the subgenual prefrontal cortex, while blood flow within the network itself appeared normal (Hamilton et al., 2015). This connects the imaging work to the response styles research on rumination described earlier. The authors acknowledged that the model supplies no mechanism for the connectivity and rests on functional connectivity findings whose meaning in fMRI is poorly understood. Its predictions have yet to be tested (Hamilton et al., 2015).

The main challenge came from the REST-meta-MDD Consortium. Pooling resting-state fMRI from 17 sites, it compared 848 patients with major depressive disorder with 794 controls and found default mode network functional connectivity decreased, not increased (Yan et al., 2019). The decrease appeared only in recurrent depression and not in first-episode drug-naïve patients. It was tied to medication rather than to how long the illness had lasted, it was linked to severity only in the recurrent group, and findings for other networks were exploratory (Yan et al., 2019).

Whether default mode connectivity rises or falls in depression is therefore unsettled.

Evolutionary Accounts

Evolutionary accounts ask whether low mood has a function. Nesse proposed that low mood, including its pessimism and lack of motivation, may confer a fitness advantage in unpropitious situations, while describing the evidence as only consistent with the idea and calling for specific tests (Nesse, 2000). Andrews and Thomson went further with the analytical rumination hypothesis, which treats depression, including its rumination, anhedonia and psychomotor changes, as an evolved aid to analyzing complex problems with limited processing resources; they drew evidence from many levels and challenged the belief that depression reflects low serotonin (Andrews & Thomson, 2009). A critical review two years later treated low mood as a possibly adaptive response to adversity, while observing that the line between healthy sadness and major depressive disorder is still debated and that what costly symptoms might gain remains unknown (Hagen, 2011). The analytical rumination hypothesis therefore remains contested, because whether symptoms this costly bring any benefit is still an open question (Hagen, 2011).

Culture and Social Context

Estimates of how common depression is differ widely between countries. In surveys across 18 countries, 12-month prevalence ranged from 2.2% in Japan to 10.4% in Brazil (Kessler & Bromet, 2013). Lifetime rates were higher in high-income countries, yet 12-month rates were similar across income groups, and part of the spread may be methodological, reflecting differences in diagnostic thresholds rather than real differences in risk (Kessler & Bromet, 2013). Direct data are missing for most countries, although where data exist the age at onset and the tendency to become chronic were broadly consistent (Kessler & Bromet, 2013). The figures therefore show that estimates vary, not why they vary, and much of the world is absent from the evidence: the surveys leave most countries uncovered, and the qualitative work described earlier drew mostly on high-income countries.

Culture also shapes which symptoms people bring forward. The comparison of Chinese and Euro-Canadian outpatients described above found somatic complaints more prominent among the Chinese patients and psychological ones among the Euro-Canadians, with the psychological difference the more robust (Ryder et al., 2008).

Social position matters as well. A random-effects meta-analysis found that people of low socioeconomic status were more likely to be depressed (OR = 1.81 for prevalence), with a smaller excess for new episodes (OR = 1.24) and a larger one for persistence (OR = 2.06), so lower status was tied more strongly to depression continuing than to its onset (Lorant et al., 2003). Only five incidence and four persistence studies were available, and results were heterogeneous, shifting with how status was defined and how the disorder was measured (Lorant et al., 2003). Perceived discrimination is also linked to poorer mental health: across 110 studies of mental health outcomes, the sample-weighted average correlation was r = −.20 (Pascoe & Smart Richman, 2009). Those are zero-order correlations, they concern discrimination as people perceive it rather than as verified, and because few studies used experimental or longitudinal designs, the direction of the pathways the authors proposed through stress responses and health behaviors could not be fully determined (Pascoe & Smart Richman, 2009).

Stigma is linked to whether people seek help. Across 144 studies with 90 189 participants, mental health stigma was associated with less help-seeking, a small effect (d = -0.27), and the most consistent links involved internalized stigma and stigma attached to treatment (Clement et al., 2015). A large proportion of the association studies were cross-sectional, most studies were conducted in the USA or Canada, and the review concerned mental health problems in general rather than depression alone (Clement et al., 2015). These findings place the cognitive accounts above in a social setting: the biased thinking and rumination this page describes arise in people whose circumstances and cultures differ widely, and the evidence base still underrepresents most of the world.

Disparities in Depression

Sexual and gender minorities carry an excess burden of depression, and the leading explanation is social. Reviewing studies that compared lesbian, gay and bisexual (LGB) adults with heterosexual adults, Meyer concluded that mental disorders were more prevalent in the LGB groups and attributed the excess to minority stress: distal stressors such as prejudice events, and proximal ones such as expectations of rejection, concealment and internalized homophobia (Meyer, 2003). He noted that epidemiological studies were few, that sexual orientation was defined in varied ways and that the stress processes were inferred rather than examined directly. A later meta-analysis of 25 studies, covering 11,971 non-heterosexual and 214,344 heterosexual people, found 12-month depression at least twice as likely and lifetime suicide attempts about two and a half times as likely (RR 2.47) in LGB people; only one study met all four quality criteria and samples were often unrepresentative (King et al., 2008). In transgender and gender diverse people, a meta-analysis of 85 cross-sectional studies linked all four minority stress processes with depression, suicidal ideation and suicide attempts, with expectations of rejection and internalized transphobia showing larger effects than distal stress or concealment; its authors called for longitudinal designs and more representative samples (Pellicane & Ciesla, 2022). The section on Suicide and Self-Harm takes up suicidality in more detail.

Prevalence and course do not rank ethnic groups in the same order. In a national household probability survey of 6,082 adults, lifetime major depressive disorder was most common in non-Hispanic whites (17.9%), then Caribbean blacks (12.9%), then African Americans (10.4%), while 12-month rates were similar across groups (Williams et al., 2007b). Chronicity ran the other way: 56.5% of affected African Americans and 56.0% of Caribbean blacks had chronic depression against 38.6% of whites, severity and disability were greater in both black groups, and most affected black respondents had received no treatment.

Detection and treatment show their own gaps. Across 96,075 adult office visits from 1995 to 2005, disparities in psychiatric settings largely narrowed, although Black patients were diagnosed less often than White patients in every period; in primary care, Black and Hispanic patients received fewer antidepressant prescriptions and the gaps did not shrink over time (Stockdale et al., 2008). The unit was the visit rather than the patient, and office staff recorded race. Among 8,762 adults in pooled national surveys, the share of depressed people with no treatment in the past year was 40.2% for non-Latino whites, set against 58.8% for African Americans, 63.7% for Latinos and 68.7% for Asian Americans; among those who did enter treatment, African Americans were particularly unlikely to receive adequate care, and all service use was self-reported (Alegría et al., 2008). One response is cultural adaptation: across 16 trials with 4,162 participants, adapted psychological treatments outperformed control conditions by a large margin (SMD −0.72), with similar effects in Western and non-Western settings, though heterogeneity was substantial (I² = 90%) and only two weak trials compared adapted with unadapted versions directly (Chowdhary et al., 2014).

Age reshapes risk at both ends of life. Two meta-analyses spanning more than 90 nations put women's excess at OR = 1.95 for diagnoses and d = 0.27 for symptoms, with the gap widening sharply in early adolescence (OR = 3.02 at ages 13 to 15) and, for diagnoses but not symptoms, larger in more gender-equal nations (Salk et al., 2017). A review of youth depression described rising rates, especially in girls, named family history, social stressors, chronic illness and sexual minority status as risk factors, and favoured indicated or targeted prevention over universal programmes (Thapar et al., 2022). At the other end, a national survey of 9,282 adults found 12-month major depressive episodes in 2.6% of those aged 65 and over against 8.3% overall, and fewer severe episodes in the oldest group, while episode duration did not differ significantly by age (p = .21) (Kessler et al., 2010).

Comorbidity

Depression rarely arrives alone, and anxiety is its most frequent companion. Baseline data from the Netherlands Study of Depression and Anxiety (N = 1,783) showed that 67% of participants with a current depressive disorder also had a current anxiety disorder, and 63% of those with an anxiety disorder were currently depressed; where both had occurred, anxiety came first in 57% of cases and depression first in only 18% (Lamers et al., 2011). Comorbid cases in that cohort reported more childhood trauma and neuroticism, earlier onset, and longer and more severe symptoms than pure cases, and the authors advised assessing both conditions routinely (Lamers et al., 2011). Part of the overlap appears to be inherited. Among 37,296 Swedish twins, the genetic correlation between lifetime major depression and generalized anxiety disorder was +1.00 in women and +0.74 in men, with genes for neuroticism accounting for about 25% of the shared genetic covariance; the diagnoses were modified DSM-IV categories from interview (Kendler et al., 2007). The combination also matters for treatment. In a secondary analysis of 2,876 STARD outpatients, those with anxious depression* remitted less often, took longer to remit, reported more side effects and fared worse at the second treatment level than nonanxious patients (Fava et al., 2008).

Trauma and substance use form a second cluster. A meta-analysis of 57 studies covering 6,670 people with current posttraumatic stress disorder put the share with co-occurring major depressive disorder at 52% (95% CI [48, 56]) (Rytwinski et al., 2013). Rates were higher in military than civilian samples and after interpersonal trauma than after natural disaster, but these differences emerged only once outliers were removed, while gender, U.S. nationality and referral type made no significant difference (Rytwinski et al., 2013). In the cross-sectional NESARC-III survey of 36,309 U.S. adults, DSM-5 major depressive disorder was associated with generalized anxiety disorder (aOR 5.7), specific phobia (aOR 2.1), alcohol use disorder (aOR 1.8) and any drug use disorder (aOR 3.0) (Hasin et al., 2018).

Chronic physical illness raises the burden further. Across 245,404 adults in 60 countries surveyed by the World Health Survey, depression lowered health scores more than angina, arthritis, asthma or diabetes did, and people with depression plus a chronic disease had worse health than those with either condition alone (Moussavi et al., 2007). Of 42 studies, the 20 with a nondiabetic comparison group showed diabetes doubling the odds of depression (OR = 2.0, 95% CI 1.8–2.2), an estimate that held across sex, diabetes type, sample source and assessment method even though prevalence ran higher with self-report (31%) than with diagnostic interview (11%) (Anderson et al., 2001). Prospective data suggest the direction is uneven: across 20 studies, baseline depression predicted incident type 2 diabetes (RR = 1.60) more strongly than baseline diabetes predicted incident depression (RR = 1.15), a reverse link the authors judged only modest, with heterogeneity and variable confounder adjustment among the studies (Mezuk et al., 2008).

Cardiovascular disease, stroke and pain show the same pattern. An American Heart Association statement that reviewed 53 studies and four meta-analyses linked depression to adverse outcomes after acute coronary syndrome, including all-cause and cardiac mortality, while noting heterogeneity in measurement, follow-up and covariates (Lichtman et al., 2014). After stroke, a meta-analysis of 61 studies and 25,488 people estimated depression frequency at 31% (95% CI 28% to 35%), with wide variation between studies and no fall relative to an earlier review (Hackett & Pickles, 2014). Pain and depression worsen each other: a literature review found pain more common in depressed cohorts and depression more common in pain cohorts, poorer recognition and outcomes of depression when pain was present, and more pain complaints and impairment among depressed patients, and it concluded that the two need joint assessment and treatment (Bair et al., 2003). Disorder-level detail is given in the comorbidity section of the major depressive disorder page.

Suicide and Self-Harm

Depression raises suicide risk, but it predicts individual outcomes poorly. Pooling 357 prediction cases from 166 longitudinal papers published between 1971 and 2014, one meta-analysis found that depression and hopelessness each forecast later suicidal ideation, attempts and death, with effects weaker than anticipated that grew smaller as the outcome grew more severe: the overall weighted odds ratios were 1.96 for ideation, 1.63 for attempts and 1.33 for death (Ribeiro et al., 2018). Hopelessness outperformed depressive symptoms, and symptom scores did not significantly predict death; the authors also reported publication bias, high heterogeneity and estimates that shrank once bias was adjusted for. A wider meta-analysis of 365 studies spanning 50 years reached a starker verdict, finding that the broad categories of risk factor predicted suicidal thoughts and behaviours only slightly better than chance, with no gain in accuracy across the decades; its authors called for a move toward machine-learning risk algorithms (Franklin et al., 2017). Among people already diagnosed with depression, a systematic review of nineteen studies identified male gender, a family history of psychiatric disorder, a previous attempt, severe depression, hopelessness, comorbid anxiety and alcohol or drug misuse as risk factors for suicide, and recommended that clinical risk assessment include them, while noting that the studies were fewer than expected and that the factors' interdependence was not examined (Hawton et al., 2013).

Self-harm covers acts with and without suicidal intent. Pooled estimates of nonsuicidal self-injury (NSSI) from nonclinical samples in many countries differ by age, at 17.2% for adolescents, 13.4% for young adults and 5.5% for adults, and once study methods were taken into account the rates showed no upward trend over time (Swannell et al., 2014). Those estimates varied widely, and the review attributed much of the spread to method, arguing that standardized measurement is essential. In adolescents, a review described self-harm and suicide as major problems linked to genetic vulnerability, psychiatric and psychological factors, family, social and cultural influences, and media and contagion effects, including the internet; it found little evidence that any treatment works and judged the usefulness of antidepressants controversial (Hawton et al., 2012).

Prevention evidence is more encouraging for behaviour than for thoughts. In a cohort comparison across nine emergency departments with 1640 veteran patients, most of them men, a safety planning intervention with telephone follow-up was associated with suicidal behaviour in 3.03% of patients over six months against 5.29% under usual care (OR = 0.56), and with greater use of outpatient mental health care; the study was not randomized, and its authors presented the approach as potentially valuable (Stanley et al., 2018). A meta-analysis of six studies with 3536 adults found that safety planning-type interventions lowered the risk of suicidal behaviour (RR = 0.570, number needed to treat 16) but did not significantly reduce ideation (P = 0.06), with few studies, not all randomised, and signs of publication bias (Nuij et al., 2021). Reviewing 1797 studies from 2005 to 2014, an expert panel found support for restricting access to lethal means, school-based awareness programmes and some treatments, insufficient evidence for primary-care screening, public education and media guidelines, and no single strategy that clearly outperformed the rest (Zalsman et al., 2016).

Antidepressant treatment in young people carries its own signal. Across 24 placebo-controlled pediatric trials with 4582 patients, antidepressant use was associated with a modest increase in suicidality, including for SSRIs in depression trials, although only one trial was individually significant and no trial recorded a completed suicide (Hammad et al., 2006). The clinical assessment of suicide risk in the diagnosed disorder is covered in the suicide risk section of the major depressive disorder page.

Help is available for anyone in crisis or thinking about suicide: in the United States, calling or texting 988 reaches the 988 Suicide & Crisis Lifeline; elsewhere, the International Association for Suicide Prevention lists crisis centres by country.

What Treatment Trials Show

The trial evidence concerns adults with a diagnosis of major depressive disorder, not low mood in general. A network meta-analysis of 522 trials with 116 477 participants, found that all 21 drugs were more effective than placebo in acute treatment and that they differed from one another only modestly (Cipriani et al., 2018). Most comparisons had wide credible intervals, certainty was moderate to very low, and the results apply to acute treatment only.

How large the drug advantage is has been disputed. Drawing on the FDA's data from 35 trials and 5,133 patients, Kirsch and colleagues found that medication beat placebo by 1.80 points on the Hamilton scale overall, which falls below the threshold NICE sets for a clinically significant difference (Kirsch et al., 2008). The difference reached clinical significance only at the extreme of very high baseline severity, and it grew there because placebo response fell rather than because the drug effect rose. No trials sampled the severe range (19–22), only one sampled the moderate range and post-approval trials were omitted, so how the pattern extends across a wider range of baseline scores remains uncertain. Pooling patient-level records from six Japanese placebo-controlled trials (n = 2464), a later meta-analysis found that drug benefit did not depend on how ill patients were at the outset, since the severity-by-drug interaction fell short of statistical significance, though only six of the eleven eligible trials supplied individual data (Furukawa et al., 2018). A later, far larger analysis of the FDA's individual participant data (232 randomized trials, 73 388 adult and child participants) put the average drug-placebo difference in acute treatment at 1.75 points in 17-item Hamilton equivalents (Stone et al., 2022). In that dataset the gap did widen with baseline severity, by a small 0.09 points for each added severity point (P<0.001), and the authors suggested, without demonstrating, that the share of participants who gain a benefit specific to the drug is about 15% (Stone et al., 2022). On what counts as clinically meaningful, estimates of the minimal important difference on the 17-item Hamilton scale span 3 to 8 points and are likely most accurate at 3 to 5, so every one sits above the average antidepressant effect of 2 points; the analysis that compared them concluded that clinical significance remains uncertain (Hengartner & Plöderl, 2022). These analyses thus agree that the average difference is about two Hamilton points; whether that average is clinically meaningful, and for whom, is unresolved.

Psychological treatments compare well. A network meta-analysis of 101 studies with 11,910 adults found that combined psychotherapy and pharmacotherapy produced more treatment response than either alone (risk ratios of 1.27, 95% CI 1.14 to 1.39, and 1.25, 95% CI 1.14 to 1.37), while psychotherapy and pharmacotherapy did not differ significantly from each other (RR = 0.99, 95% CI 0.92 to 1.08) (Cuijpers et al., 2020). Long-term effects and cost-effectiveness need further study. In a placebo-controlled trial with 241 adults, behavioral activation, a form of behavior therapy, matched antidepressant medication and outperformed cognitive therapy, but only among the more severely depressed patients (Dimidjian et al., 2006). Cognitive behavioral therapy appears to lower the risk of symptoms returning after treatment ends, whereas most other forms of psychotherapy have not been tested for such enduring effects; whether the protection is causal or compensatory, and whether it works through cognitive change, is unclear (Hollon et al., 2006). Effects of talking treatments measured against control conditions may be overstated. A meta-analysis of 117 trials of psychotherapy for adult depression (9537 participants) found signs of publication bias, and after a trim and fill adjustment the pooled effect shrank from d = 0.67 to 0.42 (Cuijpers et al., 2010). The authors acknowledged that an asymmetric funnel plot does not prove bias and that their statistical tests had weaknesses, but judged that these did not cast doubt on their main conclusion (Cuijpers et al., 2010).

How Psychological Treatments Are Thought to Work

Each of these therapies carries an account of why it should help. Cognitive therapy follows from the cognitive model, in which the beliefs held in schemas are what treatment sets out to change (Beck & Haigh, 2014). A review proposed that cognitive therapy goes along with lower activity in amygdalohippocampal regions and higher activity in higher-order frontal regions, while judging the evidence consistent rather than conclusive (Clark & Beck, 2010). Behavioral activation was tested on its own as one arm of a component analysis designed to test cognitive therapy's own theory of change: 150 outpatients with major depression were randomized to behavioral activation alone, behavioral activation plus work on automatic thoughts, or the complete therapy, which also targeted core schemas (Jacobson et al., 1996). The complete package outperformed neither component, either when treatment ended or at 6-month follow-up, and the components reduced negative thinking and dysfunctional attributional styles as much as full cognitive therapy did, even though the authors acknowledged a bias in the study favoring cognitive therapy (Jacobson et al., 1996). Because the behavioral part on its own did as well, the trial gives no evidence that adding work on automatic thoughts and core schemas improves outcomes, although attributional style predicted outcome in the behavioral activation arm. Behavioral activation was afterwards set out as a treatment in its own right (Jacobson et al., 2001). Its rationale is that inactivity, withdrawal and avoidance can generate secondary problems of their own, so activation strategies aim to help people reengage with their lives and regain contact with sources of positive reinforcement (Jacobson et al., 2001). The Dimidjian trial described above compared the outcomes of the two treatments directly, setting behavioral activation against cognitive therapy.

The outcome evidence for behavioral activation is substantial but uneven. Pooling 26 randomized trials with 1524 subjects, a meta-analysis found it better than control conditions (SMD −0.74) and than medication (SMD −0.42), although the medication comparison rested on only 4 trials and its confidence interval touched zero (Ekers et al., 2014). Most included studies were of low quality, follow-up was short, and the effect was smaller at 6–9 months (SMD −0.35) (Ekers et al., 2014). Rumination-focused CBT takes aim at the rumination discussed earlier on this page. In a phase II trial with 42 adults whose residual depression had persisted despite medication, adding it to usual care improved residual symptoms more than usual care alone, with remission in 62% versus 21% (Watkins et al., 2011). Reduced rumination statistically mediated the benefit, but because rumination and symptoms were measured at the same time, which changed first is unknown; the trial also lacked an attention control and its sample was small (Watkins et al., 2011).

How any of these treatments produce their effects remains uncertain. Reviewing 35 studies of psychological mediators in psychotherapy for depression, Lemmens and colleagues judged the research heterogeneous and methodologically unsatisfactory, named showing a causal link between change in a mediator and change in symptoms as probably the field's biggest challenge, and suggested that psychotherapy may work through several interacting mechanisms, too complex for relatively simple causal models (Lemmens et al., 2016). That conclusion matches the doubt, noted above, over whether the lasting benefit of cognitive behavioral therapy runs through cognitive change. The treatments, in short, work better than their theories of change have been shown to.

Electroconvulsive Therapy, Magnetic Stimulation, Ketamine and Esketamine

Other trials have tested treatments that act on the brain more directly. Electroconvulsive therapy (ECT) has the longest record of these. When the UK ECT Review Group pooled randomized trials in people with depressive illness, its systematic review and meta-analysis judged ECT effective over the short term (UK ECT Review Group, 2003). Real ECT did better than simulated ECT across six trials, 256 patients (SES -0.91), and it probably did better than drug therapy across 18 trials, 1144 participants (SES -0.80). Bilateral ECT held a moderate edge over unilateral ECT across 22 trials, 1408 participants (SES -0.32) (UK ECT Review Group, 2003). Only short-term efficacy was pooled, and the advantage over medication was rated probable, not certain.

For cognitive psychology, the key question about ECT is what it does to thinking and memory. Semkovska and McLoughlin's meta-analysis drew on 84 studies covering 2981 depressed patients, all assessed with standardized cognitive tests, and tracked twenty-four cognitive variables, among them executive function, anterograde memory, working memory and processing speed (Semkovska & McLoughlin, 2010). The deficits it found were largely limited to the first 0 to 3 days after treatment. Beyond 15 days, no variable stood below its pretreatment baseline and 57% of them rose above it, and no moderator variable mattered after the third day (Semkovska & McLoughlin, 2010). The review has clear limits. It included within-subjects studies only, its literature search ended in January 2009, and because no study had used a standardized test of retrograde amnesia, it could not assess the loss of memories formed before treatment (Semkovska & McLoughlin, 2010). Prospective data point the other way. A naturalistic study followed 347 patients given ECT at 7 New York facilities and found cognitive deficits still present 6 months later, among them retrograde amnesia for autobiographical information (Sackeim et al., 2007). Deficits were worse after bilateral than after right unilateral electrode placement, and worse in patients who were older, female or lower in premorbid IQ; outcomes also differed between facilities even after controls, and treatment was not randomized (Sackeim et al., 2007). The two lines of evidence differ partly in what they measured, since the meta-analysis had no standardized retrograde-amnesia tests to draw on while the prospective study examined loss of autobiographical memory.

Repetitive transcranial magnetic stimulation (rTMS) has been tested in many variants. A systematic review and network meta-analysis found rTMS more effective than sham stimulation, pooling eighty-one studies of major depressive disorder that enrolled 4233 patients, who averaged 46 years of age and were 59.1% women (Brunoni et al., 2017). Odds ratios ran from 4.66 for priming low-frequency stimulation and 3.07 for high-frequency stimulation down to 2.37 for low-frequency stimulation (Brunoni et al., 2017). Deep, accelerated and synchronized rTMS were no more effective than sham, and θ-burst stimulation, though more effective than sham for response, did not show the same advantage for remission. The estimates were imprecise and some interventions rested on few trials, so the authors called for larger randomized trials (Brunoni et al., 2017).

Intravenous racemic ketamine's rapid antidepressant effect was first reported in 2000 (Swainson et al., 2021). In that randomized, double-blind, placebo-controlled trial of 7 patients with major depression, scores on the 25-item Hamilton Depression Rating Scale fell by 14 points within 72 hours of ketamine hydrochloride at .5 mg/kg, against 0 points after saline (Berman et al., 2000). A second randomized, double-blind, placebo-controlled trial, a crossover study, gave eighteen patients with treatment-resistant major depression 0.5 mg/kg intravenously in one dose: depression improved more than with placebo within 110 minutes, and the difference was d = 1.46 at 24 hours, a very large effect, and was still significant at 1 week, at d = 0.68, a moderate to large one (Zarate et al., 2006).

Ketamine is not approved for depression and is used off-label (Swainson et al., 2021); a consensus statement on that use judged it possibly beneficial for some patients while pointing to small samples, limited safety data and nothing on efficacy over the longer term (Sanacora et al., 2017). A CANMAT task force's systematic review in treatment-resistant depression graded the evidence for a single infusion at Level 1 and for repeated infusions at the weaker Level 3, with relapse usually coming within 10 days of a single infusion, although some patients kept their response for weeks, and dissociation among the adverse effects (Swainson et al., 2021). Ketamine is a scheduled drug with abuse liability, though an expert review found no evidence that it or esketamine raised the risk of substance use disorder (McIntyre et al., 2021), and misuse and diversion are a stated risk of non-intravenous formulations (Swainson et al., 2021). In a meta-analysis of individual data from 167 patients with ideation at baseline in 10 studies, a single dose lowered suicidal ideation more than saline or midazolam, an effect that emerged within 1 day and lasted as long as 1 week (d=0.48-0.85), though not on the Beck Depression Inventory item, where the difference was not significant (Wilkinson et al., 2018). Its authors asked for research on long-term safety and on efficacy against suicide risk before clinical implementation (Wilkinson et al., 2018), and the task force rated this evidence preliminary (Swainson et al., 2021). Esketamine is one enantiomer of ketamine (Swainson et al., 2021); as a nasal spray started together with a conventional antidepressant, it received FDA approval in March 2019 for treatment-resistant depression in adults (McIntyre et al., 2021), years after the first racemic trials. The trial that compared ketamine with ECT is described in the ketamine section of the major depressive disorder page.

Esketamine has been studied in treatment-resistant depression. A phase 3 double-blind, active-controlled randomized trial at 39 outpatient referral centers randomized 227 adults to esketamine nasal spray or a placebo spray, each given alongside an oral antidepressant. At day 28, scores on the Montgomery-Åsberg Depression Rating Scale had dropped further with esketamine, a difference of -4.0 (Popova et al., 2019). Adverse events were more frequent in the esketamine group, the most common being nausea, vertigo and dissociation, and more of those patients discontinued. The comparison covered a 28-day treatment phase only (Popova et al., 2019). A commentary questioned both the efficacy evidence for esketamine and the FDA's decision to approve it (Turner, 2019).

The bodies of evidence in this subsection draw on different samples. The ECT review covered depressive illness broadly and the rTMS analysis major depressive disorder, while the second ketamine trial and the esketamine trial enrolled patients whose depression had resisted earlier treatment.

Table 2

Accounts of Depression and Their Current Standing

TheoryCore claimStatusKey source
Cognitive model of depressionAutomatic thoughts, distortions, dysfunctional beliefs and processing biases maintain depressionRevised; recast in predictive processing terms after criticism as too broad (Kube et al., 2020)Beck, 2008
Learned helplessness theoryExposure to inescapable shock leads to later escape failureRevised; passivity is the default and control is learned (Maier & Seligman, 2016)Seligman & Maier, 1967
Hopelessness theory of depressionNegative inferential styles interact with stress, in diathesis-stress form, to produce hopelessness depressionPartly supported; the diathesis-stress interaction has the most support, mainly for mild symptoms in non-clinical samples, but prospective prediction of depressive episodes is largely unexamined and support for the hopelessness depression subtype is mixed (Liu et al., 2015)Abramson et al., 1989
Response styles theoryRumination prolongs depression; distraction shortens itRevised; extended to rumination as a transdiagnostic vulnerability, with a model that gives only a partial answer (Watkins & Roberts, 2020)Nolen-Hoeksema, 1991
Impaired disengagement hypothesisDifficulty pulling attention away from negative material keeps rumination goingSupported in part; in major depressive disorder, disengagement from sad faces is slower and predicts poorer recovery of sad mood, though a causal role is not shown (Sanchez et al., 2013)Koster et al., 2011
Behavioral model of depressionLow positive reinforcement brings about the changes seen in depressionRevised; behavioral activation treatments are grounded in it, but testing its mechanism awaits better measures of activation and reinforcement (Dimidjian et al., 2011; Manos et al., 2010)Lewinsohn & Graf, 1973
Interactional theory of depressionExcessive reassurance seeking is tied to depression and to rejection by othersSupported in part; concurrent associations with depression (r = .32) and, more weakly, rejection (.14), with prospective evidence reviewed only qualitatively (Starr & Davila, 2008)Coyne, 1976
Stress generation hypothesisDepression predicts later stressful events that the person partly brings aboutSupported in part; a 57-article systematic review found the pattern replicated, with more research needed (Liu & Alloy, 2010); a 104-study Bayesian meta-analysis found generally strong support, its estimates covering psychopathology overall (Liu et al., 2024)Hammen, 1991
Serotonin hypothesis of depressionDepression reflects reduced serotonin activityContested; no consistent association across 17 studies, a null conclusion a critical commentary judged overstated (Moncrieff et al., 2023; Jauhar et al., 2023)Moncrieff et al., 2023
Glutamate hypothesis of depressionGlutamatergic neurotransmission is abnormal in depressionProposed; a meta-analysis of spectroscopy studies found medial frontal glutamate plus glutamine lower in depression, significant in medicated patients and, in the main analysis, not in unmedicated ones (Moriguchi et al., 2019)Sanacora et al., 2012
Cytokine theory of depressionInflammation drives sickness behaviour that can become depression in vulnerable peopleSupported; IL-6 and TNF-alpha raised, though heterogeneity is large and several other cytokines are unaltered (Köhler et al., 2017)Dantzer et al., 2008
Neurotrophic hypothesis of depressionLow BDNF contributes to depression; antidepressants raise itSupported; serum BDNF lower, though the evidence is noisier than first thought and the gap shrinks in newer, larger studies (Molendijk et al., 2014)Duman & Monteggia, 2006
Candidate gene-by-environment hypothesisThe 5-HTT short allele amplifies the effect of stress on depressionSuperseded; no support for 18 candidate genes in large samples (Border et al., 2019)Caspi et al., 2003
Default mode network hyperconnectivity hypothesisDepression involves excess connectivity within the default mode network, tied to ruminationContested; a 17-site consortium found default mode connectivity decreased, and only in recurrent depression (Yan et al., 2019)Greicius et al., 2007
Depressive realismDepressed people judge contingency more accurately than nondepressed peopleContested; small pooled effect, not reproduced in a preregistered replication (Moore & Fresco, 2012; Dev et al., 2022)Alloy & Abramson, 1979
Analytical rumination hypothesisDepression evolved as an aid to analyzing complex problemsContested; whether costly symptoms confer any benefit remains open (Hagen, 2011)Andrews & Thomson, 2009
Combined cognitive bias hypothesisAttention, interpretation and memory biases are interrelated in depressionProposed; in one cross-sectional eye-tracking study of mostly female students, the predicted sequence from attention to interpretation to memory bias fitted the data, though the design cannot show causation (Everaert et al., 2014)Everaert et al., 2012
Predictive processing account of depressionRigid negative predictions resist correction by prediction errorsProposed; a model awaiting future research (Kube et al., 2020)Kube et al., 2020
Stress and anhedonia modelStress disrupts reward learning and produces anhedoniaProposed; a heuristic model resting on initial evidence (Pizzagalli, 2014)Pizzagalli, 2014

Note. The Status column gives each account's present standing, and the citation in that column names the work the standing rests on.

How Brain Stimulation and Ketamine Are Thought to Work

How electroconvulsive therapy (ECT) works is unresolved. The procedure applies electricity to trigger a seizure, and the open question is which of the two carries the benefit; they always occur together, and a narrative review found preliminary support for each view (Deng et al., 2024). The neurogenesis, amnesia and anticonvulsant hypotheses that the review names are likewise not established (Deng et al., 2024). Changes of technique have still reduced harm: ultra-brief pulses (width under 0.5 ms) brought fewer adverse effects than longer pulses and can match them in efficacy when the dose is high enough relative to the individual's seizure threshold, and right unilateral or bifrontal electrode placement brought less amnesia than bitemporal placement while remaining as therapeutic, although low-dose right unilateral stimulation lacked antidepressant efficacy; the cognitive risk was lowered, not removed (Deng et al., 2024).

Repetitive transcranial magnetic stimulation (rTMS), given as excitatory one-sided stimulation aimed at the left dorsolateral prefrontal cortex (DLPFC), has an effect that is possibly related to neuronal plasticity (Schiena et al., 2021). A narrative review of 13 studies found that functional connectivity changed after treatment in regions and networks involved in emotion regulation: connectivity of the default mode network with the subgenual anterior cingulate cortex, and with the DLPFC, was lower after rTMS than at baseline (Schiena et al., 2021). The reviewers left open whether such shifts are what produces the antidepressant effect; the studies were small, stimulation settings varied, patients were also taking psychotropic drugs, and one comparison of active with sham stimulation found no significant difference in connectivity (Schiena et al., 2021).

Several mechanisms have been proposed for ketamine's antidepressant action, and a narrative review treats them as not mutually exclusive and possibly complementary (Zanos & Gould, 2018). They include inhibition of NMDA receptors at more than one site (on GABAergic interneurons, and at synaptic or extra-synaptic receptors), activation of AMPA receptors, suppression of burst firing in the lateral habenula, and molecular candidates that include mTOR and BDNF; all remain proposals, and the review's mechanistic evidence comes from preclinical studies (Zanos & Gould, 2018). For all three treatments, the evidence that they work is firmer than the account of how.

How Antidepressants Are Thought to Work

The cognitive neuropsychological hypothesis holds that antidepressants act on emotional processing before they act on mood. Drawing on behavioural and functional magnetic resonance imaging studies, a narrative review described the drugs shifting a negative emotional bias earlier than any change in mood appears, with limbic and prefrontal circuitry implicated (Harmer et al., 2009). The authors judged the account possibly consistent with cognitive theories of depression, and its standing remains that of a hypothesis: they noted that challenges remain before it can be established (Harmer et al., 2009).

How the drugs are experienced is a separate question. Among 1829 New Zealand adults prescribed antidepressants who completed an online questionnaire, more than half endorsed 8 of the 20 adverse effects listed; Sexual Difficulties (62%), Feeling Emotionally Numb (60%) and Feeling Not Like Myself (52%) were frequent, emotional and interpersonal effects such as Caring Less About Others (39%) were common, and 55% reported Withdrawal Effects (Read et al., 2014). Scores were higher in younger, less educated and lower-income respondents and varied with antidepressant type, but were not significantly related to prior depression level; the reports were self-reported, and the authors concluded only that such effects may exceed earlier estimates (Read et al., 2014). Two reviews diverge on stopping treatment. A systematic review of 24 studies found withdrawal common, often severe and frequently lasting beyond the two weeks guidelines describe, with incidence figures spanning 27% to 86%, and argued that guidelines probably misdiagnose withdrawal and need urgent updating, although the studies were methodologically diverse and only four gave a mean duration (Davies & Read, 2019). A later meta-analysis of 79 studies and 21 002 patients found discontinuation symptoms, severe ones included, more frequent after antidepressants than after placebo, yet put the net excess at approximately 15%, about one in six to seven patients, and offered it as the probable extent, to inform patients without causing undue alarm; heterogeneity was substantial, and residual or re-emerging psychopathology may account for some symptoms (Henssler et al., 2024). The trial evidence itself is covered in the treatment evidence section of the major depressive disorder page.

Emerging Treatments

Psilocybin-assisted therapy remains at an early stage of evaluation, and its trial record is more mixed than its publicity. In a six-week phase 2 double-blind trial, 59 adults whose major depression, moderate to severe, had lasted a long time received either two 25 mg doses of psilocybin or escitalopram; the arms did not differ significantly on the primary outcome, change in QIDS-SR-16 score (P = 0.17), and the higher rates under psilocybin for response (70% vs 48%) and remission (57% vs 28%) were secondary outcomes with no correction for multiple comparisons (Carhart-Harris et al., 2021). In 233 adults with treatment-resistant depression, a single 25 mg dose reduced Montgomery-Åsberg Depression Rating Scale scores more than 1 mg at week 3, whereas 10 mg did not differ from 1 mg; the 12-week sustained-response result did not support an effect, and suicidal ideation was reported in every dose group (Goodwin et al., 2022). The authors of both trials concluded that larger and longer studies are required, and the second added that psilocybin must be compared with existing treatments.

Internet-delivered cognitive behavioural therapy (iCBT) rests on a larger evidence base. An individual-participant-data network meta-analysis covering 9751 participants found guided and unguided iCBT both superior to control conditions, with guided delivery ahead immediately after treatment (mean difference -0.8 on the PHQ-9) but not at 6 or 12 months; the guidance advantage held for baseline PHQ-9 scores above 9 and was small in subthreshold depression, where unguided programmes performed about as well (Karyotaki et al., 2021).

Smartphone applications are promising for mild-to-moderate symptoms, though their efficacy evidence is still early. Pooling 18 randomised trials of 22 apps (N = 3,414), one meta-analysis reported an overall effect of g = 0.383, larger against inactive controls (g = 0.558) than against active ones (g = 0.216); effects were significant for mild-to-moderate depression but not in the underpowered major depressive disorder analyses, heterogeneity was substantial, and which app components produce benefit remained unclear (Firth et al., 2017). A fuller treatment appears in the emerging treatments section of the major depressive disorder page.

Living with Depression

The earlier sections ask where depression comes from and how it is treated. This one turns to what the condition does to ordinary life: quality of life, work, stigma and the family.

Quality of Life

Quality of life means a person's overall sense of well-being and satisfaction with daily living. Severe losses in it are common among people with depressive disorders who enter treatment trials. Pooled baseline data from 11 trials, scored on the Quality of Life Enjoyment Satisfaction Questionnaire, showed clinically severe impairment in 63% of patients with major depressive disorder, 85% of those with chronic or double depression and 56% of those with dysthymic disorder (Rapaport et al., 2005). The depressive disorders were more impaired than panic disorder, obsessive-compulsive disorder or social phobia (Rapaport et al., 2005). Symptom scales explained only a small to modest share of baseline quality of life, and every patient was entering a clinical trial (Rapaport et al., 2005).

Treatment appears to help. A meta-analysis of 37 studies of adults with major depressive disorder found moderate gains in quality of life from before to after both cognitive-behavioral therapy and selective serotonin reuptake inhibitors (Hedges' g = 0.63 and 0.79; g is a standard measure of how large a change is) (Hofmann et al., 2017). Gains after therapy held at follow-up of 1 to 7 months (Hofmann et al., 2017). Against control conditions the effect was small (g = 0.29, 8 trials) and not statistically robust, the pre-post studies varied widely, the analysis made no direct comparison of the two treatments, since only two studies tested them head to head, and publication bias could not be ruled out (Hofmann et al., 2017).

Work

A review of studies published since 2002 found that, compared with people without depression, depressed people were more often unemployed, more often absent and showed more deficits while at work (Lerner & Henke, 2008). That last outcome is called presenteeism: being on the job but performing below one's usual level. More severe symptoms went with greater effects on work, and symptom relief brought only partial recovery of work outcomes (Lerner & Henke, 2008). Differences in method across studies made the size of the effect hard to judge (Lerner & Henke, 2008).

The costs reach across national economies. A secondary analysis of an online survey of about 1,000 employees in each of eight countries found depression-related productivity costs in every one of them (Evans-Lacko & Knapp, 2016). The authors summarised presenteeism losses as tending to be 5 to 10 times those from absence, though the ratio ranged from 1.4 in Japan to 14.2 in the USA (Evans-Lacko & Knapp, 2016). Diagnosis was self-reported, the panel was recruited online with low response rates, and costs in China may have been underestimated (Evans-Lacko & Knapp, 2016).

Stigma and Relationships

Stigma is tied to reluctance to seek help. A questionnaire survey of a random community sample of 1,312 Australian adults, built around a vignette describing depression, linked stigma to lower willingness to see a professional (Barney et al., 2006). Both personal embarrassment and the expectation that others would react badly went with weaker intentions to seek help (Barney et al., 2006).

Some people turn public prejudice against themselves, a pattern called self-stigma. A cross-sectional mail survey across 13 countries of 1,182 people with bipolar disorder or depression found moderate or high self-stigma in 21.7%, about 1 in 5 (Brohan et al., 2011). Most also reported moderate or high perceived discrimination (71.6%), and 59.7% showed moderate or high resistance to stigma (Brohan et al., 2011). Empowerment, perceived discrimination, social contact, education and employment together accounted for 27% of the variation in self-stigma (Brohan et al., 2011). Respondents were charity members in an unweighted sample, so they may not represent everyone with these conditions (Brohan et al., 2011).

Stigma can also isolate. In semi-structured interviews with 22 young people aged 17 to 25, who either reported high depressive symptoms or had previously been diagnosed with depression, participants described stigma leading to loneliness, isolation and strained relationships (Prizeman et al., 2023). Most reported public stigma becoming internalized over time, and stigma lowered their self-esteem, which in turn fostered secrecy (Prizeman et al., 2023). The sample was young people only, with limited cultural and geographic range, and the effects of stigma could not be separated from those of depression itself (Prizeman et al., 2023).

Families

A meta-analysis of 193 studies of mothers and children found maternal depression linked with more internalizing problems (difficulties turned inward), more externalizing problems (difficulties directed outward), more general psychopathology and more negative and less positive affect and behavior in children (Goodman et al., 2011). Every one of these associations was small, and moderating factors altered them in patterns that differed by outcome (Goodman et al., 2011).

Research on relatives remains narrow. A systematic review of 34 qualitative publications, in a field its authors describe as dominated by a focus on carer burden, identified themes such as recognizing depression, emotional responses and interrupted relationships (Buus et al., 2024). The reviewers judged many analyses thin on context and interpretation, noted that relatives' experiences were assumed to be alike, and found social contributors largely ignored (Buus et al., 2024).

First-person accounts of seeking help and taking antidepressants appear under The Experience of Depression. A fuller treatment appears in Living with Major Depressive Disorder on the major depressive disorder page.

Worked Example

The effect sizes reported above are easier to judge when converted into proportions. The arithmetic that follows is illustrative and comes from no study; it assumes two normal distributions of equal spread whose means are d standard deviations apart. The share of the higher group scoring above the lower group's mean equals the cumulative normal value at d, and the overlap of the two distributions equals twice the cumulative normal value at minus d divided by two.

Three inputs serve as examples. The first, d = 0.32, is a value reported in the antidepressant analysis by Kirsch and colleagues, and the second, d = 0.50, is the NICE criterion for clinical significance that the same analysis applied (Kirsch et al., 2008). The third, d = 0.07, is the absolute size of the overall depressive realism effect (Moore & Fresco, 2012).

At d = 0.32, about 62.6% of the higher group lies above the lower group's mean, and the two distributions overlap by about 87.3%. At d = 0.50, the share rises to about 69.1% and the overlap falls to about 80.3%. At d = 0.07, the share is about 52.8%, barely above the 50% expected if the groups did not differ at all. Even the larger of these differences leaves most of the two distributions on top of each other, which is why an average advantage can coexist with many individuals who show none. The EffectSizeDemo below lets the reader vary d and watch both quantities change.

Interactive demonstration

What does an effect size of d look like?

Move the slider or choose a published value. The gold curve is shifted right of the navy curve by d standard deviations.

With d = 0.32, 62.6% of the gold group lies above the navy group's mean (50% would mean no difference), and the two distributions overlap by 87.3%.
Two normal distributions separated by d standard deviations; the percentages are computed from the normal curve. The preset values are those reported by Kirsch et al. (2008) for the drug and placebo difference and the NICE criterion, by Peckham, McHugh and Otto (2010) for attentional bias in dot probe studies, and by Moore and Fresco (2012) for depressive realism (shown as its absolute size).

Discussion

Several lines of evidence converge on a picture of depression as varied in form. Patients with the same diagnosis report strikingly different symptom combinations (Fried & Nesse, 2015), the standard scales share little content (Fried, 2017), and the underlying structure in young people appears dimensional (Hankin et al., 2005). A sum score on any one scale therefore compresses a great deal of information, and findings tied to one instrument may not transfer to another.

Cognitive accounts have proved durable but not static. Beck's model, learned helplessness and response styles theory all survive in revised form: the cognitive model has been recast in predictive processing terms (Kube et al., 2020), learned helplessness now treats passivity as the default (Maier & Seligman, 2016), and rumination looks more like a predictor of onset than of duration (Nolen-Hoeksema et al., 2008). Biological accounts that name a single cause have fared worse. Whether a simple shortage of serotonin causes depression is disputed: an umbrella review found no consistent association, and a critical reply judged that null conclusion overstated (Moncrieff et al., 2023; Jauhar et al., 2023). The candidate genes behind the gene-by-environment programme found no support in preregistered tests on very large samples (Border et al., 2019), while genome-wide analysis has tied depression to 102 independent variants (Howard et al., 2019). Among the behavioral and interpersonal accounts, the behavioral model stands as revised: it survives as the basis of behavioral activation (Dimidjian et al., 2011), and a critical review suggested better measurement of activation and reinforcement so that the model and its mechanism theory could be tested (Manos et al., 2010); the interactional theory and the stress generation hypothesis are each supported in part, the first by concurrent associations of reassurance seeking with depression and, more weakly, with rejection (Starr & Davila, 2008), the second by a replicated pattern in which depression predicts later dependent stress (Liu & Alloy, 2010), and neither body of evidence by itself establishes cause.

A recurring open question is whether depression's cognitive features help cause it or merely accompany it. Executive deficits are associated with depression, but that evidence could not establish causality (Snyder, 2013), and loneliness and depressive symptoms influenced each other over time (Cacioppo et al., 2006). Three designs have addressed direction for negative cognition. In a prospective cohort of 347 initially disorder-free freshmen, high cognitive risk carried 3.5-6.8 times greater odds of major, minor and hopelessness depression over 2.5 years, though the prediction was only partly specific to depression (Alloy et al., 2006). Cognitive-reactivity and priming work supports vulnerability in adults, with growing support in children and slower-accruing evidence on onset, relapse and recurrence (Scher et al., 2005). Experimental bias modification produced a depression effect that became non-significant after adjustment for publication bias, in trials of suboptimal quality: small effects, or none (Cristea et al., 2015). Prospective work thus supports vulnerability, while experiments have so far yielded only weak effects.

The cognitive findings also need to be read in their social setting. Chinese and Euro-Canadian outpatients differed in how they expressed distress, with the psychological difference more consistent than the somatic one (Ryder et al., 2008), and low socioeconomic status was associated with depression, more strongly with its persistence than with its onset, in a heterogeneous meta-analysis that had few incidence and persistence studies to draw on (Lorant et al., 2003). Stigma about mental health problems in general showed a small negative association with help-seeking, in a review whose studies were mostly cross-sectional and mostly from the USA or Canada (Clement et al., 2015). Because direct prevalence data are missing for most countries (Kessler & Bromet, 2013), the epidemiological evidence on this page underrepresents much of the world.

The burden also falls unevenly, and it seldom falls on depression alone. Meyer found mental disorders more prevalent among lesbian, gay and bisexual adults and tied the excess to minority stress, while acknowledging that the stress processes had been inferred rather than examined (Meyer, 2003); in transgender and gender diverse people, every minority stress process studied was linked to depression, suicidal ideation and suicide attempts, but only in cross-sectional data (Pellicane & Ciesla, 2022). Overlap with other conditions is the rule rather than the exception: two-thirds of the Dutch cohort participants with a current depressive disorder also had a current anxiety disorder (Lamers et al., 2011), and among people diagnosed with depression, comorbid anxiety and substance misuse were among the identified risk factors for suicide (Hawton et al., 2013). Yet knowing such associations does not translate into knowing who will act on suicidal thoughts. Broad categories of risk factor predicted suicidal thoughts and behaviours only slightly better than chance, with no gain across five decades of studies (Franklin et al., 2017).

Treatments help on average, but the average conceals variation. Antidepressants outperform placebo in acute treatment (Cipriani et al., 2018), psychotherapy matches medication and the combination does best (Cuijpers et al., 2020), and in the FDA trial data the drug advantage reached clinical significance only at very high severity (Kirsch et al., 2008), although a later analysis of individual patients from six Japanese trials found no significant moderation of efficacy by baseline severity (Furukawa et al., 2018). A far larger analysis of the FDA's individual participant data has since put the average drug-placebo difference in acute treatment at 1.75 points in 17-item Hamilton equivalents, a gap that widened by a small 0.09 points for each added point of baseline severity (Stone et al., 2022), and estimates of the minimal important difference on the 17-item Hamilton scale, which span 3 to 8 points, all sit above the average antidepressant effect of 2 points (Hengartner & Plöderl, 2022); the analyses thus agree on an average difference of about two Hamilton points, and whether that average is clinically meaningful, and for whom, is unresolved. The reasons psychological treatments help are less clear than the fact that they do: in a component trial, the complete cognitive therapy package did no better than its components, behavioral activation alone included (Jacobson et al., 1996), a result that does not by itself show that changing beliefs plays no part. A later review of 35 studies judged the research heterogeneous and methodologically unsatisfactory, and named showing a causal link between change in a mediator and change in symptoms as probably the field's biggest challenge (Lemmens et al., 2016). Decisions about treatment for any individual belong with a qualified clinician.

Who actually receives treatment is a separate matter from how well it works. Across pooled national US household surveys, African American, Latino and Asian American adults with current depression were more likely than non-Latino whites to have had no treatment in the past year (Alegría et al., 2008). Culturally adapted psychological treatments beat control conditions by a large margin, although heterogeneity was substantial and only two weak trials set adapted against unadapted versions (Chowdhary et al., 2014). Newer modes of delivery stand at different points: guided and unguided internet-delivered CBT both outperformed control conditions (Karyotaki et al., 2021), whereas in a six-week comparison psilocybin did not differ significantly from escitalopram on the primary outcome (Carhart-Harris et al., 2021).

Current Directions

Recent work has reshaped several long-standing positions. The neuroscience of learned helplessness reversed the original account, treating passivity as the default and control as the thing animals learn (Maier & Seligman, 2016). Measurement research has shown how little the common scales share in symptom content, which threatens the replicability of findings tied to a single scale (Fried, 2017).

In genetics, the shift from candidate genes to genome-wide analysis is now well established. Preregistered tests in very large samples found no support for the historical candidate genes (Border et al., 2019), while a genome-wide meta-analysis identified 102 variants and implicated prefrontal regions, with the caveat that its depression phenotypes were broad and often self-declared (Howard et al., 2019). On the neurochemical side, an umbrella review found no consistent evidence tying serotonin to depression, though a critical commentary argued that this null conclusion was overstated (Moncrieff et al., 2023; Jauhar et al., 2023).

Large network meta-analyses now anchor comparisons among treatments. They support the efficacy of all 21 antidepressants studied over placebo in acute treatment, at moderate to very low certainty (Cipriani et al., 2018), and the advantage of combining psychotherapy with medication (Cuijpers et al., 2020). Theory is moving toward computational accounts such as predictive processing, which remain proposals awaiting tests (Kube et al., 2020), and epidemiology toward adolescents, among whom depressive symptoms appear to be rising and are higher in girls (Shorey et al., 2022). In 2022 a Lancet–World Psychiatric Association Commission also published a report on depression, framed as a call for united action (Herrman et al., 2022).

The newest treatments show how unevenly evidence matures. Psilocybin is still in phase 2: in treatment-resistant depression a single 25 mg dose outperformed a 1 mg dose at week 3 while 10 mg did not, the 12-week sustained-response result gave no support, and suicidal ideation occurred in every dose group (Goodwin et al., 2022), and against escitalopram the primary outcome showed no significant difference (Carhart-Harris et al., 2021); both teams called for larger and longer trials. Internet-delivered CBT rests on firmer ground, with individual-participant data showing guided and unguided programmes both ahead of controls and guidance helping right after treatment, mainly at baseline PHQ-9 scores above 9, but not at 6 or 12 months (Karyotaki et al., 2021). Smartphone apps lowered depressive symptoms in pooled trials, more against inactive than active controls and significantly only in mild-to-moderate depression, not in the underpowered analyses of major depressive disorder, so their efficacy evidence remains early (Firth et al., 2017).

Major Depressive Disorder
The MeSH heading separates depression from depressive disorder by degree, not by kind. Depression is the broad range of lowered mood and its symptoms; major depressive disorder is a diagnosis applied when symptoms pass a threshold. The taxometric evidence that depression is dimensional (Hankin et al., 2005) suggests the threshold is a convention, and the variety of symptom profiles among diagnosed outpatients (Fried & Nesse, 2015) shows that the label alone says little about which symptoms a person has. The confusion arises because everyday speech uses one word for both.
Sadness
Sadness is an emotion tied to a particular loss or setback; depression is a broader state that also involves motivation, thinking and the body. Evolutionary accounts treat low mood as a possibly adaptive response to unpropitious situations (Nesse, 2000), which places ordinary sadness and mild low mood at the shallow end of the same range rather than outside it. The working discriminator is scope: sadness concerns an event, whereas depression extends to motivation and appraisal more broadly.
Anhedonia
Anhedonia is one component of depression, not a synonym for it, and it is itself divisible into reduced pleasure in reward and reduced motivation to pursue it (Treadway & Zald, 2011). The confusion persists because loss of interest is so prominent in descriptions of depression that it is easy to treat the part as the whole.

Common Misconceptions

Depression is caused by low serotonin.
The evidence that a simple serotonin shortfall causes depression is disputed. An umbrella review of 17 studies found no consistent association and rated the receptor and transporter evidence as weak, while a critical commentary argued that this null verdict went too far and cited tryptophan depletion and PET imaging findings against it (Moncrieff et al., 2023; Jauhar et al., 2023). The belief persists partly because antidepressants act on serotonin, but a drug's target does not establish the cause of the condition it treats.
Everyone with depression has the same symptoms.
Among 3703 depressed outpatients there were 1030 distinct symptom profiles, nearly half of them unique to one person, and the commonest profile, which was the one with every symptom scored absent, covered only 1.8% of the sample, even with symptoms scored only as present or absent (Fried & Nesse, 2015). A shared diagnosis invites the assumption of a shared condition, but it is reached by counting symptoms toward a total that many different combinations can satisfy.
Depressed people see the world more accurately.
Across 75 studies the depressive realism effect was small overall (d = -.07), depended on the paradigm and was stronger when no objective standard existed, and nondepressed people showed a larger positive bias (Moore & Fresco, 2012). The idea endures because the original contingency experiments with students produced a vivid result.

Glossary

Anhedonia.
Reduced capacity for reward, which can be divided into reduced pleasure in reward (consummatory) and reduced drive to pursue it (motivational).
Attentional bias.
Preferential attention to a class of stimuli, in depression to negative material, usually measured with the dot probe or emotional Stroop task.
Behavioral activation.
A behavior therapy for depression; in one trial it matched medication and outperformed cognitive therapy among more severely depressed adults only.
Cognitive distortion.
A distorted way of thinking; Beck's cognitive model lists it with automatic thoughts, dysfunctional beliefs and biased processing of information.
Cognitive triad.
In Beck's cognitive model, the set of negative automatic thoughts about the self, the world and the future that arise once negative schemas are activated.
Depressive realism.
The proposal that depressed people judge contingency or control more accurately than nondepressed people; meta-analysis found the effect small overall and dependent on paradigm.
Depressive symptoms.
The changes in mood, thought, motivation and bodily function that depression scales count; a MeSH entry term for depression.
Distraction.
In response styles theory, turning attention away from low mood, proposed to shorten depression; its benefit was inconsistent in correlational studies.
Effect size.
A standardized measure of the size of a difference; Cohen's d expresses the gap between two group means in standard deviation units.
Jaccard index.
The number of items two sets share divided by the number of items in either; used to measure symptom overlap between depression scales.
Learned helplessness.
Failure to escape or avoid aversive events after exposure to uncontrollable ones, first described in dogs; later work treats passivity as the default and control as what is learned.
Overgeneral autobiographical memory.
Retrieval of summarized or categorical memories in place of specific personal episodes, linked to emotional disorder.
Placebo response.
Improvement in patients given an inactive treatment; in FDA antidepressant data, a lower placebo response drove the larger drug-placebo gap at high severity.
Predictive processing.
A framework in which the brain generates predictions and updates them in light of prediction errors; applied to depression as rigid negative predictions, a proposal that awaits testing.
Rumination.
Repetitive focus on one's low mood and its possible causes; it predicted the onset of depression more clearly than its duration.
Schema.
In the generic cognitive model, an organizing structure that carries a person's memories, expectancies, rules and self-evaluations; related schemas are grouped into modes.
Self-referent encoding.
Processing words by judging whether they describe oneself; in a study of women, depressed participants later recalled depressed-content words encoded this way best.
Symptom profile.
The particular combination of symptoms a person reports; among 3703 depressed outpatients, with symptoms scored present or absent, 1030 distinct profiles occurred.

Key Researchers

Lyn Y. Abramson

(b. 1950). Professor Emerita of Psychology at the University of Wisconsin-Madison, coauthor of the attributional reformulation of learned helplessness, of the depressive realism experiments with Lauren Alloy, and of hopelessness depression as a theory-based subtype. Wikidata - Wikipedia - Faculty Page

Aaron T. Beck

(1921–2021). Psychiatrist at the University of Pennsylvania, where he was Professor Emeritus of Psychiatry, and founder of the Beck Institute for Cognitive Behavior Therapy; he introduced an inventory for measuring depression and the cognitive model of depression. Wikidata - Wikipedia - Institutional Page

Pim Cuijpers

Professor Emeritus of Clinical Psychology at Vrije Universiteit Amsterdam, whose network meta-analysis compared psychotherapies, pharmacotherapies and their combination in adult depression. ORCID - Faculty Page

Ian H. Gotlib

Marjorie Mhoon Fair Professor of Psychology at Stanford University and director of its Neurodevelopment, Affect, and Psychopathology Laboratory, who with Jutta Joormann reviewed cognition in depression. ORCID - Wikidata - Wikipedia - Faculty Page

Jutta Joormann

Richard Ely Foundation Professor of Psychology at Yale University, whose work concerns cognitive control, attention and memory in depression and their link to rumination; coauthor with Ian Gotlib of a review of cognition and depression. ORCID - Faculty Page - Institutional Page

Susan Nolen-Hoeksema

(1959–2013). Professor of Psychology and chair of the Department of Psychology at Yale University, who proposed the response styles theory of rumination and studied the gender difference in depressive symptoms. Wikidata - Wikipedia - Institutional Page

Diego A. Pizzagalli

Distinguished Professor at the University of California, Irvine, formerly Professor of Psychiatry at Harvard Medical School and McLean Hospital, whose work on anhedonia and reward processing led to an integrated model of depression, stress and anhedonia. ORCID - Wikidata - Wikipedia - Faculty Page - Institutional Page

Martin E. P. Seligman

(b. 1942). Zellerbach Family Professor of Psychology at the University of Pennsylvania and director of its Positive Psychology Center, who with Steven Maier described learned helplessness in 1967 and revisited it fifty years later. Wikidata - Wikipedia - Faculty Page

Frequently Asked Questions

What is depression in psychology?

In psychology, depression refers to a lowered mood state with related symptoms that varies by degree, and a taxometric study of children and adolescents found it behaved as a continuum rather than a separate category (Hankin et al., 2005).

Is depression caused by low serotonin?

The evidence for a simple low-serotonin cause is disputed: an umbrella review of 17 studies found no consistent association between serotonin and depression, though the quality of the underlying studies varied, and a critical commentary judged that conclusion overstated, pointing to tryptophan depletion evidence, whose own intervals were wide, and to PET imaging evidence (Moncrieff et al., 2023; Jauhar et al., 2023).

What does rumination have to do with depression?

Rumination, a repetitive focus on one's low mood, predicted later depressive disorders and new onsets in longitudinal analyses, although its link to chronicity disappeared once baseline symptoms were controlled (Nolen-Hoeksema, 2000).

How well do antidepressants and psychotherapy work?

In adults with depression, a network meta-analysis of 101 studies found that psychotherapy and medication did not differ significantly from each other and that combining them produced more treatment response than either alone (Cuijpers et al., 2020).

Are there different types of depression?

Diagnostic systems draw several categories across the range of depressive symptoms; persistent depressive disorder, for example, brings chronic major depression, dysthymia and recurrent major depression without recovery under one label and is often more disabling than episodic major depression (Schramm et al., 2020). Proposed subtypes remain contested, and a review of atypical depression reported mixed evidence on its validity as a subtype and no comprehensive treatment guidelines for it (Łojko & Rybakowski, 2017).

What does depression feel like from the inside?

In qualitative studies of young people aged 10 to 24, the experiences described most often were loneliness, sadness and pulling away from others, and some of what participants reported falls outside formal diagnostic criteria (Viduani et al., 2024). In a small interview study, adolescents described anhedonia as far broader than lost pleasure, reaching into flattened emotion, low motivation and a lost sense of belonging (Watson et al., 2020).

How often does depression occur alongside other conditions?

Often. Among 1,783 participants in a Dutch cohort, 67% of those with a current depressive disorder also had a current anxiety disorder, and where both conditions had occurred, anxiety had come first far more often than depression (57% against 18%) (Lamers et al., 2011). Physical illness shows a similar overlap: in a meta-analysis of 42 studies, the 20 with a nondiabetic comparison group showed diabetes doubling the odds of depression (Anderson et al., 2001).

Does depression predict suicide?

It raises risk but forecasts outcomes for individuals poorly. Across 357 prediction cases from 166 longitudinal papers, depression and hopelessness each predicted later suicidal ideation, attempts and death, but the effects were weaker than anticipated, smallest for death, and they shrank once publication bias was adjusted for (Ribeiro et al., 2018). Among people already diagnosed with depression, a review of nineteen studies identified several risk factors for suicide, a previous attempt and hopelessness among them, while noting that the studies were fewer than expected (Hawton et al., 2013).

How This Article Was Prepared

This is a narrative reference article, not a systematic review. Its sources were identified through a survey of the 15 most-cited works on the subject, the most-cited research of four of its key researchers and four logged searches of OpenAlex, which matched 160,600 records, of which the 31 most cited were screened by title, from 14 November 2026 to 21 November 2026.

- Considered and excluded: 11 candidate works, each with a recorded reason (for example, superseded by a later review, a single case report, or outside the article's scope). - Included: 250 sources, each confirmed against the publisher's or indexer's own record. 70 read in full text, 166 from their abstracts and 14 cited without a retrievable abstract. Abstracts came from PubMed, Crossref, OpenAlex and Scite. - Identifiers: 233 references carry a PubMed ID and 84 a PubMed Central ID, each confirmed by the National Library of Medicine against the cited DOI. - Retractions: 247 sources were checked for retractions and editorial notices; none was retracted. - Publication dates: one from the 1910s, five from the 1960s, nine from the 1970s, five from the 1980s, six from the 1990s, 56 from the 2000s, 124 from the 2010s and 44 from 2020 or later. - Checked against sources: each of the 502 cited sentences was matched to a passage in its source (480 supported by that passage, 22 resting on a source without a retrievable abstract), and an independent reviewer checked the article against those sources over seven passes before publication. - Limits: a narrative review reflects choices about which studies to include, so it can over-represent some lines of work more than a systematic review would. To limit this, each of the field's 15 most-cited works was considered; every logged search and screening decision is recorded; and the reviewer searched each cited source for contrary evidence before accepting a sentence.

See our Editorial Policy for the full method.

References

Abramson, L. Y., Metalsky, G. I., & Alloy, L. B. (1989). Hopelessness depression: A theory-based subtype of depression. Psychological Review, 96(2), 358-372. https://doi.org/10.1037/0033-295X.96.2.358

Abramson, L. Y., Seligman, M. E. P., & Teasdale, J. D. (1978). Learned helplessness in humans: Critique and reformulation. Journal of Abnormal Psychology, 87(1), 49-74. https://doi.org/10.1037/0021-843X.87.1.49

Ainsworth, N. J., Oughli, H., Lavretsky, H., Blumberger, D. M., Brown, P. J., Butters, M. A., Karp, J. F., Lenard, E., Lenze, E. J., McAndrews, M. P., Miller, J. P., Pollock, B. G., Reynolds, C. F., & Mulsant, B. H. (2025). The cognitive profile of older adults with treatment-resistant depression: An analysis of the OPTIMUM randomized controlled trial. The American Journal of Geriatric Psychiatry, 33(4), 361-371. https://doi.org/10.1016/j.jagp.2024.09.018 PMID: 39438235

Aizenstein, H. J., Baskys, A., Boldrini, M., Butters, M. A., Diniz, B. S., Jaiswal, M. K., Jellinger, K. A., Kruglov, L. S., Meshandin, I. A., Mijajlovic, M. D., Niklewski, G., Pospos, S., Raju, K., Richter, K., Steffens, D. C., Taylor, W. D., & Tene, O. (2016). Vascular depression consensus report – a critical update. BMC Medicine, 14, 161. https://doi.org/10.1186/s12916-016-0720-5 PMID: 27806704 · PMCID: PMC5093970

Alegría, M., Chatterji, P., Wells, K., Cao, Z., Chen, C.-n., Takeuchi, D., Jackson, J., & Meng, X.-L. (2008). Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatric Services, 59(11), 1264-1272. https://doi.org/10.1176/ps.2008.59.11.1264 PMID: 18971402 · PMCID: PMC2668139

Alexopoulos, G. S., Meyers, B. S., Young, R. C., Campbell, S., Silbersweig, D., & Charlson, M. (1997). 'Vascular depression' hypothesis. Archives of General Psychiatry, 54(10), 915-922. https://doi.org/10.1001/archpsyc.1997.01830220033006 PMID: 9337771

Alloy, L. B., & Abramson, L. Y. (1979). Judgment of contingency in depressed and nondepressed students: Sadder but wiser? Journal of Experimental Psychology: General, 108(4), 441-485. https://doi.org/10.1037/0096-3445.108.4.441 PMID: 528910

Alloy, L. B., Abramson, L. Y., Whitehouse, W. G., Hogan, M. E., Panzarella, C., & Rose, D. T. (2006). Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. Journal of Abnormal Psychology, 115(1), 145-156. https://doi.org/10.1037/0021-843X.115.1.145 PMID: 16492105

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425596

American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.books.9780890425787

Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001). The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care, 24(6), 1069-1078. https://doi.org/10.2337/diacare.24.6.1069 PMID: 11375373

Andrews, P. W., & Thomson, J. A., Jr. (2009). The bright side of being blue: Depression as an adaptation for analyzing complex problems. Psychological Review, 116(3), 620-654. https://doi.org/10.1037/a0016242 PMID: 19618990 · PMCID: PMC2734449

Ang, B., Horowitz, M., & Moncrieff, J. (2022). Is the chemical imbalance an 'urban legend'? An exploration of the status of the serotonin theory of depression in the scientific literature. SSM - Mental Health, 2, 100098. https://doi.org/10.1016/j.ssmmh.2022.100098

Armstrong, T., & Olatunji, B. O. (2012). Eye tracking of attention in the affective disorders: A meta-analytic review and synthesis. Clinical Psychology Review, 32(8), 704-723. https://doi.org/10.1016/j.cpr.2012.09.004 PMID: 23059623 · PMCID: PMC3556338

Baglioni, C., Battagliese, G., Feige, B., Spiegelhalder, K., Nissen, C., Voderholzer, U., Lombardo, C., & Riemann, D. (2011). Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders, 135(1-3), 10-19. https://doi.org/10.1016/j.jad.2011.01.011 PMID: 21300408

Baglioni, C., Nanovska, S., Regen, W., Spiegelhalder, K., Feige, B., Nissen, C., Reynolds, C. F., & Riemann, D. (2016). Sleep and mental disorders: A meta-analysis of polysomnographic research. Psychological Bulletin, 142(9), 969-990. https://doi.org/10.1037/bul0000053 PMID: 27416139 · PMCID: PMC5110386

Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003). Depression and pain comorbidity: A literature review. Archives of Internal Medicine, 163(20), 2433-2445. https://doi.org/10.1001/archinte.163.20.2433 PMID: 14609780

Barney, L. J., Griffiths, K. M., Jorm, A. F., & Christensen, H. (2006). Stigma about depression and its impact on help-seeking intentions. Australian & New Zealand Journal of Psychiatry, 40(1), 51-54. https://doi.org/10.1080/j.1440-1614.2006.01741.x PMID: 16403038

Bathina, K. C., ten Thij, M., Lorenzo-Luaces, L., Rutter, L. A., & Bollen, J. (2021). Individuals with depression express more distorted thinking on social media. Nature Human Behaviour, 5(4), 458-466. https://doi.org/10.1038/s41562-021-01050-7 PMID: 33574604

Beck, A. T. (1963). Thinking and depression: I. Idiosyncratic content and cognitive distortions. Archives of General Psychiatry, 9(4), 324-333. https://doi.org/10.1001/archpsyc.1963.01720160014002 PMID: 14045261

Beck, A. T. (1967). Depression: Clinical, experimental, and theoretical aspects. Hoeber Medical Division, Harper & Row.

Beck, A. T. (2008). The evolution of the cognitive model of depression and its neurobiological correlates. American Journal of Psychiatry, 165(8), 969-977. https://doi.org/10.1176/appi.ajp.2008.08050721 PMID: 18628348

Beck, A. T., & Bredemeier, K. (2016). A unified model of depression: Integrating clinical, cognitive, biological, and evolutionary perspectives. Clinical Psychological Science, 4(4), 596-619. https://doi.org/10.1177/2167702616628523

Beck, A. T., & Haigh, E. A. P. (2014). Advances in cognitive theory and therapy: The generic cognitive model. Annual Review of Clinical Psychology, 10, 1-24. https://doi.org/10.1146/annurev-clinpsy-032813-153734 PMID: 24387236

Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4(6), 561-571. https://doi.org/10.1001/archpsyc.1961.01710120031004 PMID: 13688369

Beckham, E. E., Leber, W. R., Watkins, J. T., Boyer, J. L., & Cook, J. B. (1986). Development of an instrument to measure Beck's cognitive triad: The Cognitive Triad Inventory. Journal of Consulting and Clinical Psychology, 54(4), 566-567. https://doi.org/10.1037/0022-006X.54.4.566 PMID: 3745613

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354. https://doi.org/10.1016/S0006-3223(99)00230-9 PMID: 10686270

Boelen, P. A., van den Hout, M. A., & van den Bout, J. (2006). A cognitive-behavioral conceptualization of complicated grief. Clinical Psychology: Science and Practice, 13(2), 109-128. https://doi.org/10.1111/j.1468-2850.2006.00013.x

Border, R., Johnson, E. C., Evans, L. M., Smolen, A., Berley, N., Sullivan, P. F., & Keller, M. C. (2019). No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. American Journal of Psychiatry, 176(5), 376-387. https://doi.org/10.1176/appi.ajp.2018.18070881 PMID: 30845820 · PMCID: PMC6548317

Brohan, E., Gauci, D., Sartorius, N., Thornicroft, G., & GAMIAN-Europe Study Group. (2011). Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: The GAMIAN-Europe study. Journal of Affective Disorders, 129(1-3), 56-63. https://doi.org/10.1016/j.jad.2010.09.001 PMID: 20888050

Brunoni, A. R., Chaimani, A., Moffa, A. H., Razza, L. B., Gattaz, W. F., Daskalakis, Z. J., & Carvalho, A. F. (2017). Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: A systematic review with network meta-analysis. JAMA Psychiatry, 74(2), 143-152. https://doi.org/10.1001/jamapsychiatry.2016.3644 PMID: 28030740

Buus, N., Petersen, A., McPherson, S., Meadows, G., Brand, G., & Ong, B. (2024). The relatives of people with depression: A systematic review and methodological critique of qualitative studies. Family Process, 63(3), 1469-1483. https://doi.org/10.1111/famp.12927 PMID: 37604511

Cacioppo, J. T., Hughes, M. E., Waite, L. J., Hawkley, L. C., & Thisted, R. A. (2006). Loneliness as a specific risk factor for depressive symptoms: Cross-sectional and longitudinal analyses. Psychology and Aging, 21(1), 140-151. https://doi.org/10.1037/0882-7974.21.1.140 PMID: 16594799

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402-1411. https://doi.org/10.1056/NEJMoa2032994 PMID: 33852780

Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., & Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301(5631), 386-389. https://doi.org/10.1126/science.1083968 PMID: 12869766

Chowdhary, N., Jotheeswaran, A. T., Nadkarni, A., Hollon, S. D., King, M., Jordans, M. J. D., Rahman, A., Verdeli, H., Araya, R., & Patel, V. (2014). The methods and outcomes of cultural adaptations of psychological treatments for depressive disorders: A systematic review. Psychological Medicine, 44(6), 1131-1146. https://doi.org/10.1017/S0033291713001785 PMID: 23866176 · PMCID: PMC3943384

Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. The Lancet, 391(10128), 1357-1366. https://doi.org/10.1016/S0140-6736(17)32802-7 PMID: 29477251 · PMCID: PMC5889788

Clark, D. A., & Beck, A. T. (2010). Cognitive theory and therapy of anxiety and depression: Convergence with neurobiological findings. Trends in Cognitive Sciences, 14(9), 418-424. https://doi.org/10.1016/j.tics.2010.06.007 PMID: 20655801

Clement, S., Schauman, O., Graham, T., Maggioni, F., Evans-Lacko, S., Bezborodovs, N., Morgan, C., Rüsch, N., Brown, J. S. L., & Thornicroft, G. (2015). What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies. Psychological Medicine, 45(1), 11-27. https://doi.org/10.1017/S0033291714000129 PMID: 24569086

Connors, M. H., Quinto, L., & Brodaty, H. (2019). Longitudinal outcomes of patients with pseudodementia: A systematic review. Psychological Medicine, 49(5), 727-737. https://doi.org/10.1017/S0033291718002829 PMID: 30319082

Copeland, W. E., Angold, A., Costello, E. J., & Egger, H. (2013). Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. American Journal of Psychiatry, 170(2), 173-179. https://doi.org/10.1176/appi.ajp.2012.12010132 PMID: 23377638 · PMCID: PMC3573525

Cosco, T. D., Doyle, F., Ward, M., & McGee, H. (2012). Latent structure of the Hospital Anxiety and Depression Scale: A 10-year systematic review. Journal of Psychosomatic Research, 72(3), 180-184. https://doi.org/10.1016/j.jpsychores.2011.06.008 PMID: 22325696

Cowen, P. J., & Browning, M. (2015). What has serotonin to do with depression? World Psychiatry, 14(2), 158-160. https://doi.org/10.1002/wps.20229 PMID: 26043325 · PMCID: PMC4471964

Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150(6), 782-786. https://doi.org/10.1192/bjp.150.6.782 PMID: 3651732

Coyne, J. C. (1976). Toward an interactional description of depression. Psychiatry, 39(1), 28-40. https://doi.org/10.1080/00332747.1976.11023874 PMID: 1257353

Coyne, J. C., & van Sonderen, E. (2012). No further research needed: Abandoning the Hospital and Anxiety Depression Scale (HADS). Journal of Psychosomatic Research, 72(3), 173-174. https://doi.org/10.1016/j.jpsychores.2011.12.003 PMID: 22325694

Cristea, I. A., Kok, R. N., & Cuijpers, P. (2015). Efficacy of cognitive bias modification interventions in anxiety and depression: Meta-analysis. British Journal of Psychiatry, 206(1), 7-16. https://doi.org/10.1192/bjp.bp.114.146761 PMID: 25561486

Crowe, M., Inder, M., & McCall, C. (2023). Experience of antidepressant use and discontinuation: A qualitative synthesis of the evidence. Journal of Psychiatric and Mental Health Nursing, 30(1), 21-34. https://doi.org/10.1111/jpm.12850 PMID: 35713005 · PMCID: PMC10083940

Cuijpers, P., Geraedts, A. S., van Oppen, P., Andersson, G., Markowitz, J. C., & van Straten, A. (2011). Interpersonal psychotherapy for depression: A meta-analysis. American Journal of Psychiatry, 168(6), 581-592. https://doi.org/10.1176/appi.ajp.2010.10101411 PMID: 21362740 · PMCID: PMC3646065

Cuijpers, P., Noma, H., Karyotaki, E., Vinkers, C. H., Cipriani, A., & Furukawa, T. A. (2020). A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry, 19(1), 92-107. https://doi.org/10.1002/wps.20701 PMID: 31922679 · PMCID: PMC6953550

Cuijpers, P., Smit, F., Bohlmeijer, E., Hollon, S. D., & Andersson, G. (2010). Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: Meta-analytic study of publication bias. British Journal of Psychiatry, 196(3), 173-178. https://doi.org/10.1192/bjp.bp.109.066001 PMID: 20194536

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9(1), 46-56. https://doi.org/10.1038/nrn2297 PMID: 18073775 · PMCID: PMC2919277

Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111-121. https://doi.org/10.1016/j.addbeh.2018.08.027 PMID: 30292574

Deng, Z.-D., Robins, P. L., Regenold, W., Rohde, P., Dannhauer, M., & Lisanby, S. H. (2024). How electroconvulsive therapy works in the treatment of depression: Is it the seizure, the electricity, or both? Neuropsychopharmacology, 49(1), 150-162. https://doi.org/10.1038/s41386-023-01677-2 PMID: 37488281 · PMCID: PMC10700353

Derry, P. A., & Kuiper, N. A. (1981). Schematic processing and self-reference in clinical depression. Journal of Abnormal Psychology, 90(4), 286-297. https://doi.org/10.1037/0021-843X.90.4.286 PMID: 7264058

Desmet, M. (2013). Some preliminary notes on an empirical test of Freud's theory on depression. Frontiers in Psychology, 4, 158. https://doi.org/10.3389/fpsyg.2013.00158 PMID: 23675357 · PMCID: PMC3646245

Dev, A. S., Moore, D. A., Johnson, S. L., & Garrett, K. T. (2022). Sadder ≠ wiser: Depressive realism is not robust to replication. Collabra: Psychology, 8(1), Article 38529. https://doi.org/10.1525/collabra.38529

Dimidjian, S., Barrera, M., Jr., Martell, C., Muñoz, R. F., & Lewinsohn, P. M. (2011). The origins and current status of behavioral activation treatments for depression. Annual Review of Clinical Psychology, 7, 1-38. https://doi.org/10.1146/annurev-clinpsy-032210-104535 PMID: 21275642

Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., Atkins, D. C., Dunner, D. L., & Jacobson, N. S. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74(4), 658-670. https://doi.org/10.1037/0022-006X.74.4.658 PMID: 16881773

Doblyte, S., & Jiménez-Mejías, E. (2017). Understanding help-seeking behavior in depression: A qualitative synthesis of patients' experiences. Qualitative Health Research, 27(1), 100-113. https://doi.org/10.1177/1049732316681282 PMID: 27956660

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446-457. https://doi.org/10.1016/j.biopsych.2009.09.033 PMID: 20015486

Duman, R. S., & Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59(12), 1116-1127. https://doi.org/10.1016/j.biopsych.2006.02.013 PMID: 16631126

Dybedal, G. S., Tanum, L., Sundet, K., Gaarden, T. L., & Bjølseth, T. M. (2013). Neuropsychological functioning in late-life depression. Frontiers in Psychology, 4, 381. https://doi.org/10.3389/fpsyg.2013.00381 PMID: 23818887 · PMCID: PMC3694218

Eisenlohr-Moul, T. A., Girdler, S. S., Schmalenberger, K. M., Dawson, D. N., Surana, P., Johnson, J. L., & Rubinow, D. R. (2017). Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS). American Journal of Psychiatry, 174(1), 51-59. https://doi.org/10.1176/appi.ajp.2016.15121510 PMID: 27523500 · PMCID: PMC5205545

Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D., & Gilbody, S. (2014). Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PLoS ONE, 9(6), e100100. https://doi.org/10.1371/journal.pone.0100100 PMID: 24936656 · PMCID: PMC4061095

Epperson, C. N., Steiner, M., Hartlage, S. A., Eriksson, E., Schmidt, P. J., Jones, I., & Yonkers, K. A. (2012). Premenstrual dysphoric disorder: Evidence for a new category for DSM-5. American Journal of Psychiatry, 169(5), 465-475. https://doi.org/10.1176/appi.ajp.2012.11081302 PMID: 22764360 · PMCID: PMC3462360

Evans-Lacko, S., & Knapp, M. (2016). Global patterns of workplace productivity for people with depression: Absenteeism and presenteeism costs across eight diverse countries. Social Psychiatry and Psychiatric Epidemiology, 51(11), 1525-1537. https://doi.org/10.1007/s00127-016-1278-4 PMID: 27667656 · PMCID: PMC5101346

Everaert, J., Duyck, W., & Koster, E. H. W. (2014). Attention, interpretation, and memory biases in subclinical depression: A proof-of-principle test of the combined cognitive biases hypothesis. Emotion, 14(2), 331-340. https://doi.org/10.1037/a0035250 PMID: 24512247

Everaert, J., Koster, E. H. W., & Derakshan, N. (2012). The combined cognitive bias hypothesis in depression. Clinical Psychology Review, 32(5), 413-424. https://doi.org/10.1016/j.cpr.2012.04.003 PMID: 22681914

Everaert, J., Podina, I. R., & Koster, E. H. W. (2017). A comprehensive meta-analysis of interpretation biases in depression. Clinical Psychology Review, 58, 33-48. https://doi.org/10.1016/j.cpr.2017.09.005 PMID: 28974339

Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., Warden, D., & Trivedi, M. H. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry, 165(3), 342-351. https://doi.org/10.1176/appi.ajp.2007.06111868 PMID: 18172020

Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Jr., Winokur, G., & Munoz, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26(1), 57-63. https://doi.org/10.1001/archpsyc.1972.01750190059011 PMID: 5009428

Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine, 10(11), e1001547. https://doi.org/10.1371/journal.pmed.1001547 PMID: 24223526 · PMCID: PMC3818162

Firth, J., Torous, J., Nicholas, J., Carney, R., Pratap, A., Rosenbaum, S., & Sarris, J. (2017). The efficacy of smartphone-based mental health interventions for depressive symptoms: A meta-analysis of randomized controlled trials. World Psychiatry, 16(3), 287-298. https://doi.org/10.1002/wps.20472 PMID: 28941113 · PMCID: PMC5608852

Fleming, S. K., Blasey, C., & Schatzberg, A. F. (2004). Neuropsychological correlates of psychotic features in major depressive disorders: A review and meta-analysis. Journal of Psychiatric Research, 38(1), 27-35. https://doi.org/10.1016/S0022-3956(03)00100-6 PMID: 14690768

Franklin, J. C., Ribeiro, J. D., Fox, K. R., Bentley, K. H., Kleiman, E. M., Huang, X., Musacchio, K. M., Jaroszewski, A. C., Chang, B. P., & Nock, M. K. (2017). Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research. Psychological Bulletin, 143(2), 187-232. https://doi.org/10.1037/bul0000084 PMID: 27841450

Freud, S. (1957). Mourning and melancholia. In J. Strachey (Ed. & Trans.), The standard edition of the complete psychological works of Sigmund Freud (Vol. 14, pp. 237-258). Hogarth Press. (Original work published 1917)

Fried, E. I. (2017). The 52 symptoms of major depression: Lack of content overlap among seven common depression scales. Journal of Affective Disorders, 208, 191-197. https://doi.org/10.1016/j.jad.2016.10.019 PMID: 27792962

Fried, E. I., & Nesse, R. M. (2015). Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study. Journal of Affective Disorders, 172, 96-102. https://doi.org/10.1016/j.jad.2014.10.010 PMID: 25451401 · PMCID: PMC4397113

Furukawa, T. A., Maruo, K., Noma, H., Tanaka, S., Imai, H., Shinohara, K., Ikeda, K., Yamawaki, S., Levine, S. Z., Goldberg, Y., Leucht, S., & Cipriani, A. (2018). Initial severity of major depression and efficacy of new generation antidepressants: Individual participant data meta-analysis. Acta Psychiatrica Scandinavica, 137(6), 450-458. https://doi.org/10.1111/acps.12886 PMID: 29611870

Goodman, S. H., Rouse, M. H., Connell, A. M., Broth, M. R., Hall, C. M., & Heyward, D. (2011). Maternal depression and child psychopathology: A meta-analytic review. Clinical Child and Family Psychology Review, 14(1), 1-27. https://doi.org/10.1007/s10567-010-0080-1 PMID: 21052833

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine, 387(18), 1637-1648. https://doi.org/10.1056/NEJMoa2206443 PMID: 36322843

Gotlib, I. H., & Joormann, J. (2010). Cognition and depression: Current status and future directions. Annual Review of Clinical Psychology, 6, 285-312. https://doi.org/10.1146/annurev.clinpsy.121208.131305 PMID: 20192795 · PMCID: PMC2845726

Greicius, M. D., Flores, B. H., Menon, V., Glover, G. H., Solvason, H. B., Kenna, H., Reiss, A. L., & Schatzberg, A. F. (2007). Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry, 62(5), 429-437. https://doi.org/10.1016/j.biopsych.2006.09.020 PMID: 17210143 · PMCID: PMC2001244

Hackett, M. L., & Pickles, K. (2014). Part I: Frequency of depression after stroke: An updated systematic review and meta-analysis of observational studies. International Journal of Stroke, 9(8), 1017-1025. https://doi.org/10.1111/ijs.12357 PMID: 25117911

Hagen, E. H. (2011). Evolutionary theories of depression: A critical review. Canadian Journal of Psychiatry, 56(12), 716-726. https://doi.org/10.1177/070674371105601203 PMID: 22152640

Hames, J. L., Hagan, C. R., & Joiner, T. E. (2013). Interpersonal processes in depression. Annual Review of Clinical Psychology, 9, 355-377. https://doi.org/10.1146/annurev-clinpsy-050212-185553 PMID: 23297787

Hamilton, J. P., Farmer, M., Fogelman, P., & Gotlib, I. H. (2015). Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience. Biological Psychiatry, 78(4), 224-230. https://doi.org/10.1016/j.biopsych.2015.02.020 PMID: 25861700 · PMCID: PMC4524294

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56-62. https://doi.org/10.1136/jnnp.23.1.56 PMID: 14399272 · PMCID: PMC495331

Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63(3), 332-339. https://doi.org/10.1001/archpsyc.63.3.332 PMID: 16520440

Hammen, C. (1991). Generation of stress in the course of unipolar depression. Journal of Abnormal Psychology, 100(4), 555-561. https://doi.org/10.1037/0021-843X.100.4.555 PMID: 1757669

Hankin, B. L., Fraley, R. C., Lahey, B. B., & Waldman, I. D. (2005). Is depression best viewed as a continuum or discrete category? A taxometric analysis of childhood and adolescent depression in a population-based sample. Journal of Abnormal Psychology, 114(1), 96-110. https://doi.org/10.1037/0021-843X.114.1.96 PMID: 15709816

Harmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009). Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. British Journal of Psychiatry, 195(2), 102-108. https://doi.org/10.1192/bjp.bp.108.051193 PMID: 19648538

Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018). Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry, 75(4), 336-346. https://doi.org/10.1001/jamapsychiatry.2017.4602 PMID: 29450462 · PMCID: PMC5875313

Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. American Journal of Psychiatry, 163(4), 689-696. https://doi.org/10.1176/ajp.2006.163.4.689 PMID: 16585445

Hawton, K., Casañas i Comabella, C., Haw, C., & Saunders, K. (2013). Risk factors for suicide in individuals with depression: A systematic review. Journal of Affective Disorders, 147(1-3), 17-28. https://doi.org/10.1016/j.jad.2013.01.004 PMID: 23411024

Hawton, K., Saunders, K. E. A., & O'Connor, R. C. (2012). Self-harm and suicide in adolescents. The Lancet, 379(9834), 2373-2382. https://doi.org/10.1016/S0140-6736(12)60322-5 PMID: 22726518

Hengartner, M. P., & Plöderl, M. (2022). Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression. BMJ Evidence-Based Medicine, 27(2), 69-73. https://doi.org/10.1136/bmjebm-2020-111600 PMID: 33593736

Henssler, J., Schmidt, Y., Schmidt, U., Schwarzer, G., Bschor, T., & Baethge, C. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 526-535. https://doi.org/10.1016/S2215-0366(24)00133-0 PMID: 38851198

Henz, A., Ferreira, C. F., Oderich, C. L., Gallon, C. W., Castro, J. R. S., Conzatti, M., Fleck, M. P. A., & Wender, M. C. O. (2018). Premenstrual syndrome diagnosis: A comparative study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST). Revista Brasileira de Ginecologia e Obstetrícia, 40(1), 20-25. https://doi.org/10.1055/s-0037-1608672 PMID: 29132173 · PMCID: PMC10467366

Herrman, H., Patel, V., Kieling, C., Berk, M., Buchweitz, C., Cuijpers, P., Furukawa, T. A., Kessler, R. C., Kohrt, B. A., Maj, M., McGorry, P., Reynolds, C. F., III, Weissman, M. M., Chibanda, D., Dowrick, C., Howard, L. M., Hoven, C. W., Knapp, M., Mayberg, H. S., . . . Wolpert, M. (2022). Time for united action on depression: A Lancet–World Psychiatric Association Commission. The Lancet, 399(10328), 957-1022. https://doi.org/10.1016/S0140-6736(21)02141-3 PMID: 35180424

Hjordt, L. V., Stenbæk, D. S., Ozenne, B., Mc Mahon, B., Hageman, I., Hasselbalch, S. G., & Knudsen, G. M. (2017). Season-independent cognitive deficits in seasonal affective disorder and their relation to depressive symptoms. Psychiatry Research, 257, 219-226. https://doi.org/10.1016/j.psychres.2017.07.056 PMID: 28780278

Hofmann, S. G., Curtiss, J., Carpenter, J. K., & Kind, S. (2017). Effect of treatments for depression on quality of life: A meta-analysis. Cognitive Behaviour Therapy, 46(4), 265-286. https://doi.org/10.1080/16506073.2017.1304445 PMID: 28440699 · PMCID: PMC5663193

Hollon, S. D., Stewart, M. O., & Strunk, D. (2006). Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annual Review of Psychology, 57, 285-315. https://doi.org/10.1146/annurev.psych.57.102904.190044 PMID: 16318597

Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., Alloza, C., Shen, X., Barbu, M. C., Xu, E. Y., Whalley, H. C., Marioni, R. E., Porteous, D. J., Davies, G., Deary, I. J., . . . McIntosh, A. M. (2019). Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience, 22(3), 343-352. https://doi.org/10.1038/s41593-018-0326-7 PMID: 30718901 · PMCID: PMC6522363

Iglewicz, A., Seay, K., Zetumer, S. D., & Zisook, S. (2013). The removal of the bereavement exclusion in the DSM-5: Exploring the evidence. Current Psychiatry Reports, 15(11), 413. https://doi.org/10.1007/s11920-013-0413-0 PMID: 24136623

Jacobson, N. S., Dobson, K. S., Truax, P. A., Addis, M. E., Koerner, K., Gollan, J. K., Gortner, E., & Prince, S. E. (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64(2), 295-304. https://doi.org/10.1037/0022-006X.64.2.295 PMID: 8871414

Jacobson, N. S., Martell, C. R., & Dimidjian, S. (2001). Behavioral activation treatment for depression: Returning to contextual roots. Clinical Psychology: Science and Practice, 8(3), 255-270. https://doi.org/10.1093/clipsy.8.3.255

Jauhar, S., Arnone, D., Baldwin, D. S., Bloomfield, M., Browning, M., Cleare, A. J., Corlett, P., Deakin, J. F. W., Erritzoe, D., Fu, C., Fusar-Poli, P., Goodwin, G. M., Hayes, J., Howard, R., Howes, O. D., Juruena, M. F., Lam, R. W., Lawrie, S. M., McAllister-Williams, H., . . . Cowen, P. J. (2023). A leaky umbrella has little value: Evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry, 28(8), 3149-3152. https://doi.org/10.1038/s41380-023-02095-y PMID: 37322065 · PMCID: PMC10618084

Joormann, J., & Gotlib, I. H. (2010). Emotion regulation in depression: Relation to cognitive inhibition. Cognition and Emotion, 24(2), 281-298. https://doi.org/10.1080/02699930903407948 PMID: 20300538 · PMCID: PMC2839199

Kaiser, R. H., Andrews-Hanna, J. R., Wager, T. D., & Pizzagalli, D. A. (2015). Large-scale network dysfunction in major depressive disorder: A meta-analysis of resting-state functional connectivity. JAMA Psychiatry, 72(6), 603-611. https://doi.org/10.1001/jamapsychiatry.2015.0071 PMID: 25785575 · PMCID: PMC4456260

Karyotaki, E., Efthimiou, O., Miguel, C., Bermpohl, F. M. G., Furukawa, T. A., Cuijpers, P., & Individual Patient Data Meta-Analyses for Depression (IPDMA-DE) Collaboration. (2021). Internet-based cognitive behavioral therapy for depression: A systematic review and individual patient data network meta-analysis. JAMA Psychiatry, 78(4), 361-371. https://doi.org/10.1001/jamapsychiatry.2020.4364 PMID: 33471111 · PMCID: PMC8027916

Kendler, K. S. (2016). The phenomenology of major depression and the representativeness and nature of DSM criteria. American Journal of Psychiatry, 173(8), 771-780. https://doi.org/10.1176/appi.ajp.2016.15121509 PMID: 27138588

Kendler, K. S. (2020). The origin of our modern concept of depression—The history of melancholia from 1780-1880: A review. JAMA Psychiatry, 77(8), 863-868. https://doi.org/10.1001/jamapsychiatry.2019.4709 PMID: 31995137

Kendler, K. S., Gardner, C. O., Gatz, M., & Pedersen, N. L. (2007). The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychological Medicine, 37(3), 453-462. https://doi.org/10.1017/S0033291706009135 PMID: 17121688

Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Causal relationship between stressful life events and the onset of major depression. American Journal of Psychiatry, 156(6), 837-841. https://doi.org/10.1176/ajp.156.6.837 PMID: 10360120

Kessler, R. C., & Bromet, E. J. (2013). The epidemiology of depression across cultures. Annual Review of Public Health, 34, 119-138. https://doi.org/10.1146/annurev-publhealth-031912-114409 PMID: 23514317 · PMCID: PMC4100461

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003). The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289(23), 3095-3105. https://doi.org/10.1001/jama.289.23.3095 PMID: 12813115

Kessler, R. C., Birnbaum, H., Bromet, E., Hwang, I., Sampson, N., & Shahly, V. (2010). Age differences in major depression: Results from the National Comorbidity Survey Replication (NCS-R). Psychological Medicine, 40(2), 225-237. https://doi.org/10.1017/S0033291709990213 PMID: 19531277 · PMCID: PMC2813515

King, M., Semlyen, J., Tai, S. S., Killaspy, H., Osborn, D., Popelyuk, D., & Nazareth, I. (2008). A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry, 8, 70. https://doi.org/10.1186/1471-244X-8-70 PMID: 18706118 · PMCID: PMC2533652

Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), e45. https://doi.org/10.1371/journal.pmed.0050045 PMID: 18303940 · PMCID: PMC2253608

Koster, E. H. W., De Lissnyder, E., Derakshan, N., & De Raedt, R. (2011). Understanding depressive rumination from a cognitive science perspective: The impaired disengagement hypothesis. Clinical Psychology Review, 31(1), 138-145. https://doi.org/10.1016/j.cpr.2010.08.005 PMID: 20817334

Koukopoulos, A., & Sani, G. (2014). DSM-5 criteria for depression with mixed features: A farewell to mixed depression. Acta Psychiatrica Scandinavica, 129(1), 4-16. https://doi.org/10.1111/acps.12140 PMID: 23600771

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606-613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x PMID: 11556941 · PMCID: PMC1495268

Kube, T., Schwarting, R., Rozenkrantz, L., Glombiewski, J. A., & Rief, W. (2020). Distorted cognitive processes in major depression: A predictive processing perspective. Biological Psychiatry, 87(5), 388-398. https://doi.org/10.1016/j.biopsych.2019.07.017 PMID: 31515055

Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F. (2017). Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Acta Psychiatrica Scandinavica, 135(5), 373-387. https://doi.org/10.1111/acps.12698 PMID: 28122130

Lamers, F., van Oppen, P., Comijs, H. C., Smit, J. H., Spinhoven, P., van Balkom, A. J. L. M., Nolen, W. A., Zitman, F. G., Beekman, A. T. F., & Penninx, B. W. J. H. (2011). Comorbidity patterns of anxiety and depressive disorders in a large cohort study: The Netherlands Study of Depression and Anxiety (NESDA). The Journal of Clinical Psychiatry, 72(3), 341-348. https://doi.org/10.4088/JCP.10m06176blu PMID: 21294994

Le, J., Thomas, N., & Gurvich, C. (2020). Cognition, the menstrual cycle, and premenstrual disorders: A review. Brain Sciences, 10(4), 198. https://doi.org/10.3390/brainsci10040198 PMID: 32230889 · PMCID: PMC7226433

Lee, Y. Y., Stockings, E. A., Harris, M. G., Doi, S. A. R., Page, I. S., Davidson, S. K., & Barendregt, J. J. (2019). The risk of developing major depression among individuals with subthreshold depression: A systematic review and meta-analysis of longitudinal cohort studies. Psychological Medicine, 49(1), 92-102. https://doi.org/10.1017/S0033291718000557 PMID: 29530112

Leibenluft, E. (2011). Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. American Journal of Psychiatry, 168(2), 129-142. https://doi.org/10.1176/appi.ajp.2010.10050766 PMID: 21123313 · PMCID: PMC3396206

Lemmens, L. H. J. M., Müller, V. N. L. S., Arntz, A., & Huibers, M. J. H. (2016). Mechanisms of change in psychotherapy for depression: An empirical update and evaluation of research aimed at identifying psychological mediators. Clinical Psychology Review, 50, 95-107. https://doi.org/10.1016/j.cpr.2016.09.004 PMID: 27770716

Lerner, D., & Henke, R. M. (2008). What does research tell us about depression, job performance, and work productivity? Journal of Occupational and Environmental Medicine, 50(4), 401-410. https://doi.org/10.1097/jom.0b013e31816bae50 PMID: 18404013

Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration. (2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ, 365, l1476. https://doi.org/10.1136/bmj.l1476 PMID: 30967483 · PMCID: PMC6454318

Lewinsohn, P. M., & Graf, M. (1973). Pleasant activities and depression. Journal of Consulting and Clinical Psychology, 41(2), 261-268. https://doi.org/10.1037/h0035142 PMID: 4147832

Lichtman, J. H., Froelicher, E. S., Blumenthal, J. A., Carney, R. M., Doering, L. V., Frasure-Smith, N., Freedland, K. E., Jaffe, A. S., Leifheit-Limson, E. C., Sheps, D. S., Vaccarino, V., & Wulsin, L. (2014). Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific statement from the American Heart Association. Circulation, 129(12), 1350-1369. https://doi.org/10.1161/CIR.0000000000000019 PMID: 24566200

Lin, K., Xu, G., Lu, W., Ouyang, H., Dang, Y., Lorenzo-Seva, U., Guo, Y., Bessonov, D., Akiskal, H. S., So, K.-F., & Lee, T. M. C. (2014). Neuropsychological performance in melancholic, atypical and undifferentiated major depression during depressed and remitted states: A prospective longitudinal study. Journal of Affective Disorders, 168, 184-191. https://doi.org/10.1016/j.jad.2014.06.032 PMID: 25061955

Liu, R. T., & Alloy, L. B. (2010). Stress generation in depression: A systematic review of the empirical literature and recommendations for future study. Clinical Psychology Review, 30(5), 582-593. https://doi.org/10.1016/j.cpr.2010.04.010 PMID: 20478648 · PMCID: PMC3049314

Liu, R. T., Hamilton, J. L., Boyd, S. I., Dreier, M. J., Walsh, R. F. L., Sheehan, A. E., Turnamian, M. R., Workman, A. R. C., & Jorgensen, S. L. (2024). A systematic review and Bayesian meta-analysis of 30 years of stress generation research: Clinical, psychological, and sociodemographic risk and protective factors for prospective negative life events. Psychological Bulletin, 150(9), 1021-1069. https://doi.org/10.1037/bul0000431 PMID: 38900550 · PMCID: PMC11872340

Liu, R. T., Kleiman, E. M., Nestor, B. A., & Cheek, S. M. (2015). The hopelessness theory of depression: A quarter-century in review. Clinical Psychology: Science and Practice, 22(4), 345-365. https://doi.org/10.1111/cpsp.12125 PMID: 26709338 · PMCID: PMC4689589

Lorant, V., Deliège, D., Eaton, W., Robert, A., Philippot, P., & Ansseau, M. (2003). Socioeconomic inequalities in depression: A meta-analysis. American Journal of Epidemiology, 157(2), 98-112. https://doi.org/10.1093/aje/kwf182 PMID: 12522017

Maccallum, F., & Bryant, R. A. (2013). A cognitive attachment model of prolonged grief: Integrating attachments, memory, and identity. Clinical Psychology Review, 33(6), 713-727. https://doi.org/10.1016/j.cpr.2013.05.001 PMID: 23792468

Maier, S. F., & Seligman, M. E. P. (2016). Learned helplessness at fifty: Insights from neuroscience. Psychological Review, 123(4), 349-367. https://doi.org/10.1037/rev0000033 PMID: 27337390 · PMCID: PMC4920136

Maj, M., Pirozzi, R., Magliano, L., Fiorillo, A., & Bartoli, L. (2007). Phenomenology and prognostic significance of delusions in major depressive disorder: A 10-year prospective follow-up study. The Journal of Clinical Psychiatry, 68(9), 1411-1417. https://doi.org/10.4088/JCP.v68n0913 PMID: 17915981

Manos, R. C., Kanter, J. W., & Busch, A. M. (2010). A critical review of assessment strategies to measure the behavioral activation model of depression. Clinical Psychology Review, 30(5), 547-561. https://doi.org/10.1016/j.cpr.2010.03.008 PMID: 20444531

McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D. V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J. G., Lee, Y., Lui, L. M. W., Mansur, R. B., Papakostas, G. I., Subramaniapillai, M., Thase, M., Vieta, E., Young, A. H., Zarate, C. A., Jr., & Stahl, S. (2021). Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation. American Journal of Psychiatry, 178(5), 383-399. https://doi.org/10.1176/appi.ajp.2020.20081251 PMID: 33726522 · PMCID: PMC9635017

Meyer, I. H. (2003). Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychological Bulletin, 129(5), 674-697. https://doi.org/10.1037/0033-2909.129.5.674 PMID: 12956539 · PMCID: PMC2072932

Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008). Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care, 31(12), 2383-2390. https://doi.org/10.2337/dc08-0985 PMID: 19033418 · PMCID: PMC2584200

Miguel, N., Marquez-Arrico, J. E., Jodar, M., Navarro, J. F., & Adan, A. (2023). Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review. European Neuropsychopharmacology, 75, 41-58. https://doi.org/10.1016/j.euroneuro.2023.06.006 PMID: 37453267

Molendijk, M. L., & de Kloet, E. R. (2015). Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology, 62, 389-391. https://doi.org/10.1016/j.psyneuen.2015.08.028 PMID: 26386543

Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A. A., Penninx, B. W. J. H., & Elzinga, B. M. (2014). Serum BDNF concentrations as peripheral manifestations of depression: Evidence from a systematic review and meta-analyses on 179 associations (N=9484). Molecular Psychiatry, 19(7), 791-800. https://doi.org/10.1038/mp.2013.105 PMID: 23958957

Möller, H.-J., & Falkai, P. (2023). Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review. European Archives of Psychiatry and Clinical Neuroscience, 273(1), 1-3. https://doi.org/10.1007/s00406-022-01549-8 PMID: 36790577 · PMCID: PMC9957868

Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2023). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry, 28(8), 3243-3256. https://doi.org/10.1038/s41380-022-01661-0 PMID: 35854107 · PMCID: PMC10618090

Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry, 134(4), 382-389. https://doi.org/10.1192/bjp.134.4.382 PMID: 444788

Moore, M. T., & Fresco, D. M. (2012). Depressive realism: A meta-analytic review. Clinical Psychology Review, 32(6), 496-509. https://doi.org/10.1016/j.cpr.2012.05.004 PMID: 22717337

Moriguchi, S., Takamiya, A., Noda, Y., Horita, N., Wada, M., Tsugawa, S., Plitman, E., Sano, Y., Tarumi, R., ElSalhy, M., Katayama, N., Ogyu, K., Miyazaki, T., Kishimoto, T., Graff-Guerrero, A., Meyer, J. H., Blumberger, D. M., Daskalakis, Z. J., Mimura, M., & Nakajima, S. (2019). Glutamatergic neurometabolite levels in major depressive disorder: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Molecular Psychiatry, 24(7), 952-964. https://doi.org/10.1038/s41380-018-0252-9 PMID: 30315224 · PMCID: PMC6755980

Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007). Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. The Lancet, 370(9590), 851-858. https://doi.org/10.1016/S0140-6736(07)61415-9 PMID: 17826170

Möller, H.-J., Bandelow, B., Volz, H.-P., Barnikol, U. B., Seifritz, E., & Kasper, S. (2016). The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice. European Archives of Psychiatry and Clinical Neuroscience, 266(8), 725-736. https://doi.org/10.1007/s00406-016-0684-7 PMID: 27002521 · PMCID: PMC5097109

Na, K.-S., Kang, J. M., & Cho, S.-E. (2021). Prevalence of DSM-5 mixed features: A meta-analysis and systematic review. Journal of Affective Disorders, 282, 203-210. https://doi.org/10.1016/j.jad.2020.12.149 PMID: 33418368

Nesse, R. M. (2000). Is depression an adaptation? Archives of General Psychiatry, 57(1), 14-20. https://doi.org/10.1001/archpsyc.57.1.14 PMID: 10632228

Nolen-Hoeksema, S. (1991). Responses to depression and their effects on the duration of depressive episodes. Journal of Abnormal Psychology, 100(4), 569-582. https://doi.org/10.1037/0021-843X.100.4.569 PMID: 1757671

Nolen-Hoeksema, S. (2000). The role of rumination in depressive disorders and mixed anxiety/depressive symptoms. Journal of Abnormal Psychology, 109(3), 504-511. https://doi.org/10.1037/0021-843x.109.3.504

Nolen-Hoeksema, S., Larson, J., & Grayson, C. (1999). Explaining the gender difference in depressive symptoms. Journal of Personality and Social Psychology, 77(5), 1061-1072. https://doi.org/10.1037/0022-3514.77.5.1061 PMID: 10573880

Nolen-Hoeksema, S., Wisco, B. E., & Lyubomirsky, S. (2008). Rethinking rumination. Perspectives on Psychological Science, 3(5), 400-424. https://doi.org/10.1111/j.1745-6924.2008.00088.x PMID: 26158958

Nuij, C., van Ballegooijen, W., de Beurs, D., Juniar, D., Erlangsen, A., Portzky, G., O'Connor, R. C., Smit, J. H., Kerkhof, A., & Riper, H. (2021). Safety planning-type interventions for suicide prevention: Meta-analysis. The British Journal of Psychiatry, 219(2), 419-426. https://doi.org/10.1192/bjp.2021.50 PMID: 35048835

Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016). Major depressive disorder. Nature Reviews Disease Primers, 2, 16065. https://doi.org/10.1038/nrdp.2016.65 PMID: 27629598

Pariante, C. M., & Lightman, S. L. (2008). The HPA axis in major depression: Classical theories and new developments. Trends in Neurosciences, 31(9), 464-468. https://doi.org/10.1016/j.tins.2008.06.006 PMID: 18675469

Parker, G., Fink, M., Shorter, E., Taylor, M. A., Akiskal, H., Berrios, G., Bolwig, T., Brown, W. A., Carroll, B., Healy, D., Klein, D. F., Koukopoulos, A., Michels, R., Paris, J., Rubin, R. T., Spitzer, R., & Swartz, C. (2010). Issues for DSM-5: Whither melancholia? The case for its classification as a distinct mood disorder. American Journal of Psychiatry, 167(7), 745-747. https://doi.org/10.1176/appi.ajp.2010.09101525 PMID: 20595426 · PMCID: PMC3733615

Pascoe, E. A., & Smart Richman, L. (2009). Perceived discrimination and health: A meta-analytic review. Psychological Bulletin, 135(4), 531-554. https://doi.org/10.1037/a0016059 PMID: 19586161 · PMCID: PMC2747726

Peckham, A. D., McHugh, R. K., & Otto, M. W. (2010). A meta-analysis of the magnitude of biased attention in depression. Depression and Anxiety, 27(12), 1135-1142. https://doi.org/10.1002/da.20755 PMID: 21049527

Pellicane, M. J., & Ciesla, J. A. (2022). Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: Systematic review and meta-analysis. Clinical Psychology Review, 91, 102113. https://doi.org/10.1016/j.cpr.2021.102113 PMID: 34973649

Pezawas, L., Angst, J., & Kasper, S. (2005). Recurrent brief depression revisited. International Review of Psychiatry, 17(1), 63-70. https://doi.org/10.1080/00207390500064650 PMID: 16194772

Pizzagalli, D. A. (2014). Depression, stress, and anhedonia: Toward a synthesis and integrated model. Annual Review of Clinical Psychology, 10, 393-423. https://doi.org/10.1146/annurev-clinpsy-050212-185606 PMID: 24471371 · PMCID: PMC3972338

Pizzagalli, D. A., Holmes, A. J., Dillon, D. G., Goetz, E. L., Birk, J. L., Bogdan, R., Dougherty, D. D., Iosifescu, D. V., Rauch, S. L., & Fava, M. (2009). Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. American Journal of Psychiatry, 166(6), 702-710. https://doi.org/10.1176/appi.ajp.2008.08081201 PMID: 19411368 · PMCID: PMC2735451

Pjrek, E., Friedrich, M.-E., Cambioli, L., Dold, M., Jäger, F., Komorowski, A., Lanzenberger, R., Kasper, S., & Winkler, D. (2020). The efficacy of light therapy in the treatment of seasonal affective disorder: A meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics, 89(1), 17-24. https://doi.org/10.1159/000502891 PMID: 31574513

Popova, V., Daly, E. J., Trivedi, M., Cooper, K., Lane, R., Lim, P., Mazzucco, C., Hough, D., Thase, M. E., Shelton, R. C., Molero, P., Vieta, E., Bajbouj, M., Manji, H., Drevets, W. C., & Singh, J. B. (2019). Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: A randomized double-blind active-controlled study. American Journal of Psychiatry, 176(6), 428-438. https://doi.org/10.1176/appi.ajp.2019.19020172 PMID: 31109201

Porsolt, R. D., Le Pichon, M., & Jalfre, M. (1977). Depression: A new animal model sensitive to antidepressant treatments. Nature, 266(5604), 730-732. https://doi.org/10.1038/266730a0 PMID: 559941

Prigerson, H. G., Boelen, P. A., Xu, J., Smith, K. V., & Maciejewski, P. K. (2021). Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale. World Psychiatry, 20(1), 96-106. https://doi.org/10.1002/wps.20823 PMID: 33432758 · PMCID: PMC7801836

Prizeman, K., Weinstein, N., & McCabe, C. (2023). Effects of mental health stigma on loneliness, social isolation, and relationships in young people with depression symptoms. BMC Psychiatry, 23(1), 527. https://doi.org/10.1186/s12888-023-04991-7 PMID: 37479975 · PMCID: PMC10362624

Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401. https://doi.org/10.1177/014662167700100306

Radoš, S. N., Akik, B. K., Žutić, M., Rodriguez-Muñoz, M. F., Uriko, K., Motrico, E., Moreno-Peral, P., Apter, G., & Lambregtse-van den Berg, M. (2024). Diagnosis of peripartum depression disorder: A state-of-the-art approach from the COST Action Riseup-PPD. Comprehensive Psychiatry, 130, 152456. https://doi.org/10.1016/j.comppsych.2024.152456 PMID: 38306851

Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005). Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry, 162(6), 1171-1178. https://doi.org/10.1176/appi.ajp.162.6.1171 PMID: 15930066

Read, J., Cartwright, C., & Gibson, K. (2014). Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research, 216(1), 67-73. https://doi.org/10.1016/j.psychres.2014.01.042 PMID: 24534123

Ribeiro, J. D., Huang, X., Fox, K. R., & Franklin, J. C. (2018). Depression and hopelessness as risk factors for suicide ideation, attempts and death: Meta-analysis of longitudinal studies. British Journal of Psychiatry, 212(5), 279-286. https://doi.org/10.1192/bjp.2018.27 PMID: 29587888

Riso, L. P., du Toit, P. L., Blandino, J. A., Penna, S., Dacey, S., Duin, J. S., Pacoe, E. M., Grant, M. M., & Ulmer, C. S. (2003). Cognitive aspects of chronic depression. Journal of Abnormal Psychology, 112(1), 72-80. https://doi.org/10.1037/0021-843X.112.1.72

Rnic, K., Santee, A. C., Hoffmeister, J.-A., Liu, H., Chang, K. K., Chen, R. X., Neufeld, R. W. J., Machado, D. A., Starr, L. R., Dozois, D. J. A., & LeMoult, J. (2023). The vicious cycle of psychopathology and stressful life events: A meta-analytic review testing the stress generation model. Psychological Bulletin, 149(5-6), 330-369. https://doi.org/10.1037/bul0000390 PMID: 37261747

Rock, P. L., Roiser, J. P., Riedel, W. J., & Blackwell, A. D. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029-2040. https://doi.org/10.1017/s0033291713002535 PMID: 24168753

Rodebaugh, T. L., Scullin, R. B., Langer, J. K., Dixon, D. J., Huppert, J. D., Bernstein, A., Zvielli, A., & Lenze, E. J. (2016). Unreliability as a threat to understanding psychopathology: The cautionary tale of attentional bias. Journal of Abnormal Psychology, 125(6), 840-851. https://doi.org/10.1037/abn0000184 PMID: 27322741 · PMCID: PMC4980228

Rosenthal, N. E., Sack, D. A., Gillin, J. C., Lewy, A. J., Goodwin, F. K., Davenport, Y., Mueller, P. S., Newsome, D. A., & Wehr, T. A. (1984). Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry, 41(1), 72-80. https://doi.org/10.1001/archpsyc.1984.01790120076010 PMID: 6581756

Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. (2003). The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54(5), 573-583. https://doi.org/10.1016/s0006-3223(02)01866-8 PMID: 12946886

Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeim, H. A., Kupfer, D. J., Luther, J., & Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905-1917. https://doi.org/10.1176/ajp.2006.163.11.1905 PMID: 17074942

Ryder, A. G., Yang, J., Zhu, X., Yao, S., Yi, J., Heine, S. J., & Bagby, R. M. (2008). The cultural shaping of depression: Somatic symptoms in China, psychological symptoms in North America? Journal of Abnormal Psychology, 117(2), 300-313. https://doi.org/10.1037/0021-843X.117.2.300 PMID: 18489206

Rytwinski, N. K., Scur, M. D., Feeny, N. C., & Youngstrom, E. A. (2013). The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: A meta-analysis. Journal of Traumatic Stress, 26(3), 299-309. https://doi.org/10.1002/jts.21814 PMID: 23696449

Sackeim, H. A., Prudic, J., Fuller, R., Keilp, J., Lavori, P. W., & Olfson, M. (2007). The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology, 32(1), 244-254. https://doi.org/10.1038/sj.npp.1301180 PMID: 16936712

Salk, R. H., Hyde, J. S., & Abramson, L. Y. (2017). Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychological Bulletin, 143(8), 783-822. https://doi.org/10.1037/bul0000102 PMID: 28447828 · PMCID: PMC5532074

Samamé, C., Szmulewicz, A. G., Valerio, M. P., Martino, D. J., & Strejilevich, S. A. (2017). Are major depression and bipolar disorder neuropsychologically distinct? A meta-analysis of comparative studies. European Psychiatry, 39, 17-26. https://doi.org/10.1016/j.eurpsy.2016.06.002 PMID: 27810614

Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., & Nemeroff, C. B. (2017). A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry, 74(4), 399-405. https://doi.org/10.1001/jamapsychiatry.2017.0080 PMID: 28249076

Sanacora, G., Treccani, G., & Popoli, M. (2012). Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology, 62(1), 63-77. https://doi.org/10.1016/j.neuropharm.2011.07.036 PMID: 21827775 · PMCID: PMC3205453

Sanchez, A., Vazquez, C., Marker, C., LeMoult, J., & Joormann, J. (2013). Attentional disengagement predicts stress recovery in depression: An eye-tracking study. Journal of Abnormal Psychology, 122(2), 303-313. https://doi.org/10.1037/a0031529 PMID: 23421524

Scher, C. D., Ingram, R. E., & Segal, Z. V. (2005). Cognitive reactivity and vulnerability: Empirical evaluation of construct activation and cognitive diatheses in unipolar depression. Clinical Psychology Review, 25(4), 487-510. https://doi.org/10.1016/j.cpr.2005.01.005 PMID: 15914266

Schiena, G., Franco, G., Boscutti, A., Delvecchio, G., Maggioni, E., & Brambilla, P. (2021). Connectivity changes in major depressive disorder after rTMS: A review of functional and structural connectivity data. Epidemiology and Psychiatric Sciences, 30, e59. https://doi.org/10.1017/S2045796021000482

Schramm, E., Klein, D. N., Elsaesser, M., Furukawa, T. A., & Domschke, K. (2020). Review of dysthymia and persistent depressive disorder: History, correlates, and clinical implications. The Lancet Psychiatry, 7(9), 801-812. https://doi.org/10.1016/S2215-0366(20)30099-7 PMID: 32828168

Seligman, M. E. P., & Maier, S. F. (1967). Failure to escape traumatic shock. Journal of Experimental Psychology, 74(1), 1-9. https://doi.org/10.1037/h0024514 PMID: 6032570

Semkovska, M., & McLoughlin, D. M. (2010). Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biological Psychiatry, 68(6), 568-577. https://doi.org/10.1016/j.biopsych.2010.06.009 PMID: 20673880

Semkovska, M., Quinlivan, L., O'Grady, T., Johnson, R., Collins, A., O'Connor, J., Knittle, H., Ahern, E., & Gload, T. (2019). Cognitive function following a major depressive episode: A systematic review and meta-analysis. The Lancet Psychiatry, 6(10), 851-861. https://doi.org/10.1016/S2215-0366(19)30291-3 PMID: 31422920

Shorey, S., Ng, E. D., & Wong, C. H. J. (2022). Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. British Journal of Clinical Psychology, 61(2), 287-305. https://doi.org/10.1111/bjc.12333 PMID: 34569066

Snyder, H. R. (2013). Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychological Bulletin, 139(1), 81-132. https://doi.org/10.1037/a0028727 PMID: 22642228 · PMCID: PMC3436964

Solmi, M., Pigato, G. G., Roiter, B., Guaglianone, A., Martini, L., Fornaro, M., Monaco, F., Carvalho, A. F., Stubbs, B., Veronese, N., & Correll, C. U. (2018). Prevalence of catatonia and its moderators in clinical samples: Results from a meta-analysis and meta-regression analysis. Schizophrenia Bulletin, 44(5), 1133-1150. https://doi.org/10.1093/schbul/sbx157 PMID: 29140521 · PMCID: PMC6101628

Spitzer, R. L., Endicott, J., & Robins, E. (1978). Research diagnostic criteria: Rationale and reliability. Archives of General Psychiatry, 35(6), 773-782. https://doi.org/10.1001/archpsyc.1978.01770300115013 PMID: 655775

Spreng, R. N., Mar, R. A., & Kim, A. S. N. (2009). The common neural basis of autobiographical memory, prospection, navigation, theory of mind, and the default mode: A quantitative meta-analysis. Journal of Cognitive Neuroscience, 21(3), 489-510. https://doi.org/10.1162/jocn.2008.21029 PMID: 18510452

Stanley, B., Brown, G. K., Brenner, L. A., Galfalvy, H. C., Currier, G. W., Knox, K. L., Chaudhury, S. R., Bush, A. L., & Green, K. L. (2018). Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry, 75(9), 894-900. https://doi.org/10.1001/jamapsychiatry.2018.1776 PMID: 29998307 · PMCID: PMC6142908

Starr, L. R., & Davila, J. (2008). Excessive reassurance seeking, depression, and interpersonal rejection: A meta-analytic review. Journal of Abnormal Psychology, 117(4), 762-775. https://doi.org/10.1037/a0013866 PMID: 19025224

Stetler, C., & Miller, G. E. (2011). Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Medicine, 73(2), 114-126. https://doi.org/10.1097/PSY.0b013e31820ad12b PMID: 21257974

Stewart, D. E., & Vigod, S. (2016). Postpartum depression. New England Journal of Medicine, 375(22), 2177-2186. https://doi.org/10.1056/NEJMcp1607649 PMID: 27959754

Stockdale, S. E., Lagomasino, I. T., Siddique, J., McGuire, T., & Miranda, J. (2008). Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995-2005. Medical Care, 46(7), 668-677. https://doi.org/10.1097/MLR.0b013e3181789496 PMID: 18580385 · PMCID: PMC3956700

Stone, M. B., Yaseen, Z. S., Miller, B. J., Richardville, K., Kalaria, S. N., & Kirsch, I. (2022). Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: Individual participant data analysis. BMJ, 378, e067606. https://doi.org/10.1136/bmj-2021-067606 PMID: 35918097 · PMCID: PMC9344377

Stringaris, A., Goodman, R., Ferdinando, S., Razdan, V., Muhrer, E., Leibenluft, E., & Brotman, M. A. (2012). The Affective Reactivity Index: A concise irritability scale for clinical and research settings. Journal of Child Psychology and Psychiatry, 53(11), 1109-1117. https://doi.org/10.1111/j.1469-7610.2012.02561.x PMID: 22574736 · PMCID: PMC3484687

Swainson, J., McGirr, A., Blier, P., Brietzke, E., Richard-Devantoy, S., Ravindran, N., Blier, J., Beaulieu, S., Frey, B. N., Kennedy, S. H., McIntyre, R. S., Milev, R. V., Parikh, S. V., Schaffer, A., Taylor, V. H., Tourjman, V., van Ameringen, M., Yatham, L. N., Ravindran, A. V., & Lam, R. W. (2021). The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force recommendations for the use of racemic ketamine in adults with major depressive disorder. The Canadian Journal of Psychiatry, 66(2), 113-125. https://doi.org/10.1177/0706743720970860 PMID: 33174760 · PMCID: PMC7918868

Swannell, S. V., Martin, G. E., Page, A., Hasking, P., & St John, N. J. (2014). Prevalence of nonsuicidal self-injury in nonclinical samples: Systematic review, meta-analysis and meta-regression. Suicide and Life-Threatening Behavior, 44(3), 273-303. https://doi.org/10.1111/sltb.12070 PMID: 24422986

Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013). The vascular depression hypothesis: Mechanisms linking vascular disease with depression. Molecular Psychiatry, 18(9), 963-974. https://doi.org/10.1038/mp.2013.20 PMID: 23439482 · PMCID: PMC3674224

Telles-Correia, D., & Marques, J. G. (2015). Melancholia before the twentieth century: Fear and sorrow or partial insanity? Frontiers in Psychology, 6, 81. https://doi.org/10.3389/fpsyg.2015.00081 PMID: 25691879 · PMCID: PMC4314947

Thapar, A., Eyre, O., Patel, V., & Brent, D. (2022). Depression in young people. The Lancet, 400(10352), 617-631. https://doi.org/10.1016/S0140-6736(22)01012-1 PMID: 35940184

Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews, 35(3), 537-555. https://doi.org/10.1016/j.neubiorev.2010.06.006 PMID: 20603146 · PMCID: PMC3005986

Turner, E. H. (2019). Esketamine for treatment-resistant depression: Seven concerns about efficacy and FDA approval. The Lancet Psychiatry, 6(12), 977-979. https://doi.org/10.1016/S2215-0366(19)30394-3 PMID: 31680014

Uher, R., Payne, J. L., Pavlova, B., & Perlis, R. H. (2014). Major depressive disorder in DSM-5: Implications for clinical practice and research of changes from DSM-IV. Depression and Anxiety, 31(6), 459-471. https://doi.org/10.1002/da.22217 PMID: 24272961

UK ECT Review Group. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: A systematic review and meta-analysis. The Lancet, 361(9360), 799-808. https://doi.org/10.1016/S0140-6736(03)12705-5 PMID: 12642045

Viduani, A., Arenas, D. L., Benetti, S., Wahid, S. S., Kohrt, B. A., & Kieling, C. (2024). Systematic review and meta-synthesis: How is depression experienced by adolescents? A synthesis of the qualitative literature. Journal of the American Academy of Child and Adolescent Psychiatry, 63(10), 970-990. https://doi.org/10.1016/j.jaac.2023.11.013 PMID: 38340896

Wakefield, J. C., & First, M. B. (2012). Validity of the bereavement exclusion to major depression: Does the empirical evidence support the proposal to eliminate the exclusion in DSM-5? World Psychiatry, 11(1), 3-10. https://doi.org/10.1016/j.wpsyc.2012.01.002 PMID: 22294996 · PMCID: PMC3266762

Wakeling, S., Stukas, A. A., Wright, B. J., & Evans, L. (2020). Negative feedback seeking and excessive reassurance seeking behavior and depression: A meta-analytic review. Journal of Social and Clinical Psychology, 39(9), 788-823. https://doi.org/10.1521/jscp.2020.39.9.788

Walker, W. H., II, Walton, J. C., DeVries, A. C., & Nelson, R. J. (2020). Circadian rhythm disruption and mental health. Translational Psychiatry, 10, Article 28. https://doi.org/10.1038/s41398-020-0694-0 PMID: 32066704 · PMCID: PMC7026420

Watkins, E. R. (2008). Constructive and unconstructive repetitive thought. Psychological Bulletin, 134(2), 163-206. https://doi.org/10.1037/0033-2909.134.2.163 PMID: 18298268 · PMCID: PMC2672052

Watkins, E. R., & Roberts, H. (2020). Reflecting on rumination: Consequences, causes, mechanisms and treatment of rumination. Behaviour Research and Therapy, 127, 103573. https://doi.org/10.1016/j.brat.2020.103573 PMID: 32087393

Watkins, E. R., Mullan, E., Wingrove, J., Rimes, K., Steiner, H., Bathurst, N., Eastman, R., & Scott, J. (2011). Rumination-focused cognitive–behavioural therapy for residual depression: Phase II randomised controlled trial. British Journal of Psychiatry, 199(4), 317–322. https://doi.org/10.1192/bjp.bp.110.090282 PMID: 21778171

Watson, R., Harvey, K., McCabe, C., & Reynolds, S. (2020). Understanding anhedonia: A qualitative study exploring loss of interest and pleasure in adolescent depression. European Child & Adolescent Psychiatry, 29(4), 489-499. https://doi.org/10.1007/s00787-019-01364-y PMID: 31270605 · PMCID: PMC7103575

Webb, R., & Ayers, S. (2015). Cognitive biases in processing infant emotion by women with depression, anxiety and post-traumatic stress disorder in pregnancy or after birth: A systematic review. Cognition and Emotion, 29(7), 1278-1294. https://doi.org/10.1080/02699931.2014.977849 PMID: 25472032

Wilkinson, S. T., Ballard, E. D., Bloch, M. H., Mathew, S. J., Murrough, J. W., Feder, A., Sos, P., Wang, G., Zarate, C. A., Jr., & Sanacora, G. (2018). The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. American Journal of Psychiatry, 175(2), 150-158. https://doi.org/10.1176/appi.ajp.2017.17040472 PMID: 28969441 · PMCID: PMC5794524

Williams, D. R., González, H. M., Neighbors, H., Nesse, R., Abelson, J. M., Sweetman, J., & Jackson, J. S. (2007). Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: Results from the National Survey of American Life. Archives of General Psychiatry, 64(3), 305-315. https://doi.org/10.1001/archpsyc.64.3.305 PMID: 17339519

Williams, J. M. G., Barnhofer, T., Crane, C., Hermans, D., Raes, F., Watkins, E., & Dalgleish, T. (2007). Autobiographical memory specificity and emotional disorder. Psychological Bulletin, 133(1), 122-148. https://doi.org/10.1037/0033-2909.133.1.122 PMID: 17201573 · PMCID: PMC2834574

Woody, C. A., Ferrari, A. J., Siskind, D. J., Whiteford, H. A., & Harris, M. G. (2017). A systematic review and meta-regression of the prevalence and incidence of perinatal depression. Journal of Affective Disorders, 219, 86-92. https://doi.org/10.1016/j.jad.2017.05.003 PMID: 28531848

World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (CDDR). World Health Organization. https://www.who.int/publications/i/item/9789240077263

Yan, C.-G., Chen, X., Li, L., Castellanos, F. X., Bai, T.-J., Bo, Q.-J., Cao, J., Chen, G.-M., Chen, N.-X., Chen, W., Cheng, C., Cheng, Y.-Q., Cui, X.-L., Duan, J., Fang, Y.-R., Gong, Q.-Y., Guo, W.-B., Hou, Z.-H., Hu, L., ... Zang, Y.-F. (2019). Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proceedings of the National Academy of Sciences, 116(18), 9078-9083. https://doi.org/10.1073/pnas.1900390116 PMID: 30979801 · PMCID: PMC6500168

Zalsman, G., Hawton, K., Wasserman, D., van Heeringen, K., Arensman, E., Sarchiapone, M., Carli, V., Höschl, C., Barzilay, R., Balazs, J., Purebl, G., Kahn, J. P., Sáiz, P. A., Lipsicas, C. B., Bobes, J., Cozman, D., Hegerl, U., & Zohar, J. (2016). Suicide prevention strategies revisited: 10-year systematic review. The Lancet Psychiatry, 3(7), 646-659. https://doi.org/10.1016/S2215-0366(16)30030-X PMID: 27289303

Zaninotto, L., Guglielmo, R., Calati, R., Ioime, L., Camardese, G., Janiri, L., Bria, P., & Serretti, A. (2015). Cognitive markers of psychotic unipolar depression: A meta-analytic study. Journal of Affective Disorders, 174, 580-588. https://doi.org/10.1016/j.jad.2014.11.027 PMID: 25560194

Zaninotto, L., Solmi, M., Veronese, N., Guglielmo, R., Ioime, L., Camardese, G., & Serretti, A. (2016). A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. Journal of Affective Disorders, 201, 15-24. https://doi.org/10.1016/j.jad.2016.04.039 PMID: 27156095

Zanos, P., & Gould, T. D. (2018). Mechanisms of ketamine action as an antidepressant. Molecular Psychiatry, 23(4), 801-811. https://doi.org/10.1038/mp.2017.255 PMID: 29532791 · PMCID: PMC5999402

Zarate, C. A., Jr., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856-864. https://doi.org/10.1001/archpsyc.63.8.856 PMID: 16894061

Zhu, X., Wang, X., Xiao, J., Liao, J., Zhong, M., Wang, W., & Yao, S. (2012). Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biological Psychiatry, 71(7), 611-617. https://doi.org/10.1016/j.biopsych.2011.10.035 PMID: 22177602

Zimmerman, M., Martin, J., McGonigal, P., Harris, L., Kerr, S., Balling, C., Kiefer, R., Stanton, K., & Dalrymple, K. (2019). Validity of the DSM-5 anxious distress specifier for major depressive disorder. Depression and Anxiety, 36(1), 31-38. https://doi.org/10.1002/da.22837 PMID: 30311733

Zisook, S., Corruble, E., Duan, N., Iglewicz, A., Karam, E. G., Lanouette, N., Lebowitz, B., Pies, R., Reynolds, C., Seay, K., Shear, M. K., Simon, N., & Young, I. T. (2012). The bereavement exclusion and DSM-5. Depression and Anxiety, 29(5), 425-443. https://doi.org/10.1002/da.21927 PMID: 22495967

Østergaard, S. D., Meyers, B. S., Flint, A. J., Mulsant, B. H., Whyte, E. M., Ulbricht, C. M., Bech, P., & Rothschild, A. J., on behalf of the STOP-PD Study Group. (2014). Measuring treatment response in psychotic depression: The Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account. Journal of Affective Disorders, 160, 68-73. https://doi.org/10.1016/j.jad.2013.12.020 PMID: 24439830 · PMCID: PMC3981944

Łojko, D., & Rybakowski, J. K. (2017). Atypical depression: Current perspectives. Neuropsychiatric Disease and Treatment, 13, 2447-2456. https://doi.org/10.2147/NDT.S147317 PMID: 29033570 · PMCID: PMC5614762